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TR-223 Carcinogenesis Studies of
Eugenol (CAS No. 97-53-0) in F344/N Rats
andB6C3F1 Mice (Feed Studies)
Carcinogenesis studies of eugenol (>99% pure), a
widely used flavor additive and chemical intermediate,
were conducted by feeding diets containing 6,000 or
12,500ppmofeugenoltogroupsof50femaleF344/Nrats
and by feeding diets containing 3,000 or 6,000 ppm to
groups of50 male F344/N rats and B6C3F1 mice ofeach
sex for 103 weeks. Groups of40 rats and 50 mice ofeach
sex served as controls. Dose levels selected for the two
year studies were based on thirteen-week (91-day) stud-
ies in which dietary concentrations for the six groups
ranged from 0 to 12,500 ppm. Other than a -10% dif-
ference from controls in bodyweights in the 12,500 ppm
male rats, no chemicallyrelated gross or histopathologic
effects were observed.
In the two-year studies,with the exception ofthe high
dose female rats and female mice, final body weights of
the treated groups were comparable to their respective
controls. No significant differences in survival were
apparent for any of the eight groups receiving eugenol
and for the appropriate controls. Food consumption
among groups was not different in comparison with
controls - rats: males .97%,females >91%;mice: males
.94%,females>90%.
There were no significant observable differences
between treated and control groups of rats for either
nonneoplastic (toxic) lesions or neoplasms that could be
attributed to eugenol. Increases in tumor incidences
were diagnosed for low dose male rats with alveolar,
bronchiolar adenomas or carcinomas (combined), for
C-cell adenomas ofthe thyroid gland in low dose female
rats, and forendometrial stromal polyps ofthe uterus in
high dose female rats. Fibroadenomas ofthe mammary
gland were decreased in dosed groups of female rats
compared with controls. None ofthese differences were
considered tobe associatedwith the dietaryadministra-
tion ofeugenol.
In male mice, the low dose animals had an increased
incidence(P<0.05)ofbothhepatocellularadenomas(con-
trol, 4/50; low dose, 13/50; high dose, 10/49) and
hepatocellular carcinomas (10/50, 20/50, 9/49) when com-
pared with control animals. A significant increase in
hepatic neoplasms was not observed in high dose ani-
mals. No single liver tumor type was observed in female
mice with a statistically significant increased incidence.
When the incidences offemale mice with hepatocellular
adenoma or carcinoma were combined (2/50, 7/49, 9/49),
therewas adose-related positivetrend andtheincidence
ofliver neoplasms in high dose animals was higher than
incontrols (P<0.05).
Eugenol was given in the diets offemale F344/N rats
(0, 0.6, or 1.25%) and ofmale F344/N rats and male and
female B6C3F1 mice (0, 0.3, or 0.6%) for 103 weeks.
Under these experimental conditions, there was no evi-
dence ofcarcinogenicity observed for male or female
rats. For mice there was equivocal evidence of car-
cinogenicity since eugenol caused increased incidences
of both carcinomas and adenomas of the liver in male
mice at the 3,000 ppm dietary level and because eugenol
was associated with an increase in the combined inci-
dences of hepatocellular carcinomas or adenomas in
female mice.
Synonym: 1-allyl-3-methoxy-4-hydroxybenzene
Report Date: December 1983
TR-224 Carcinogenesis Bioassay of Tara
Gum (CAS No. 39300-88-4) in F344 Rats
and B6C3F1 Mice (Feed Study)
A carcinogenesis bioassay of tara gum, a potential
stabilizer for cosmetics and foods, was conducted by
feeding diets containing 25,000 or 50,000 ppm ofthe test
substance to 50 F344 rats and 50 B6C3F1 mice ofeither
sexfor103weeks.Groupsof50untreatedratsandmiceof
either sex served as controls.
In the chronic bioassay, mean body weights of dosed
and control rats ofeither sex were comparable over the
course ofthe study. Feed consumption by low- and high-
dosemaleratswas92%and95%thatofthecontrols, and
feed consumption bylow- and high-dose female rats was
87% and 79% that ofthe controls. Mean bodyweights of
high-dose mice of either sex were lower than those of
controls; feed consumption by dosed mice was compar-
able with that of controls. Although the rats and mice
mighthavebeenabletotoleratehigherdoses,50,000ppm
(5%) is the recommended maximum concentration of a
testsubstance mixed infeed, according to the guidelines
ofthe Bioassay Program.
No tumorswere observed in increased incidences that
were considered to be related to administration of tara
gumtoeitherspecies. Interstitialcelltumorsofthetestis
inmaleratswereobservedinastatisticallysignificant(P
< 0.003 for trend and group comparisons) positive
relationship (40/48 controls; 46/46 low dose; 48/48 high
dose); because these tumors are present in almost all
agedF344maleratsandbecauseofthemarginalstatisti-
calsignificancewhentime-adjustedanalyses areapplied,
theseincreases are notregarded asbeingrelated to tara
gum administration.
Asignificant (P<0.05) negativetrendwas observed in
the proportion of male rats with pancreatic islet cell
adenoma (5/45 controls, 1/44 lowdose, 0/45 high dose), of
female mice with alveolar/bronchiolar adenomas (7/50,
2/49, 2/50), and of female mice with hepatocellular ade-
nomas (9/49, 4/49,1/50).
Under the conditions of this bioassay, tara gum was
not carcinogenic for F344 rats or B6C3F1 mice ofeither
sex.
Report Date: March 1982ABSTRACTS FROMLONG-TERMCANCER STUDIES, 1976-1992
TR-225 Carcinogenesis Bioassay ofD &
C Red No. 9 (CAS No. 5160-02-1) in F344
Rats and B6C3F1 Mice (Feed Study)
A carcinogenesis bioassay of D & C Red No. 9, a
pigment used in topical drugs and cosmetics, was con-
ducted by feeding diets containing 1,000 or 3,000 ppm of
thetestsubstance (89.8% pure)togroups of50F344rats
ofeither sex for 103 weeks. Similar groups of50 B6C3F1
mice received diets containing 1,000 or 2,000 ppm ofthe
testsubstancefor103weeks.Groups of50untreatedrats
and mice ofeither sex served as controls.
In a 13-week subchronic study, the spleens of most
dosed ratswereenlarged andpigment (unidentified)was
presentintherenaltubularepithelium. Lymphoreticular
hyperplasiaofthymiclymphnodeswasfoundin 75-100%
offemales receiving 6,000-50,000 ppm D & C Red No. 9
and in 70-100% ofmale rats receiving 3,000-25,000 ppm.
Hemosiderosis oftheliverwas observed atthehigh-dose
levels in male and female rats. Mice receiving 1,250 ppm
ormore D &C RedNo.9hadcongestion ofthespleenand
hemosiderin deposits. Thus,the selection ofdosesforthe
chronic study was based on the appearance of hemo-
siderosis and the incidences and severity of splenic
lesions observed in the 91-day subchronic study.
In the chronic study, meanbodyweights ofdosed rats
of either sex and of male mice were comparable with
thoseofcontrols.Afterweek50,themeanbodyweightof
high-dose female mice was lower than that of the con-
trols. No compound-related effects on survival orclinical
signs were observed for rats or mice ofeither sex. With
the possible exception of female mice, all other dosed
groups ofrats ormicemighthavetolerated higherdoses,
thus a clear maximum tolerated dose may not have been
utilized in this study.
Splenic sarcomas (0/50, 0/50,26/48; P<0.001) and neo-
plastic nodules oftheliver(0/50,6/50,7/49; P<0.01)were
observed in high-dose male rats at incidences signifi-
cantly higher than those in the controls. Incidences of
neoplastic nodules inthe livers (1/50,1150, 5/50) offemale
rats showed a statistically signiflcant (P<0.05) trend.
Nonneoplastic splenic lesions were also observed in
dosed male and female rats.
Lymphocytic leukemia was observed in dosed male
(10/50, 2/50, 2/50) and female (10/50, 2/50, 1150) rats at
statistically significant (P<0.05) decreased incidences,
compared with controls. Adenomas or carcinomas ofthe
preputial gland in male rats (7/50, 2/50, 0/50) occurred
with astatisticallysignificant (P<0.01)negativerelation-
ship to dose of D & C Red No. 9 (P=0.007).
Underthe conditions ofthisbioassay, D & C Red No.9
was carcinogenic for male F344 rats causing an
increasedincidence ofsarcomas ofthespleenand adose-
related increase in neoplastic nodules ofthe liver. D & C
Red No. 9 was not considered to be carcinogenic to
female F344 rats, although the increased incidence of
neoplastic nodules ofthe liver may have been associated
withadministration ofthetestchemical. D & CRedNo.9
was not carcinogenic for B6C3F1 mice ofeither sex.
Synonyms: 5-chloro-2-[(2-hydroxy-1-naphthalenyl)
azo]-4-methylbenzene sulfonicacid,bariumsalt; C.I.Pig-
ment Red; C.I. Pigment Red 53:1; C.I. Pigment Red,
barium salt
Report date: May 1982
TR-226 Carcinogenesis Bioassay of C.I.
Solvent Yellow 14 (CAS No. 842-07-9) in
F344/N Rats andB6C3F1 Mice (Feed Study)
A carcinogenesis bioassay of C.I. Solvent Yellow 14
(94.1% pure), awidelyused monoazo dye, was conducted
byfeedingdietscontaining250or500ppmofC.I. Solvent
Yellow 14 to groups of50 F344 rats ofeither sex for 103
weeks. Similar groups of50 B6C3F1 mice received diets
containing 500 or 1,000 ppm ofC.I. SolventYellow 14 for
103weeks. Groupsof50untreatedratsandmiceofeither
sex served as controls.
Throughout thebioassay, meanbodyweights ofdosed
rats and mice were slightlylower than those ofcontrols.
No compound-related clinical signs oreffects on survival
were observed.
Increases in nonneoplastic lesions included cardiac
valve fibrosis for male and female rats, lymphoid hyper-
plasia ofthe lung for male rats, and for female rats, bile
duct hyperplasia, focal atrophy ofthe pancreatic acinus,
and nephropathy. None ofthese effectswere observed in
mice.
Neoplastic nodules of the liver occurred in rats of
either sexwith a dose-related trend that was significant
(male, P<0.001; female, P=0.005), and the incidences in
the high-dose groups were significantly higher than
those inthe controls (male: control, 5/50; low-dose, 10/50;
high-dose, 30/50, P<0.001 and female: control, 2/50; low-
dose, 3/49; high-dose, 10/48, P=0.011).
Lymphomas orleukemias occurred in low-dose female
mice at an incidence significantly (P<0.05) higher than
that in the controls (12/50, 23/50, 17/50). Because of the
lack ofa dose-related trend and because the incidence in
the high-dose group was not significant, the association
betweentheincreasedincidence ofhematopoietictumors
in the low-dose group and the administration of C.I.
SolventYellow14is notclearlyestablished. Theincidence
oflymphomas orleukemias inmalemicewas higher(not
statistically significant) than that in the corresponding
controls (5/49, 10/50, 10/50); in both low- and high-dose
rats of either sex the incidence was significantly
(P<0.001) lowerthan thatin controls.
Under the conditions of this bioassay, C.I. Solvent
Yellow 14 was carcinogenic in male and female F344/N
rats, as evidenced by increased incidences of neoplastic
nodules of the liver. C.I. Solvent Yellow 14 was not
carcinogenic for B6C3F1 mice ofeither sex.
Synonym: 1-(phenylazo)-2-naphthol
Report Date: September 1982
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TR-227 Carcinogenesis Bioassay ofGum
Arabic (CAS No. 9000-01-5) in F344 Rats
and B6C3F1 Mice (Feed Study)
A carcinogenesis bioassay of gum arabic (81-86%
pure), a widely used food stabilizer, was conducted by
feeding diets containing 25,000 or50,000 ppm ofthe test
substance to 50 F344 rats and 50 B6C3F1 mice ofeach
sex for 103 weeks. Groups ofuntreated rats and mice of
each sex served as controls.
Throughout most ofthe study, mean body weights of
dosed male and female mice and ofdosed male ratswere
comparable with those of the controls; mean body
weights ofthedosedfemaleratswere slightlylowerthan
those ofthe controls. No othercompound-related clinical
signs or effects on survival were observed. Mean daily
feed consumption by high-dose rats and mice of either
sex was 85% to 94% that ofthe controls. The high dose
(50,000 ppm) used in this bioassay is the maximum
concentration (5%) currently used in feed studies.
Statistically significant (P<0.05) increasing trends
were observed for the number of female mice with
hepatocellular carcinomas (1/49, 2/50, 6/50), and with
total liver tumors (4/49, 2/50, 10/50). No statistically
significant differences were obtained when comparing
the control rates with those observed in the treated
groups. These observations were not considered to be
clearlyassociatedwiththedietaryadministrationofgum
arabic. Thus, no compound-related neoplastic or non-
neoplasticlesionswerefoundinrats ormiceofeithersex.
Underthe conditions ofthisbioassay, gum arabicwas not
carcinogenic for F344 rats or B6C3F1 mice ofeither sex
Synonym: gum acacia
Report Date: May 1982
TR-228 Carcinogenesis Bioassay of
Vinylidene Chloride (CAS: 75-35-4) in F344
Rats and B6C3F1 Mice (Gavage Study)
A subchronic and a chronic carcinogenesis study of
vinylidene chloride (99% pure), a widely used chemical
intermediate and monomer, were conducted in F344/N
rats and B6C3F1/N mice. In subchronic studies, groups
of 10 rats and 10 mice of either sex were administered
vinylidene chloride in corn oil by gavage five times per
week at 0, 5,15, 50,100, or250 mg/kgbodyweight for 13
weeks. At the end of this study, representative tissues
from these animals were subjected to histopathological
examination. The liver was identified as a target organ
for vinylidene chloride toxicity.
In the 104-week chronic exposure study, conducted
primarilyto determinepossible carcinogenicpotentialof
vinylidene chloride bythe oral route, 50 F344/N rats and
50 B6C3F1/N mice of either sex were gavaged with
vinylidene chloride suspended in corn oil atdose levels of
1 or5mg/kg(rats) and 2 or10mg/kg(mice). Groups of50
rats and 50 mice ofeither sexreceived corn oil alone and
served as vehicle controls.
Throughout most ofthe study, mean body weights of
the dosed rats of either sex and high-dose female mice
were slightly lower than those of the controls. The
absence ofcompound-related effects on survival or clini-
cal signs suggests that the rats and mice of either sex
could have tolerated higher doses. While no significant
differences in survival were observed for any group of
rats,12controland10low-dosemaleswerekilledacciden-
tally during week 82; this may have compromised the
sensitivity ofthe male rats study.
The results ofhistopathological examination indicated
an increased incidence of necrosis of the liver in high-
dose male and low-dose female mice and chronic renal
inflammation in high-dose rats ofeither sex.
The only observed significant (P>0.05) increase in
tumor incidence occurred in low-dose female mice: lym-
phoma(2/48, 9/49,6/50) and lymphomaorleukemia(7/48,
15/49, 7/50). These increases were not considered to be
related to vinylidene chloride administration because
similar effects were not found in the high-dose female
mice or in male mice or rats.
Underthe conditions ofthis bioassay, vinylidene chlo-
ride administered by gavage was not carcinogenic for
F344/N rats or B6C3F1/N mice of either sex. However,
since the use ofa maximum tolerated dose in this study
has not been clearly demonstrated and since previously
reportedstudieshaveshownthatcarcinogenicityisasso-
ciated with inhalation exposure to vinylidene chloride,
this studyshould notbe taken asproofthatthe chemical
is not a carcinogen.
Report Date: May 1982
Synonyms: 1,1-dichloroethylene; VDC; 1,1-DCE
TR-229 Carcinogenesis Bioassay ofGuar
Gum (CAS No. 9000-30-0) in F344 Rats and
B6C3F1 Mice (Feed Study)
A carcinogenesis bioassay ofguar gum, awidelyused
foodstabilizer,wasconductedbyfeedingdietscontaining
25,000 or 50,000 ppm of the test substance from two
batches having purities of 83.5% and 91.9% to 50 F344
rats and 50 B6C3F1 mice of either sex for 103 weeks.
Groupsof50untreated ratsandmice ofeithersexserved
as controls. The rodents might have tolerated higher
doses but 50,000 ppm (5% ofdiet) is the upper limit for
chronic feeding studies in the Bioassay Program, and
this level represented the maximum tolerated dose
(MTD) for females ofboth species in the present study.
After week 20 in mice and week 40 in rats, mean body
weights ofhigh-dose femaleswerelowerthan those ofthe
untreated controls. No compound-related clinical signs or
adverse effects on survival were observed. Feed consump-
tion by dosed rats and dosed mice ofeither sex was lower
than that ofthe controls. There wereincreased incidences
ofadenomasofthepituitary(8/45,18%controls;17/46,37%
low dose; 17/43, 40%o high dose) in male rats and phe-
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ochromocytomas ofthe adrenal (0/50, o; 5/50, 10%; 6/50,
12%) in female rats, butthese differences (P<0.035) were
considered to be unrelated to administration ofguargum.
When pituitary adenomas or carcinomas and when phe-
ochromocytomas or malignant pheochromocytomas are
combined, the statistical differences disappear.
Hepatocellular carcinomas (15/44, 34%; 6/50, 12%;
6/49, 12%) occurred in treated male mice at incidences
significantly(PK 0.011) lower than that in controls. The
combined incidence ofmalemicewitheitherhepatocellu-
laradenomasorcarcinomas (16/44,36%; 12/50,24%; 7/49,
14%) was also significantly (P=0.013) lower in the high-
dose group.
Under the conditions of this bioassay, guar gum was
not carcinogenic for F344 rats or B6C3F1 mice ofeither
sex.
Report Date: March 1982
TR-230 Carcinogenesis Bioassay ofAgar
(CAS No. 9002-18-0) in F344 Rats and
B6C3F1 Mice (Feed Study)
A carcinogenesis bioassay of agar isolated from
Pterocladia, a gelling agent used in foods and phar-
maceuticals, was conducted on groups of 50 F344 rats
and 50 B6C3F1 mice of either sex which were fed diets
containing25,000 or50,000 ppmofthetestsubstance for
103weeks. Groupsof50untreatedrats andmiceofeither
sex served as controls.
Mean body weights of dosed and control male rats
were comparable throughout the study. After week 80,
mean body weights of dosed female rats were slightly
lower than those ofthe controls. Mean body weights of
dosed and control male mice were comparable through-
out the study. The mean body weights of dosed female
micewerelowerthanthoseofthecontrols atweek20and
remained lower throughout the study. No compound-
related effects on survival, feed consumption, clinical
signs of toxicity, or tumor incidence were observed.
Although therats ofeithersexandmalemicemighthave
been able to tolerate higher doses, 50,000 ppm was the
administered high-dose level since that is the maximum
concentration ofatestsubstanceinfeedrecommendedin
the guidelines ofthe Bioassay Program.
A statistically significant trend (P = 0.015) was
observed for the increased incidence of cortical ade-
nomas ofthe adrenalgland (control, 0/50; low-dose, 0/50;
high-dose, 4/50) in female rats; the difference between
controlandhigh-dosegroupswasnotsignificant. Inmale
mice the incidence of hepatocellular adenomas (control,
0/49; low-dose, 3/50; high-dose, 7/50) was significantly
(P=0.007) increased in the high-dose group when com-
pared with controls; likewise, the overall trend was
significant (P=0.005). Theincidence oftotallivertumors
(control, 9/49; low-dose, 8/50; high-dose, 13/50) did not
differ significantly among the groups. Neither of these
increases (in cortical adenomas or in liver tumors) was
considered to be compound related.
Undertheconditions ofthisbioassay, theagarisolated
fromPterocladia was not carcinogenic for F344 rats or
B6C3F1 mice ofeither sex.
Report Date: March 1982
TR-231 Carcinogenesis Bioassay of
Stannous Chloride (CAS No. 7772-99-8) in
F344/N Rats and B6C3F1/N Mice (Feed
Study)
Stannous chloride is an inorganic tin compound used
as a food preservative, a stabilizer for colors, perfumes,
andsoaps, andasareducingagentintinplating. Itisalso
used as amordantinprinting, asilveringagentforglass
and plastics, a catalyst for curing phenolic resins, an
additivetodrillingmuds,andanantisludgeagentforoils.
The chronic phase of a carcinogenesis bioassay for
stannous chloride was conducted by feeding diets con-
taining1,000 or2,000ppmstannouschloride to groups of
50F344/Nratsand50B6C3F1/Nmiceofeach sexfor105
weeks. Similar groups ofuntreated rats and mice served
as controls.
In this study, the concentrations oftininbone, kidney,
and liver were no higher than those attained in other
lifetime studies utilizing 11100 of the dose, suggesting
that organ accumulation oftin was not dose dependent,
but probably limited by absorption.
Meanbodyweightgainandfeedconsumption ofdosed
and control rats and mice were comparable. Survival of
high-dosemaleratswas somewhatlowerthanthatofthe
control and low-dose groups (37/50, control; 39/50, low-
dose;30/50,high-dose). Survivalofcontrolmalemicewas
less (P<0.05) than that of either dosed group (32/50,
42/50, 45/50); survival ofthe female mice appeared to be
dose related (38/50, 33/50, 28/50).
C-cell adenomas ofthe thyroid (2/50,9/49,5/50), C-cell
adenomasorcarcinomascombined(2/50,13/49,8/50), and
adenomas ofthe lung (0/50, 0/50, 3/50) in male rats; and
hepatocellular carcinomas or adenomas combined (3/49,
4/49, 8/49) and histiocytic malignant lymphomas (0/50,
0/49, 4/49) in female mice occurred with significant
(P<0.05) positive trends and/or with significantly
(P<0.05) increased incidences in the dosed groupswhen
compared with the paired controls. However, when the
lung adenomas in male rats are combined with lung
carcinomas and when all lymphomas in female mice are
considered, no statistical significance remains. For the
thyroid C-cell tumors in male rats and for the liver
tumors in female mice, the incidences in the high-dose
groups were not significantly different from the histor-
ical control rates at that laboratory (C-cell tumors:
32/288,11.1%; livertumors: 24/297,8%). Whenthe histor-
icalcontrolrateisusedasabasisforcomparison,thelow-
dose incidence ofthyroid C-cell tumors remains signifl-
cant(P<0.01).
Under the conditions of this bioassay, stannous chlo-
ridewasjudged nottobecarcinogenicformaleorfemale
F344/N rats or B6C3F1/N mice, although C-cell tumors
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ofthe thyroid gland in male rats may have been associ-
ated with the administration ofthe test chemical.
Report Date: June 1982
TR-232 Carcinogenesis Studies of
Pentachloroethane (CAS: 76-01-7) in F344/
N Rats and B6C3F1 Mice (Gavage Study)
A carcinogenesis bioassay of technical grade pen-
tachloroethane (95.5% pure, with 4.2% hexachloro-
ethane) was conducted by administering the test chemi-
cal in corn oil by gavage to groups of 50 male and 50
female F344/ N rats at doses of 75 or 150 mg/ kg body
weight and to groups of50 male and 50 female B6C3F1
mice atdosesof250 or500mg/kg. (Pentachloroethaneis
a solvent that was used primarily as an intermediate in
the manufacture of tetrachloroethylene.) Doses were
administered for103weeks for rats and 41-103 weeks for
mice. Groups of50 rats and 50 mice ofeach sex received
corn oil by gavage on the same dosing schedule and
served as vehicle controls. Prechronic testing (single-
dose and 14-day and 13-week repeated-dose studies) did
notindicate target organ toxicityforpentachloroethane.
The dosage levels for the 2-year study were selected on
the basis of survival and body weight gains during the
prechronic test phase.
Survivalofhigh-dose ratsofeach sexwassignificantly
(P<0.05) less than that of the controls. Mean body
weights of dosed male and female rats were lower than
those of the corresponding controls during the second
yearofthe study. Final meanbodyweights forratswere
4%-5% lower for male rats and 8%-12% lower for female
rats when compared to controls.
Chronic, diffuse inflammation of the kidney, dis-
tinguishable from nephropathy seen in aging F344/ N
rats,wasfoundinmaleratsinasignificant(P<0.001)and
dose-relatedincidence (control,4/50,8%; low-dose,14/49,
29%; high-dose, 33/50, 66%). Mineralization ofthe renal
papilla, considered to be secondary to chronic inflamma-
tion, was also observed at increased incidences in dosed
male rats.
Pentachloroethane administration did not cause any
increased incidences oftumors in either male or female
rats. [See Note Added Subsequent to Peer Review.]
Statistically significant negative trends were detected
for subcutaneous tissue fibromas among males and for
pituitary adenomas in both sexes.
Forty-two high-dose male mice died by week 41, and
the 8 remaining animals in the group were killed at that
time. Twenty-five male control mice were killed at week
44 to serve as controls for the high-dose males. Only
22/50(44%)ofthelow-dosemalemicesurvivedtotheend
of the study. All high-dose female mice were dead by
week 74, and only 9/50 (18%) low-dose females survived
to the end ofthe study. Meanbodyweights ofmice were
lower than those ofcontrols.
The incidence ofhepatocellular carcinomawas signifi-
cantly elevated in all groups of dosed mice (male: 4/48,
8%; 26/44, 59%, P<0.001; 7/45,16%; female: 1146, 2%;
28/42, 67%, P<0.001;13/45, 29% P<0.001). Early mor-
talities in the high-dose male mice precluded an evalua-
tion of their lifetime incidence of hepatocellular
carcinoma. There was a significant increase in incidence
over that observed among 25 controls killed at week 44
(0/25 versus 7/45, P<0.05). There was also a significant
(P<0.001) dose-related increase in hepatocellular ade-
noma in female mice (2/46, 4%; 8/42,19%; 19/45, 42%).
Under the conditions ofthis bioassay, technical grade
pentachloroethane containing 4.2% hexachloroethane (a
known carcinogeninmice)wasnotcarcinogenicinF344/
N rats. The decreased survival ofdosed rats might have
reduced the sensitivity for a carcinogenic response in
this species. Pentachloroethane was nephrotoxic to male
rats. Technical grade pentachloroethane was car-
cinogenic for B6C3F1 mice, causing hepatocellular car-
cinomas in males and females, and adenomas in females.
NOTE ADDED SUBSEQUENT TO PEER REVIEW
After the Peer Review Panel meeting in June 1981, the
NationalToxicologyProgramdeterminedthatthekidney
(especially in male F344/N rats) was a target organ for
the short-chain chlorinated aliphatic hydrocarbons. This
awareness came from the nonneoplastic and neoplastic
diagnoses made on related chemicals in this class.
Alertedtothislead,theNTPre-examinedtheoriginally-
prepared histology slides on the rat kidney from the
pentachloroethane bioassay. During the re-reading,
additional renal tubular adenomas were discovered.
Unfortunately, these slides were lost after they arrived
at the Gulf South Research Institute laboratory; by
necessity, a new set ofslides was prepared.
In the second set of slides, three additional renal
tubular-cell adenomaswere discovered: onein alow-dose
male and two in high-dose males; none were found in
treated females or in male and female vehicle controls.
Thus, rare tubular-cell adenomas ofthe kidney occurred
in male rats with a dose-related trend (P<0.05), and the
incidenceinthehigh-dosegroupwassuggestive(P<0.06;
0/50, 1/49, 4/50). Additionally, one control and one low-
dose male each had an adenocarcinoma and anotherlow-
dose male had a carcinoma ofthe kidney (not otherwise
specified); combining tubular-cell tumors reduced the
statistical differences (1/50,2/49,4/50). These tumors are
uncommon in male vehicle controls in the bioassay pro-
gram, occurring in 1/293 (0.3%) at this bioassay testing
laboratory and in 4/998 (0.4%) in all NCI/ NTP bioassay
testing laboratories. All tumors in these gavage controls
were adenocarcinomas. The National Toxicology Pro-
gram considersthattheseraretubular-celltumorsofthe
kidneyinmale ratsindicate atargetorgan andmayhave
been associated with the administration of pen-
tachloroethane. These additional tumor diagnoses were
not presented to the Peer Review Panel. These are,
however, the incidence rates recorded and analyzed sta-
tistically in this technical report (See Table 5, Table Al,
and TableA3 in the full document).
Report Date: April 1983
Synonyms: pentalin
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TR-233 Carcinogenesis Bioassay of
2-Biphenylamine Hydrochloride (CAS No.
2185-92-4) in F344/N Rats and B6C3F1 Mice
(FeedStudy)
2-Biphenylamine (2-aminobiphenyl) is a chemical
intermediateusedinthemanufacture ofC.I.Acid Red15.
It is present as a contaminant in 4-biphenylamine (a
rubber antioxidant) and in diphenylamine (a dye inter-
mediate, stabilizer for nitrocellulose explosives, and a
topical agent for prevention ofscrewworm infestation in
animals).
Single-dose, 14-day, and 13-week studies were con-
ducted using technical-grade 2-biphenylamine (2-
aminobiphenyl) containingupto2.5%ofthecarcinogenic
contaminant, 4-biphenylamine. When the contamination
was recognized, analytical development was begun to
purify the material. The salt, 2-biphenylamine hydro-
chloride, was prepared to obtain a more pure test prod-
uct, which contained 0.006%-0.049% 4-biphenylamine.
The prechronic tests were completed by the time
purification was accomplished, so data from a second 14-
daystudywith2-biphenylaminehydrochloridewereused
to help set dose levels for the chronic study.
The results ofthe comparative 14-day studies showed
that technical-grade 2-biphenylamine was more toxic to
mice than rats than 2-biphenylamine hydrochloride as
evidenced by greater incidence of splenomegaly and
greater weight gain depression.
The technical-grade 2-biphenylamine caused a dose-
related decreaseinhemoglobin concentration andadose-
related increase in leucocyte count in male and female
mice in the 13-week study. Hemosiderosis, congestion,
and extramedullary hematopoiesis were present in the
spleens ofnearly all rats receiving 3,000 ppm or more of
the chemical, and in nearly all mice with 1,000 ppm or
more 2-biphenylamine in their diets.
The chronic study was conducted with the purified
2-biphenylamine hydrochloride byfeeding diets contain-
ing1,000 or3,000ppm2-biphenylamine hydrochloride to
groups of49 or 50 F344/N rats and 50 B6C3F1 mice of
each sex for 103 weeks. Groups of50 rats and 50 mice of
each sex served as controls. Survival ofdosed male and
female rats and dosed female mice was comparable with
thatofthe corresponding controls. Survival ofhigh-dose
male mice was significantly (P<0.010) less than that of
low-dose and control male mice.
There were little or no differences in body weight
changes for rats or mice between dosed and control
groups, although there was a slight decrease in body
weight gain at the end of the study for high-dose male
(-11%) and female (-8%) rats.
Inflammatorycells andinterstitial fibrosis were found
in increased incidence in the kidneys ofdosed male rats
as compared with controls and were considered to be
compound related. In addition to the increase in renal
inflammation and fibrosis, dosed male rats had more
focal cellular changes of the liver than did the controls.
There were no increased or decreased incidences of
tumors in rats that could be associated with chemical
administration.
Myelomonocytic leukemia in male rats (control, 14/50;
low-dose, 1150; high-dose, 4/50) and fibroadenomas of
the mammary gland in female rats (22/50, 10/49, 9/50)
occurred with significantly (P<0.03) decreasing trends
andtheincidencesinthe dosed groupsweresignificantly
(P<0.02) lower than that in the controls. There were no
increased or decreased incidences oftumors in rats that
could be associated with chemical administration.
Hemangiosarcomas from all sites occurred in female
mice with a statistically significant (P.- 0.002) positive
trend.Theobservedincidenceofhemangiosarcomaswas
0/49, 1/50, and 7/50 in the control, low-dose, and high-
dose groups, respectively. The incidence in the high-
dose group was significantly (P<0.01) higher than that
in controls. The conclusion that this was due to
2-biphenylamine rather than the contaminant, 4-
biphenylamine, is supported by the absence of urinary
bladder tumors, which are common to 4-biphenylamine.
Hemangiosarcomas also occurred in male micewith a
statistically significant positive trend (P=0.040 by a life
tabletest),withincidences of0/50,2/50, and3/50. Noneof
the pairwise comparisons were statistically different.
The development of hemangiosarcomas may have been
curtailed in the high-dose group ofmale mice, since only
21/50 survived until the termination of the study. The
hemangiosarcomas found in female mice are uncommon
with only 6/816 (0.7%) previously seen in controls at the
samelaboratory.Therateforcontrolmalemiceisequally
low: 7/803 (0.9%).
Alveolar/bronchiolar adenomas ofthelungoccurred at
asignificantly (P<0.01) decreased rateinmalemicewith
an incidence in dose groups lower (P<0.05) than that in
controls.
Under the conditions ofthe bioassay, 2-biphenylamine
hydrochloride was not carcinogenic for F344/N rats of
either sex. 2-Biphenylamine hydrochloride was carcino-
genic for B6C3F1 female mice, inducing hemangio-
sarcomasatvarioussites.Theevidenceforanassociation
between the administration of 2-biphenylamine hydro-
chloride and the increased incidence of hemangio-
sarcomas in male mice was equivocal.
Report Date: October 1982
TR-234 Carcinogenesis Bioassay ofAllyl
Isothiocyanate (CAS No. 57-06-7) in F344/N
Rats and B6C3F1 Mice (Gavage Study)
A 2-year carcinogenesis bioassay of food-grade allyl
isothiocyanate (greater than 93% purity), a flavoring
agent, was conducted by administering 12 or 25 mg/kg
allyl isothiocyanate in corn oil five times per week by
gavage to groups of50 F344/N rats and 50 B6C3F1 mice
ofeach sexfor103weeks.Groupsof50rats and50miceof
each sex received corn oil alone and served as vehicle
controls.
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A single-dose study, a 14-day study, and a 13-week
study were performed before the chronic study was
conducted. Pathologic findings seen in the 14-day study
at 50 mg/kgincluded athickened mucosal surface ofthe
stomachinratsandmiceandathickenedurinarybladder
wall in male mice. No gross or microscopic lesions were
seen atthe highest dose level (25 mg/kg) in the 13-week
study.
In the chronicstudy, survival ofthe dosed and control
rats ofeach sex was comparable. Throughout the study,
themeanbodyweightsofhigh-dosemaleratswerelower
than those ofthe eontrols, while during the last half of
the study the mean body weights of the low-dose and
high-dose female rats were higher than the mean body
weights of the control animals. Final body weights in
control and dosed groups were comparable.
Transitional-cell papillomas in the urinary bladder
occurred in dosed male rats with a statistically signifi-
cant trend (P<0.05; controls, 0/49, 0%; low-dose, 2/49,
4%; high-dose, 4/49, 8%). This tumor has not been
observed among568 untreated male control F344/n rats
at this laboratory. The incidence of transitional
papillomas in male vehicle control rats in all laboratories
in the NCI/NTP Bioassay Program is 1/994 (0.1%). Epi-
thelial hyperplasia in the urinary bladder was also
observed at increased incidences in dosed male rats
(0/49, 1/49, 6/49). The hyperplasia did not occur in the
same animals that had papillomas.
Fibrosarcomas in the subcutaneous tissue occurred in
female rats with a statistically positive trend (P<0.05;
controls, 0/50, 0%; low-dose, 2/49, 4%; high-dose, 4/49,
8%). This tumor has not been observed among 568
untreated male control F344/N rats at this laboratory.
The incidence of transitional- cell papillomas in male
vehicle control rats in all laboratories in the NCI/NTP
BioassayProgram is 1/994 (0.1%). Epithelial hyperplasia
in the urinary bladder was also observed at increased
incidences in dosed male rats (0/49, 1/49, 6/49). The
hyperplasia did not occur in the same animals that had
papillomas.
Fibrosarcomas in the subcutaneous tissue occurred in
female rats with a statistically significant positive trend
(P<0.05; controls, 0/50, 0%; low-dose, 0/50, 0%; high-
dose, 3/50, 6%), but the incidence in the high-dose group
was not significant when compared with that in the
control group. The historical incidence of this lesion is
1/591 (0.2%) in untreated control female F344/N rats at
thislaboratoryand 9/999(0.9%) infemale gavage control
rats in all laboratories in the Bioassay Program.
Survival of control and dosed female mice, although
comparable, was unusually low. Mean body weights of
high-dose mice ofeach sexwerehigherthan those ofthe
controls throughout most of-the study. Final body
weights in the control and dosed groups were compar-
able. The mice probably did not receive the maximum
tolerated dose ofallyl isothiocyanate.
Theincreasedincidenceofcytoplasmicvacuolizationin
the liver of dosed male mice was related to administra-
tion ofallyl isothiocyanate (controls, 2/49, 4%; low-dose,
8/49, 16%; high-dose, 13/50, 26%).
Under the conditions of this bioassay, allyl isothiocya-
nate was carcinogenic for male F344/N rats, causing
transitional-cell papillomas in the urinary bladder. Evi-
dence for associating allyl isothiocyanate with sub-
cutaneous fibrosarcomas in female F344/N rats was
equivocal. Allylisothiocyanatewith subcutaneous fibrosar-
comas in female F344/N rats was equivocal. Allyl isothio-
cyanate was not carcinogenic for B6C3F1 mice of either
sex.
Report Date: October 1982
TR-235 Carcinogenesis Bioassay of
Zearalenone (CAS No. 17924-92-4) in F344/
N Rats andB6C3F1 Mice (Feed Study)
A carcinogenesis bioassay of zearalenone, an
estrogenic mycotoxin, was conducted by feeding diets
containing 25 or 50 ppm zearalenone to groups of 50
F344/Nratsofeachsexand50or100ppmtogroupsof50
B6C3F1 miceofeach sexfor103weeks. Groups of50rats
and 50 mice of each sex served as controls. Estimates
based on food consumption data indicate that the low-
and high-dose rats received daily doses ofabout 1 and 2
mg, respectively, ofzearalenone per kg ofbody weight.
Low-dose and high-dose mice received estimated daily
doses of about 7-10 and 14-20 mg, respectively, of
zearalenone per kg ofbodyweight.
Survival of dosed and control rats of each sex was
comparable. Meanbodyweightgains ofdosed rats ofeach
sex were lower than those ofthe corresponding controls;
depression in mean body weight gain was dose related.
Final body weights of dosed rats were <9% lower than
thoseofcontrolrats.Theaveragedailyfeedconsumptionof
dosed rats ofeach sexwas 91%-102% that ofcontrols.
Inflammation of the prostate, testicular atrophy, and
hepatocellular cytoplasmic vacuolization (male rats), and
nephrosis(maleandfemalerats)werecompound-related.
Retinopathy and cataracts occurred in low- and high-
dose male rats and in low-dose female rats, and were
associated with the closeness to fluorescent light. No
compound-related, increased tumor incidences were
observed in rats in the chronic study.
Survival of dosed and control mice of each sex was
comparable. Mean bodyweight gains ofhigh-dose male
and low-dose female mice were lower than those of the
controls. Terminalbodyweights ofdosedmicewere <8%
below those of control mice. The average daily feed
consumption by dosed mice ofeach sexwas 97-99% that
ofthe controls.
Myelofibrosis inthebonemarrow,uterinefibrosis, and
cystic ducts in the mammary gland were related to the
administration of zearalenone in female mice. The inci-
dence of hepatocellular adenomas in female mice was
doserelated(P<0.003),andtheincidenceofthesetumors
in high-dose female mice was significantly higher (P<
0.006) than those in the controls (control, 0/50; low-dose,
2/49; high-dose, 7/49). Pituitaryadenomas occurredwith
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statistically significant positive trends (P.< 0.022 for
malesandP< 0.001 forfemales). The incidences ofthese
tumors in high-dose mice were significantly increased
relative to controls (P. 0.032 for males: 0/40, 4/45, 6/44;
andP. 0.003 for females: 3/46, 2/43,13/42).
Undertheconditions ofthisbioassay, zearalenonewas
not carcinogenic for F344/N rats of either sex.
Zearalenone should be considered carcinogenic in
B6C3F1 mice, as evidenced by the increased proportion
ofmale and femalemicewith pituitary adenomas and by
theincreasedproportionoffemalemicewithhepatocellu-
lar adenomas.
Synonym: trans-zearalenone
Report Date: October 1982
TR-236 Carcinogenesis Bioassay of
D-Mannitol (CAS No. 69-65-8) in F344/N
Rats and B6C3F1 Mice (Feed Study)
A carcinogenesis bioassay of D-mannitol (98%-100%
pure), afoodanddrugadditive,wasconductedbyfeeding
diets containing 25,000 or 50,000 ppm D-mannitol to
groupsof50F344/Nratsand50B6C3F1 miceofeachsex
for 103 weeks. Groups of50 rats and 50 mice ofeach sex
served as controls.
Survival and mean bodyweights ofdosed and control
male rats and ofdosed and controlmice ofeach sexwere
comparable. Survival ofhigh-dosefemaleratswassignif-
icantly higher (P<0.05) than that ofthe low-dose female
rats. However, neitherthe survival ofthelow-dose group
nor that ofthe high-dose group was significantly differ-
entfromthatofthecontrols.Throughoutthestudy,mean
bodyweight gain ofdosed female rats was depressed (<
10%) relative to that of controls. Feed consumption by
dosed and control rats'and mice ofeach sex was similar.
Although the rats and mice of each sex might have
been able to tolerate higher doses, a dietary level of
50,000 ppm (5%) is the maximum concentration ofa test
substance in feed recommended in the guidelines ofthe
Bioassay Program.
Dilatation ofthe gastric fundal gland was observed in
the increased incidence in dosed female rats when com-
pared with that ofcontrols (control, 6/50, 12%; low dose,
23/50, 46%; high dose, 23/50, 46%). Retinopathy and
cataracts occurred at increased incidences in high-dose
male and low- and high-dose female rats.
A mild nephrosis, characterized by focal vacuolization
of the renal tubular epithelium, was observed in
increased incidence in dosed mice of each sex and was
considered to be related to administration ofD-mannitol
(males: control, 15/50, 30%; low dose, 29/50, 58%; high
dose, 30/47, 64%; females: control, 1148, 2%; low dose,
3/48, 6%; high dose, 14/49, 29%).
Under the conditions ofthisbioassay, D-mannitol was
not carcinogenic for F344/N rats or B6C3F1 mice of
eithersex.
Report Date: September 1982
TR-237 Carcinogenesis Studies of1,1,1,2-
Tetrachloroethane (CAS: 630-20-6) in F344/
N Rats and B6C3F1 Mice (Gavage Studies)
Carcinogenesis studies of technical grade 1,1,1,2-
tetrachloroethane (>99% pure) were conducted by
administering the test chemical in corn oil by gavage to
groups of50male and 50female F344/N rats at doses of
125 or 250 mg/kg bodyweight and to groups of50 male
and50femaleB6C3F1 miceatdoses of250or500mg/kg.
(1,1,1,2-tetrachloroethane is used as a chemical inter-
mediate in the production of trichloroethylene and
tetrachloroethylene). Doses were administered five
times perweekfor 103weeks. Dueto chemicallyinduced
toxicity, high-dose micereceived the chemical foronly65
weeks. Groups of50rats and50mice ofeach sexreceived
corn oil by gavage on the same dosing schedule and
served as vehicle controls.
The chemical produced cumulative toxic effects with
signs of central nervous system involvement from week
44forward inthechronicstudy,resultingin significantly
lower survival of high-dose male rats (P= 0.001), and
possibly decreasing the incidence of late-developing
tumors in this group. Mean body weights of dosed and
controlratsofeach sexweresimilar. Fourteencontrol, 10
low-dose, and 3 high-dose male rats and 2 control, 5 low-
dose,and8high-dosefemaleratswerekilledaccidentally
during the study; of these, 11 control and 7 low-dose
males died apparently from heat stress during week 62
as a result of a 6-hour elevated temperature (>34°C) in
the animal room.
Neither hepatocellular neoplastic nodules alone nor
hepatocellular carcinomas alone occurred in statistically
significant incidences in male rats, but the combined
incidence ofmaleratswith eitherhepatocellularneoplas-
tic nodules or carcinomas occurred with a statistically
significant positive trend (P<0.05) in the life table test
(controls, 0/49, 0%; low-dose, 1/49, 2%; high-dose, 3/48,
6%). A single hepatocellular carcinoma occurred in the
high-dose group. The combined incidence oflivertumors
in the high-dose males (3/48, 6%) did not greatly exceed
the historical incidences of liver tumors in groups of
vehicle controls in otherstudies atthis laboratory(5/243,
2.1%; range 0%-4%). However, reduced survival of the
high-dose group in the present study may have reduced
thesensitivityofthisbioassayfordetectinglivertumors.
Mineralization ofthe kidney increased in a dose-related
fashion in the male rats (12/48,19/50, 26/48).
Fibroadenomas in the mammary gland of female rats
occurredwith astatisticallysignificant(P<0.05)increased
incidence in the low-dose group as compared with the
controls (6/49, 15/49, 7/46). The incidence in the high-dose
group was not different than that in the controls.
The combined incidence of adenomas, adenocar-
cinomas, and carcinomas inthepituitarygland offemale
rats showed a statistically significant (P<0.05) negative
trend and the incidence in the high dose group was
significantly (P<0.05) less than that in the controls
(18/39, 16/45, 7/42).
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Mean body weight of high-dose mice was less than
thatofcontrols afterweek20inmales and afterweek40
in females. Clinical signs of central nervous system
toxicity occurred at week 51 in both sexes of high-dose
mice and by week 66 they were dead or moribund and
werekilled. Survivaloflow-dosefemaleswasalsosignifi-
cantly (P<0.05) less than that ofcontrols.
The maximum tolerated dose was exceeded in high-
dose mice. Inflammation, necrosis, fattymetamorphosis,
and hepatocytomegaly were observed in increased inci-
dences in the livers ofhigh-dose male and female mice.
The major neoplastic histopathological effects occurred
in the liver, where dose-related statistically significant
(P<0.05) increases in the incidence of hepatocellular
adenomas occurredinbothmaleandfemalemice:vehicle
controls, low-, and high-dose male mice had rates of13%
(6/48), 30% (14/46), and 42%, (21150); corresponding per-
centages in female mice were 8% (4/49),17% (8/46), and
50% (24/48). Evidenceforthe association between 1,1,1,2-
tetrachloroethane anddevelopmentofhepatocellularcar-
cinomas in mice was limited because ofpoor survival in
the high-dose groups. Nevertheless, there was an
increased incidence of hepatocellular carcinomas in
female mice despite the reduced survival in the dosed
groups (controls,1V49,2%;low-dose, 5/46,11%;high-dose,
6/48, 13%). There was no clear effect in male mice.
Under the conditions of these studies, 1,1,1,2-
tetrachloroethane was not demonstrated to be carcino-
genic in F344/N rats, although the observed increase in
the proportion of male rats with liver tumors may have
been associated with the administration of 1,1,1,2-
tetrachloroethane; accidental killing of 27 male and 15
female rats reduced the sensitivity of this bioassay for
detecting a carcinogenic response. 1,1,1,2-Tetrachlo-
roethane was carcinogenic for B6C3F1 mice, causing an
increased proportion offemale mice with hepatocellular
carcinomas and an increased proportion of male and
female mice with hepatocellular adenomas; the
decreased survival in high-dose male and female mice
compromisedtheabilityofthisbioassaytofurtherdeter-
minethepresence orabsence ofacarcinogeniceffectand
gave clear evidence that these doses were toxic.
Report Date: May 1983
TR-238 Carcinogenesis Bioassay of
Ziram (CAS No. 137-30-4) in F344/N Rats
and B6C3F1 Mice (Feed Study)
A carcinogenesis bioassay of ziram (89% pure, with
6.5% thiram), a fungicide and a rubber vulcanization
accelerator, was conducted in F344/N rats and in
B6C3F1 mice.Groupsof50ratsofeach sexreceiveddiets
containing300 or600ppmofcommercial gradeziramfor
103 weeks; groups of49 or 50 mice ofeach sex received
dietscontaining600or1,200ppmziram; andgroups of50
rats and50miceofeachsexservedasuntreatedcontrols.
The average daily consumption of ziram by low- and
high-dose rats, through the majority of the study, was
about 11 and 22 mg/kg for males and 13 and 26 for
females. The average dailyconsumption ofzirambylow-
and high-dose mice, through the majority of the study,
was 122 and 196 mg/kg for males and about 131 and 248
mg/kg for females.
Survival and feed consumption and mean body
weightsofratsofeachsexwerenotadverselyaffectedby
ziram; rats ofeach sexcouldhavetolerated higherdoses.
C-Cellcarcinomas ofthethyroidinmalerats occurred
withastatisticallysigniflcantpositivetrend(P<0.01)and
the incidence in the high-dose group was significantly
higher (P<0.05) than that in the controls (control, 0/50,
0%; low-dose, 2/49,4%; high-dose, 7/49,14%) and higher
than thatpreviously observed in control male rats atthe
same laboratory (18/584, 3%; range 0% to 8%). The
combined incidence ofmales with either C-cell adenoma
or carcinoma also showed a statistically significant
(P<0.05)positivetrend (control,4/50,8%;low-dose,9/49,
18%; high-dose, 12/49, 24%). There were no significant
histopathologic changes noted in the follicular cells.
Survival of male and female mice was not adversely
affected by ziram in feed; mean body weight gain by
dosed male mice throughout the study and byhigh-dose
female mice afterweek 80 was depressed by15% to 20%
relative to the controls. Average daily feed consumption
by high-dose males and high-dose females was, respec-
tively, 78% and 85% that of the controls. Mice probably
could not have tolerated higher doses.
The incidence of alveolar/bronchiolar adenomas was
significantly (P<0.05) increased in female mice (control,
2/50,4%;low-dose, 5/49,10%; high-dose, 10/50,20%). The
combined incidence ofalveolar/bronchiolar adenomas or
carcinomas in female mice showed a statistically signifi-
cant (P<0.05) positive trend. The incidence in the high-
dosegroupwassignificantly(P<0.05)higherthanthatin
the controls (control, 4/50,8%; low-dose, 6/49,12%; high-
dose, 1150, 22%). Pulmonary adenomatous hyperplasia
consistentwithchronicSendaivirusinfection(confirmed
by serologic analysis performed on untreated animals
from the same animal shipment and present in the same
room) was observed in control and dosed male mice
(control, 15/49, 31%; low-dose, 19/50, 38%; high-dose,
16/49, 33%) as well as in control and dosed female mice
(control, 18/50, 36%; low-dose, 27/49, 55%; high-dose,
26/50, 52%). Six of the 26 high-dose females without
pulmonary adenomatous hyperplasia had pulmonary
tumors, whereas 4 of the 24 high-dose females without
pulmonary adenomatous hyperplasia also had pulmon-
ary tumors. Only 1 of 27 low-dose females with ade-
nomatous hyperplasia had a pulmonary tumor.
There was a significant decrease in the incidence of
mammaryfibroadenomas in high-dose female rats (con-
trol, 16/50, 32%; low-dose, 17/50, 34%; high-dose, 8/50,
16%). Significant dose-related decreased incidences of
liver carcinomas in male mice (control, 13/49, 27%; low-
dose, 8/50, 16%; high-dose, 1149, 2%) and of liver ade-
nomas in female mice (control, 7/50,14%; low-dose, 2/50,
4%; high-dose, 0/50, 0%) were observed.
Under the conditions ofthese studies, ziram was car-
cinogenic for male F344/N rats, causing increased inci-
dences ofC-cell carcinomas ofthe thyroid gland. Ziram
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was notcarcinogenic foreitherfemale F344/Nrats orfor
male B6C3F1 mice. Increased incidences of alveolar/
bronchiolar adenomas and of combined alveolar/
bronchiolar adenomas or carcinomas occurred in female
B6C3F1 mice. However, the interpretation of this
increaseinlungtumorsiscomplicatedbyanintercurrent
Sendai virus infection.
Synonym: zinc dimethyldithiocarbamate
Report Date: April 1983
TR-239 Carcinogenesis Bioassay ofBis(2-
chloro-l-methylethyl)ether (-70%) (CAS
No. 108-60-1) Containing 2-Chloro-l-
methylethyl(2-chloropropyl)ether (-30%)
(CAS No. 83270-31-9) in B6C3F1 Mice
(GavageStudy)
Bis(2-chloro-1-methylethyl) ether is a beta-haloether
that has been used extensively in paint and varnish
removers, spotting agents, and cleaning solutions.
BCMEE has also been used as an intermediate in the
manufacture of dyes, resins, and pharmaceuticals and
hasbeenaddedtosoapsolutionstoaidintextilecleaning.
Bis(2-chloro-1-methylethyl) ether has been a by-product
in the manufacture of propylene oxide and propylene
glycol. It is the active ingredient of a nematocide devel-
oped and used on field crops in Japan.
A carcinogenesis bioassay of bis(2-chloro-1-
methylethyl)ether (-70%), containing -30% 2-chloro-1-
methylethyl(2-chloropropyl) ether, was conducted by
administering 100 or 200 mg/kg bis(2-chloro-1-
methylethyl)ether in corn oilbygavage 5 times perweek
for 103 weeks to groups of50 B6C3F1 mice ofeach sex.
Fiftymice ofeach sexreceived corn oil alone and served
as vehicle controls. Survival and mean body weights of
dosed and control mice ofeach sex were comparable.
The incidence of alveolar/bronchiolar adenomas occur-
red in apositive dose-related trend formalemice (P<0.05:
control 5/50, 10%; low-dose 13/50, 26%; high-dose 11150,
22%)andforfemalemice (P<0.02: 1/50, 2%;4/50,8%;8/50,
16%). The number offemale mice in the high-dose group
withadenomaswassignificantly(P<0.03)greaterthanthat
in controls. The combined incidences in dosed males and in
high-dose females were significantly higher (P< 0.04 for
males andP< 0.01 for females) than those in the controls
(males: 6/50,12%;15/50,30%;13/50,26%;females: 1V50,2%;
4/50, 8%; 10/50, 20%).
The incidence of hepatocellular carcinomas (5/50,
10%;13/50, 26%; 17/50, 34%) and the combined incidence
ofhepatocellular adenomas and carcinomas (13/50, 26%,
23/50, 46%, 27/50, 54%) in male mice were statistically
significantbythetrendtests (P<0.01) andtheincidences
in the high-dose group were significantly higher than
those in the controls (P<0.01). Metastases to the lung
occurred in 1/50 control, 4/50 low-dose, 3/50 high-dose
male mice. Fattymetamorphosis was found in increased
incidence in the livers of dosed male mice (control 2/50;
16/50 low-dose; 15/50 high-dose).
Squamouscellpapillomaswerefoundinthestomachor
forestomachintwohigh-dosefemales, onelow-dosemale,
and one high-dose male. A squamous cell carcinomawas
found in the forestomach of a third high-dose female.
These tumorswereprobablyrelated to administration of
the test compound, since they are rarely observed in
vehicle control and untreated control B6C3F1 mice.
Under the conditions of this bioassay, bis(2-chloro-1-
methylethyl)ether, containing 2-chloro-1-methylethyl(2-
chloropropyl)ether, was carcinogenic for B6C3F1 mice,
causingincreasedincidences ofalveolar/bronchiolar ade-
nomas in male and females and hepatocellular car-
cinomas in males. In addition, the occurrence of a low
incidence of squamous cell papillomas or carcinomas in
the stomach or forestomach offemales (a rare tumor in
B6C3F1 mice) was probably associated with the admin-
istration ofbis(2-chloro-1-methylethyl)ether.
Synonyms for bis(2-chloro-1-methylethyl) ether:
BCMEE; bis(2-chloroisopropyl) ether; BCPE
Report Date: December 1982
Note: Bis(2-chloro-1-methylethyl) ether was previously
tested in F344 ratsbygavage (SeeTR-191,reported1979).
TR-240 Carcinogenesis Bioassay of
Propyl Gallate (CAS No. 121-79-9) in F344/
N Rats and B6C3F1 Mice (Feed Study)
Propylgallateis awhitetonearlywhiteodorlesspowder
having a slightly bitter taste. Solutions of propyl gallate
turn dark in the presence ofiron or iron salts.
Propylgallatehasbeenusedsince1948asanantioxidant
to stabilize cosmetics, food packagingmaterials, and foods
containing fats. As an additive, it may be found in edible
fats, oils, mayonnaise, shortening, baked goods, candy,
dried meat, fresh pork sausage, and dried milk, and it is
used in hair grooming products, pressure-sensitive adhe-
sives, lubricating oil additives, and transforming oils.
A carcinogenesis bioassay of propyl gallate was con-
ducted by feeding diets containing 6,000 or 12,000 ppm
propyl gallate to groups of50 F344/N rats and 50B6C3Fj
mice ofeach sexfor103weeks. Groups of50untreated rats
and 50 untreated mice ofeach sex served as controls.
Survivalofrats andmicewas notadverselyaffectedby
propyl gallate, but mean bodyweights ofdosed rats and
mice ofeach sexwerelowerthanthose ofthe controls.At
104weeks, meanbodyweights oflow- and high-dose rats
were 4% and 8% lower than those of the controls for
males and 11% and 19% lower than those ofthe controls
for females. Similarly, mean body weights of low- and
high-dose mice were 5% and 8% lower than those ofthe
controls formales and11% (both dosegroups) lowerthan
those ofthe controls for females.
Thyroid follicular-cell adenomas or carcinomas (com-
bined) occurred in male rats with a statistically signifi-
cant (P<0.05) positive trend, but the incidences in the
dosed groups were not statistically significant in direct
comparisons with the control groups. Moreover, the inci-
dence of high-dose male rats with follicular-cell tumors
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(3/50, 6%) was not statistically different from the histor-
ical control rate (14/584, 2.4%) for the laboratory that
conducted this bioassay.
Rare tumors (an astrocytoma or a glioma) were found
inthebrains oftwolow-dosefemalerats.Theincidenceof
all brain tumors in the Bioassay Program is only 0.86%.
The absence of this tumor in the high-dose female rat
group reduces the likelihood thatthis tumoris related to
propyl gallate administration.
Increased incidences of hepatic cytoplasmic vacuoliza-
tion and suppurative inflammation of the prostate were
observed in dosed male rats. These findings were con-
sidered to be related to administration ofpropyl gallate.
Thmors (mostlybenign) ofthe preputial gland, islet-cell
tumors of the pancreas, and pheochromocytomas of the
adrenal gland were observed with significantly (P<0.05)
higher incidences in the low-dose male rats, but there was
little evidence of an effect in the high-dose group. The
incidences ofmale ratswith tumors ofthe preputial gland
were1/50 (2%)forcontrols,8/50(16%)forthelow-dose, and
0/50 (0%) for the high-dose group. Islet-cell tumors ofthe
pancreas occurred in 2/50 (4%) control males, 9/50 (18%)
low-dose males, and 4/50 (8%) for high-dose males. Phe-
ochromocytomas of the adrenal gland were observed in
4/50 (8%) control males, 13/48 (25%) low-dose males, and
8/50 (16%) high-dose males.
Negative trends (P<0.05) were observed forleukemia
in male rats (16/50, 7/50, 6/50) and for fibroadenomas of
the mammary gland in female rats (11/50, 2/50, 5/50).
Inmalemice, malignantlymphomawas observedwith
asignificantly(P 0.014)positivetrend(control,1/50,2%;
low-dose, 3/49, 6%; high-dose, 8/50, 16%), and the inci-
denceinthehigh-dosegroupwassignificantly(P.<0.028)
higher than that observed in the concurrent controls.
However, the high-dose incidence was not statistically
different from the historical rate (60/640, 9.4%) for the
laboratory that conducted this bioassay.
Adenomas ofthe liver in female mice occurred with a
statisticallysignificant(P<0.022)positivetrend, andthe
incidence in the high-dose group was significantly (P.
0.039) higher than that of the controls (0/50, 0%; 2/50,
4%; 5/49, 10%). The incidences of hepatocellular ade-
nomas or carcinomas (combined) were similar in control
and dosed groups (3/50, 6%; 3/50, 6%; 5/49, 10%).
Negative trends (P<0.05) were obtained for fibromas
of the skin or subcutaneous tissue in male mice (5/50,
1/49, 0/50).
Under the conditions of this bioassay, propyl gallate
was not considered carcinogenic for F344/N rats,
although there was evidence of an increased proportion
oflow-dose male rats with preputial gland tumors, islet-
cell tumors ofthe pancreas, and pheochromocytomas of
the adrenal glands; rare tumors ofthe brain occurred in
two low-dose females. Propyl gallate was not considered
to be carcinogenic for B6C3F1 mice of either sex,
althoughtheincreasedincidence ofmalignantlymphoma
inmalemicemayhavebeenrelated tothedietaryadmin-
istration ofpropyl gallate.
Synonyms: 2,4,5 trihydroxybenzoic acid propyl ester;
gallic acid propyl ester; Progallin P; Tennox PG
Report Date: December 1982
TR-241 Proceedings of a Working
Seminar on the Optimal Use ofFacilities
for Carcinogenicity/Toxicity Testing
Note to the Reader: The proceedings ofthis working
seminar held in May, 1980, were neverpublished and are
not available.
TR-242 Carcinogenesis Bioassay of
Diallyl Phthalate (CAS No. 131-17-9) in
B6C3F1 Mice (Gavage Study)
Diallyl phthalate is a widely used crosslinking agent
for unsaturated polyesters. Diallyl phthalate or diallyl
phthalate polyester blends are used primarily as plas-
ticizersandcarriersforaddingcatalysts andpigmentsto
polyesters and in molding, electrical parts, laminating
compounds, and impregnation ofmetal castings. Rubber
compounds, epoxyformulations, andpolyurethanefoams
may also contain diallyl phthalate. Annual production of
diallyl phthalate in the United States exceeds 5,000
pounds; precise figures are not available.
A carcinogenesis bioassay of diallyl phthalate (99%
pure)wasconductedbyadministering0 (vehicle control),
150,or300mg/kgdiallylphthalateincornoilbygavage,5
days perweekfor103weeks, to groups of50male and 50
female B6C3F1 mice. Survival rates and mean body
weights of dosed mice were not different from those of
the controls, and pathological lesions unrelated to pro-
liferative changes were not observed. Therefore, a max-
imallytolerated dose forthe purposes ofcarcinogenicity
testing may not have been achieved.
The incidences of lymphoma and either lymphoma or
leukemia in dosed male mice were no significantly
greater than those in the controls according to pairwise
comparisons (P=0.051 to P=0.096), but the trend tests
were statistically significant by either life table or inci-
dental tumor analysis (P=0.031 to P=0.045). The inci-
denceoflymphomasinthehigh-dosemalemicewas12/50
(24%) in comparison with 6/50 (12%) in the controls.
Recenthistoricalincidencesattheperforminglaboratory
andinthe NTPBioassayProgramwere18/120(15%) and
71/661 (11%), respectively. Since the incidence of high-
dose male mice with leukemia was not significantly
greater than that of concurrent or historical controls at
theperforminglaboratorybypairwise comparisons, this
marginal increase was considered only to be equivocally
related to diallyl phthalate administration.
Increased incidences of squamous cell papillomas,
hyperplasia, and inflammatory lesions of the for-
estomach were observed in diallyl phthalate-dosed mice
ofboth sexes in adose-related manner. Papillomas ofthe
forestomach were observed in 0%, 2%, and 4% of the
control, low-dose, and high-dose mice ofboth sexes. The
recenthistoricalincidenceofthistumoringavagecontrol
mice from both the performing laboratory and other
laboratories within the Bioassay Program was less than
1%. Forestomach hyperplasiawas diagnosed in 0%, 15%,
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and18%, andin8%,2%, and29%ofthe control, low-dose,
and high-dose male and female mice, respectively;
chronic inflammation ofthe forestomach was diagnosed
in0%, 9%, and16%andin4%,2%, and18%ofthecontrol,
low-dose, and high-dose male and female mice, respec-
tively. Because of the numerical elevation of the for-
estomachpapillomas inthe high-dosemiceofboth sexes,
the concomitant observation ofdose related forestomach
hyperplasia, and the rarity of this tumor in corn oil
(gavage) control B6C3F1 mice, the development of
squamous cell papillomas of the forestomach may have
been related to diallyl phthalate administration.
Underthe conditions ofthisbioassay, the development
of chronic inflammation and hyperplasia of the for-
estomach in both male and female B6C3F1 mice was
considered to be related to the administration of diallyl
phthalate. The development ofsquamous cell papillomas
ofthe forestomach may also have been related to chemi-
cal administration, butthe available data are insufficient
to indicate a clear cause and effect relationship. An
increase in the incidence ofmale mice with lymphomas
wasobserved,butthisincreasewasconsidered onlytobe
equivocally related to diallyl phthalate administration.
The results of this bioassay, therefore, do not indicate
that diallyl phthalate is carcinogenic in B6C3F1 mice,
although a maximum tolerated dose may not have been
achieved. A carcinogenicity study by the National Tox-
icology Program ofdiallyl phthalate in male and female
Fisher 344/N rats, employing daily gavage doses of 0
(vehicle control), 50, or 100 mg/kg body weight is cur-
rently being evaluated.
Report Date: April 1983
Note: Diallyl Phthalate was subsequentlytested in F344
rats by gavage (See TR-284, reported 1985).
TR-243 Carcinogenesis Studies of
¶frichloroethylene (Without
Epichlorohydrin) (CAS No. 79-01-6) in
F344/N Rats and B6C3F1 Mice (Gavage
Studies)
Trichloroethylene (TCE) is an industrial solvent used
for vapor degreasing and cold cleaning of fabricated
metalparts. TCE has alsobeenused as acarriersolvent
for the active ingredients ofinsecticides and fungicides,
as a solvent for waxes, fats, resins, and oils, as an
anesthetic for medical and dental use, and as an extrac-
tant for spice oleoresins and for caffeine from coffee.
Trichloroethylene may be found in printing inks, var-
nishes, adhesives, paints, lacquers, spot removers, rug
cleaners, disinfectants, and cosmetic cleansing fluids.
TCE mayalso beused as achain terminator inpolyvinyl
chlorideproductionandasanintermediateintheproduc-
tion ofpentachloroethane. Trichloroethylene is nolonger
used with food, drugs, or cosmetics.
Carcinogenesis studies of epichlorohydrin-free tri-
chloroethylenewereconductedbyadministeringthetest
chemicalin cornoilbygavagetogroupsof50maleand50
female F344/N rats and B6C3F1 mice. Dosage levels
were 500 and 1,000 mg/kg for rats and 1,000 mg/kg for
mice. Trichloroethylene was administered five times per
week for 103 weeks, and surviving animals were killed
betweenweeks103and107.Groupsof50ratsand50mice
of each sex received corn oil by gavage on the same
schedule and served as vehicle controls. Groups of 50
male and 50 female rats were used as untreated
controls.
The dosage levels selected for the 2-year study were
based on the results ofthe 13-week studies. Groups of10
male and10femaleratsreceivedTCE bygavageatdoses
of 125 to 2,000 mg/kg (males) and 62.5 to 1,000 mg/kg
(females) for 13 weeks. Groups of10 male and 10 female
micereceivedgavagedoses of375to6,000mg/kgofTCE
for 13 weeks. Survival, body weight gains, and previous
experience with TCE were used to select doses for the
2-year study. All rats survived the 13-week study, but
males receiving 2,000 mg/kg exhibited a 24% difference
in final bodyweight. At the 1,000 mg/kg dose, final body
weights for males (-3%) and for females (-2%) were
similar to those of controls. The doses selected for the
2-year study in rats were 500 and 1,000 mg/kg for both
sexes. The initial doses used in the earlier bioassay in
Osborne-Mendel rats were 549 and 1,097 mg/kg for both
sexes. A total of 8/10 male mice and 10/10 female mice
receiving doses ofTCE as high as 1,500 mg/kg survived
the13-weekexperimentalperiod. The single dosagelevel
selected forthe2-yearstudyin micewas1,000mg/kgfor
both sexes. This dosewas less than the high doseused in
the earlier bioassay in B6C3F1 mice (2,339 mg/kg for
males and 1,739 for females) and was similar to the
previous low doses (1,169 mg/kg for males and 869 for
females).
In the 2-year study, the survival of both low and
high dose male rats and dosed male mice was less
(P. 0.005) than that of the vehicle controls. Mean body
weightsofdosedratsofeachsexwerelowerthanthoseof
thevehiclecontrols, and afterweek65, thedecrementsin
body weight gains were dose related. The mean body
weight of dosed male mice was lower than that of the
vehicle controls throughout the study, while those ofthe
dosed and vehicle control female mice were comparable.
Cytomegaly (toxic nephrosis) of the kidney was
observed in 96/98 male and in 97/97 female rats given
TCE, with none being found in male or female vehicle
controlrats. Thislesionwasmore severeinmales,partic-
ularly in the high dose group. Cytomegalywas observed
in45/50malemiceandin48/49femalemiceadministered
TCE, and in none of the vehicle controls. Renal tubular
cell adenocarcinomas were found in the three high dose
male rats; these neoplasms were observed in those male
rats killed at the end of the study (0/33, 0/20, and 3/16,
19%). Theincidence in the high dose male rats atthe end
of the study was greater (P<0.05) than that in the
controls. Renal tubular cell adenocarcinomas are consid-
ered uncommon occurrences in F344/N rats, with 3/748
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(0.4%) being observed in historical vehicle gavage con-
trols.Additionalrenaltumorsindosedmaleratsincluded
onetransitional cellcarcinomaoftherenalpelvisandtwo
tubular cell adenomas in low dose animals and one car-
cinomaoftherenalpelvisin ahigh doseanimal. Norenal
neoplasms were found in vehicle control rats; one untre-
ated control male rat had a transitional cell papilloma of
therenalpelvis. Infemalerats, onetubularcell adenocar-
cinoma was found in the high dose group.
An increased incidence (P<0.05, life table) of per-
itonealmesotheliomaswas detectedinlowdosemalerats
(control, V50; low dose, 5/50; high dose, V49). Meso-
theliomas havebeendiagnosed in16/752 (2.1%)historical
vehicle control male F344/N rats, and the increased
incidence in the present study may have been related to
the administration ofTCE.
The results in male F344/N rats were considered
equivocal for detecting a carcinogenic response because
bothgroupsreceivingTCE showed significantlyreduced
survival compared tovehicle controls (35/50, 70%, 20/50,
40%; 16/50, 32%) and because 20% ofthe animals in the
high dose group were killed accidently by gavage
error.
Negative trends were observed for chromophobe ade-
nomas ofthe pituitary gland and forendometrial stomal
polyps in female rats. These decreases were not consid-
ered to be related to the administration ofTCE.
The administration ofTCE to mice caused increased
incidences ofhepatocellular carcinoma in males (control,
8/48; dosed,3V50; P<0.001) andinfemales (control,2/48;
dosed, 13/49; P<0.005). Hepatocellular carcinomas
metastasizedtothelungsinfivedosedmalemiceandone
control male mouse, and none were observed in females.
The incidence ofhepatocellular adenomas was increased
in male mice (control, 7/48; dosed 14/50) and in female
mice (control, 4/48; dosed, 16/49; P<0.05).
Under the conditions of these studies, epichlorohy-
drin-freetrichloroethylene causedrenaltubular-cellneo-
plasms in male F344/N rats, produced toxic nephrosis in
both sexes, and shortened the survival time of males.
This experiment in male F344/N rats was considered to
be inadequate to evaluate the presence or absence of a
carcinogenic response to trichloroethylene. For female
F344/N rats receiving trichloroethylene, containing no
epichlorohydrin, there was no evidence of carcino-
genicity. TIichloroethylene (without epichlorohydrin)
was carcinogenic for B6C3F1 mice, causing increased
incidences of hepatocellular carcinomas in males and
females and ofhepatocellular adenomas in females.
Synonym: TCE
Report Date: May 1990
Note: Trichloroethylene was previously tested in
Osborne-Mendel rats and B6C3F1 mice by gavage (See
TR-2, reported 1977) and also in four rat strains (ACI,
August, Marshall, and Osborne-Mendel) by gavage (See
TR-273, reported 1988).
TR-244 lbxicology and Carcinogenesis
Studies ofa Polybrominated Biphenyl
Mixture (Firemaster FF-1) in F344/N Rats
andB6C3F1 Mice (Gavage Studies)
Firemaster FF-1, a flame retardant composed ofpoly-
brominated biphenyls (PBB), was responsible for wide-
spread environmental contamination and animal losses
in Michigan startingin 1973. This studywas undertaken
to characterize the long-term toxic and carcinogenic
potential of this PBB mixture in rats and mice of each
sex. Fisher 344/N rats and B6C3F1 mice were given 125
oral doses ofPBB overa6-monthperiod - 0, 0.1,0.3, 1.0,
3.0, or 10.0 mg/kg bodyweight/day (5 days/week).
A dose-related decrease in body weight gain was
observed in both male and female rats and male mice,
although there was no significant difference in food
consumption. At the end ofthe 6-month exposure, there
was a dose-dependent decrease in thymus weights in
rats. The liver appeared to be the primary target organ.
Dose-relatedhepatotoxic effectswere characterized bya
marked increase in liver weight, with accentuation of
hepatic lobular markings. Microscopically, there was
moderate to marked hepatocellular swelling, disorganiz-
ation and single cell necrosis ofhepatocytes, fatty infil-
tration, and bile duct proliferation. At the 6-month
observation, atypical hepatocellular foci were observed
at a low incidence in dosed rats and mice. Hepatic por-
phyrin levels were markedly increased in both rats and
mice, excessively in females. Levels ofporphyrin tended
todecreasegradually,primarilyinmice,followingcessa-
tion of exposure. The significant decreases in serum
thyroxine (T4) and triiodothyronine (T3) in rats suggest
that PBB mayinterfere with thyroid hormone secretion.
Total serum protein was decreased in dose-related
fashion in female rats primarily due to dose-related
decreases in albumin. Therewas asignificantincreasein
the serum levels of gamma glutamyl transpeptidase
(GGTP) in female rats given 10.0 mg/kg of PBB. There
was a dose-related decrease in serum glucose in female
rats, a dose-related decrease in the serum triglyceride
levelindosedmalerats, exceptatthelowestdose (0.1mg/
kg), and a dose-related increase in the serum levels of
cholesterol in both male and female rats.
Serum levels of GGTP were increased only in female
mice given 10.0 mg/kg ofPBB. There was a 5- to 6-fold
increase in the activity ofserum glutamic pyruvic trans-
aminase (SGPT) in male and female mice in the 10.0mg/
kg groups. Serum enzyme activity ofalkaline phosphate
(AP)was alsoincreasedinmicegiventhehighestdoseof
PBB.Therewasasignificantdose-relatedincreaseinthe
serum levels ofcholesterol in female mice, and the high-
estdose groupwas significantlygreaterthanthe control
female mice. Serum glucose was significantly decreased
in female mice administered 10.0 mg/kg ofPBB.
To determine the carcinogenic potential of PBB, rats
and mice dosed for 6 months were observed without
exposure to PBB for an additional 23 or 24 months,
respectively (lifetime observation). The dosing (0.3 mg/
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kg or higher dose levels) shortened the survival time in
male rats, whereas no such effectwas observed in dosed
females. There was also evidence of shortened survival
time in the 10.0 mg/kg PBB-dosed mice. A significantly
higher incidence ofatypical hepatocellular foci, neoplas-
tic nodules, hepatocellularcarcinomas, and cholangiocar-
cinomas was observed in dosed rats. The incidence of
hepatocellularcarcinomawas increasedinbothmale and
female mice (highest dose level) compared with control
male and female mice. The incidence of hepatic neo-
plasms appeared to be dose dependent in rats and mice.
Livertumorswere observed primarilyinthosegroups of
animals to which PBB was given in doses sufficient to
induce readily observable hepatic toxicity.
Under the conditions ofthese studies, polybrominated
biphenyl mixture (Firemaster FF-1) was carcinogenic
for Fisher 344/N rats and B6C3F1 mice of each sex,
inducing neoplastic nodules, hepatocellular carcinomas,
and cholangiocarcinomas in rats and hepatocellular car-
cinomas in mice. Other toxicities included porphyrogenic
effects and hepatotoxicity.
Synonym: Firemaster FF-1
Report Date: June 1983
TR-245 Carcinogenesis Bioassay of
Melamine (CAS No. 108-78-1) in F344/N
Rats and B6C3F1 Mice (Feed Study)
Acarcinogenesis bioassayofmelamine (>95% pure), a
chemical intermediate in the manufacture of amino
resins and plastics, was conducted by feeding diets con-
taining2,250 or4,500ppmmelaminetogroups of50male
F344/N rats and 50 B6C3F1 mice of each sex for 103
weeks. Groups of 49 male rats, 50 female rats, 49 male
mice, and 50 female mice served as controls.
Mean body weights of dosed rats of each sex were
lower than those ofthe controls after week 20. Survival
ofhigh-dose male rats was significantly lower (PK 0.05)
than that ofthe controls. Survival ofall other dosed rat
groups was comparable with that ofthe respective con-
trols.
Transitional-cell carcinomas in the urinary bladder of
malerats occurredwithastatisticallysignificantpositive
trend(PK 0.002; controls, 0/45; low-dose,0/50; high-dose,
8/49,16%) and the incidence in the high-dose group was
significantlyhigher(PK 0.016)thanthatinthecontrols.A
transitional-cell papilloma was observed in the urinary
bladder of an additional high-dose male rat. These
tumors were not observed in statistically significant
proportions in female rats. Seven ofthe eight high-dose
male rats with the transitional-cell carcinomas also had
bladder stones. An association (P< 0.001) was found
between bladder stones and bladder tumors in male
rats.
Chronic inflammation, distinguishable from the
nephropathy observed in aging F344/N rats, was signifi-
cantlyincreased (P< 0.01) in the kidney ofdosed female
rats (controls, 4/50, 8%; low-dose, 17/50, 34%; high-dose,
41150, 82%) and is attributed to the administration of
melamine.
The mean body weight of high-dose male mice was
lower than that of controls after week 50 of the study.
Themeanbodyweights ofdosed andcontrolfemalemice
were comparable throughout the study. Survival ofhigh-
dose male micewas significantly less (P<0.02) than that
of the controls. Survival of all other dosed groups was
similar to that ofthe respective controls.
Acute and chronic inflammation and epithelial hyper-
plasia of the urinary bladder were found in increased
incidence in dosed male mice. The incidence of bladder
stones in dosed male mice was increased relative to
controls (control, 2/45, 4%; low dose, 40/47, 85%; high-
dose, 41V45, 93%); however, there was no evidence of
bladder tumor development in this species. Also, four
high-dose female mice had bladder stones without any
tumors.
Under the conditions of this bioassay, melamine was
carcinogenic for male F344/N rats, causing transitional-
cell carcinomas in the urinary bladder. With one excep-
tion, urinary bladder stones were observed in male rats
that had transitional-cell carcinomas. Melamine was not
carcinogenic forfemale F344/N rats orfor B6C3F1 mice
ofeither sex.
Synonyms: 2,4,6-triamino-s-triazine; cyanurotriamide
Report Date: March 1983
TR-246 Lifetime Carcinogenesis Studies
ofChrysotile Asbestos (CAS No. 12001-29-5)
in Syrian Golden Hamsters (Feed Studies)
Carcinogenesis studies ofshortrange(SR),intermedi-
aterange(IR), orintermediaterangechrysotile asbestos
in combination with the intestinal carcinogen 1,2-
dimethylhydrazine dihydrochloride (DMH) were con-
ducted with male and female Syrian golden hamsters.
Both forms ofchrysotile asbestos were administered at
the concentration of 1% in pelleted diet for the entire
lifetime ofthehamsters startingwithmothers ofthetest
animals. Group sizesvariedfrom125 to253. Startingat6
weeksofage,maleandfemalehamstersintheintermedi-
aterangechrysotile/DMH studyweregivenoraldoses of
DMH (4 mg/kg) every other week for a total of5 doses.
There was no adverse effect on body weight gain or
survival by either form of asbestos or by asbestos in
combination with DMH.
A significant increase (P<0.05) in adrenal cortical
adenomaswas observed inmale hamsters exposed to SR
and IR chrysotile asbestos and in females treated with
IR chrysotile asbestos when compared to the pooled
control groups (males: pooled controls, 25/466, 5%; SR
chrysotile, 26/299, 11%; IR chrysotile, 24/244, 10%;
females: pooled controls, 15/468, 3%; IR chrysotile,
18/234, 8%). However, statistical significance was lost
when these dosed groups were compared with concur-
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rent control groups (males: SR control, 7/115, 6%; IR
control, 7/115, 6%; females: SR control, 4/112, 4%; IR
control, 6/118, 5%).
The results of the combination study (IR chrysotile
plus DMH) did notyield a significant increase in tumors
above the background level observed in the DMH group
alone orin the untreated control group. The DMH failed
to yield a background level of intestinal tumors high
enough to provide a valid test of the cocarcinogenic
potential of chrysotile asbestos. For this reason, the
cocarcinogenic potential oforallyadministered asbestos
should be considered untested.
Under the conditions of these studies, neither short
range chrysotile nor intermediate range chrysotile
asbestos was carcinogenic when ingested at 1% levels in
the diet by male and female Syrian golden hamsters.
While there were increases in the rates ofadrenal corti-
cal adenomas in male and female hamsters exposed to
intermediate range chrysotile asbestos compared to the
pooled groups, these incidence rates were not different
when compared with the concurrent control groups.
Additionally, the biologic importance of adrenal tumors
in the absence of target organ (gastrointestinal tract)
neoplasia is questionable. The cocarcinogenesis studies
using IR chrysotile asbestos and 1,2-dimethylhydrazine
dihydrochloride were considered inadequate because
therewas noincrease inintestinalneoplasiainthe DMH
group.
Report Date: July 1990
Note: Chrysotile Asbestos was also tested in F344 rats
administered in feed (See TR-295, reported 1985).
TR-247 Carcinogenesis Bioassay of
L-Ascorbic Acid (Vitamin C) (CAS No.
50-81-7) in F344/N Rats and B6C3F1 Mice
(FeedStudy)
L-Ascorbic acidisessential formanyphysiologic func-
tions in animals and humans, mostly biochemical reac-
tions involving oxidation.
L-Ascorbicacidisapprovedforuseasadietarysupple-
ment and chemical preservative by the U.S. Food and
Drug Administration and is on the FDAs list of sub-
stances generally recognized as safe.
L-Ascorbic acid may be used in soft drinks as an
antioxidant for flavor ingredients, in meat and meat-
containing products, for curing and pickling, in flour to
improvebakingquality, inbeeras astabilizer, infats and
oils as an antioxidant, and in a wide variety offoods for
vitamin C enrichment. L-Ascorbic acid mayalso find use
in stain removers, hair waving preparations; plastics
manufacture, photography, and water treatment.
A carcinogenesis bioassay of L-ascorbic acid (>97%
pure) was conducted by administering diets containing
25,000 or 50,000 ppm L-ascorbic acid to groups of 50
F344/N rats and 50 B6C3F1 mice of each sex for 103
weeks. Controls consisted of 50 untreated rats and un-
treated mice of each sex. Fifty-thousand ppm is the
highest dose recommended for chronic studies.
Survival ofdosed andcontrolfemale rats and ofdosed
and control female mice were comparable. Survival of
high-dose maleratswas slightlygreaterthanthatofthe
controls (P=0.087). Survival ofhigh-dose malemicewas
significantlygreater(P=0.009)thanthatofthecontrols.
Throughout most of the study, mean body weights of
dosedfemaleratsanddosedfemalemicewerelowerthan
those ofthe controls. Final body weights were compar-
able among groups, exceptfor the high-dose female rats
(<13%); marginal differences (<8%) were observed
for low-dose female rats and for dosed female mice
(8%-11%). Food consumption was equivalent among
groups.
Most observational differences were confined to the
female rat. The incidence of low-dose female rats with
undifferentiated (mononuclear-cell) leukemias (control,
6/50, 12%; low-dose, 17/50, 34%; high-dose, 12/50, 24%)
was significantly higher (P<0.02) than that in controls.
Thesetumorswerenotconsideredtoberelatedtoadmin-
istration ofL-ascorbic acid because they did not occurin
the female high-dose group at incidences significantly
greater(P>0.07)thanthoseinthecontrols,thetrendtest
was not significant (P.0.07), and no increases were
observed for male rats.
Under the conditions ofthis bioassay, L-ascorbic acid
was notcarcinogenicformaleandfemale F344/N rats or
male and female B6C3F1 mice.
Synonym: vitamin C
Report Date: March 1983
TR-248 Carcinogenesis Studies of4,4'-
Methylenedianiline Dihydrochioride (CAS
No. 13552-44-8) in F344/N Rats and B6C3Fj
Mice (DrinkingWaterStudies)
4,4'-Methylenedianilineisusedprimarilyasachemical
intermediate in the closed system production ofisocya-
nates and polyisocyanates. These chemicals are used
extensively in the manufacture of rigid polyurethane
foams for thermal insulation and in the production of
semiflexible polyurethane foams for automobile safety
cushioning. The saturated isocyante of 4,4'-
methylenedianiline [4,4'-methylene-bis(cyclohexy-
lisocyanate)] is an intermediate in the production of
light-stable, high-performance polyurethane coatings.
4,4'-Methylenedianiline is also a curing agent for epoxy
resins and urethane elastomers, a dye intermediate, and
a corrosion inhibitor.
Carcinogenesis studies of 4,4'-methylenedianiline
dihydrochloride (98.6% pure) were conducted by admin-
istering this chemical in the drinking water of F344/N
rats and B6C3F1 mice. Groups of50 rats and 50 mice of
each sex received drinking water containing 150 or 300
ppm 4,4'-methylenedianiline dihydrochloride (dosage
expressed as the free base) for 103 weeks. Groups of50
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rats and 50 mice of each sex, given drinking water
adjusted with 0.1N HCl to the pH (3.7) of the 300-ppm
formulation, served as controls.
Survival was comparable among groups except for
male mice receiving the high dose of 4,4'-methy-
lenedianiline dihydrochloride; survival in thatgroupwas
lower(P=0.006)thanthatincontrols. Meanbodyweight
was reduced in high dose female rats and in high dose
maleandfemalemice.Waterconsumptionwasreducedin
a dose-related manner in both sexes of rats. No
compound-related clinical effects were observed.
Compound-related nonneoplasticlesions ofthethyroid
in female rats included follicular cysts and hyperplasia.
The incidence of thyroid follicular cell hyperplasia was
elevated in high dose male and female mice. The inci-
dences of thyroid neoplasms in the high dose groups
were elevated compared with those ofthe control groups
for both sexes of both species. Thyroid follicular cell
carcinomawasincreased inmalerats (controls, 0/49; low
dose, 0/47; high dose, 7/48,15%: P. 0.012). Follicular cell
adenoma was increased in high dose female rats (0/47;
2/47, 4%; 17/48, 35%: P<0.001), in high dose male mice
(0/47; 3/49, 6%; 16/49, 33%: P<0.001), and in high dose
female mice (0/50; 1/47, 2%; 13/50, 26%: P<0.001) as
compared with controls. In female rats, thyroid C-cell
adenoma was also elevated in a dose-related manner
(0/47; 3/47,6%; 6/48,13%, P. 0.029).
Dose-related increases in nonneoplastic lesions were
observed for male rats (nonspecific liver dilatation) and
for male and female rats (fatty metamorphosis and focal
cellular change). Liver degeneration was present in 80%
ofthe low dose and 60% ofthe high dose male mice but
was not found in the controls. Neoplastic nodules ofthe
liverwere observed at greater incidences (P< 0.002) for
low and high dose male rats as compared with controls
(control, 1/50, 2%; low dose, 12/50, 24%, P. 0.002; high
dose 25/50, 50%, P<0.001). Hepatocellular adenoma was
increased in a dose-related manner in dosed female mice
(3/50,6%;9/50,18%; 12/50,24%, P<0.011). Hepatocellular
carcinoma was observed in greater incidence in dosed
male mice (10/49, 20%; 33/50, 66%, P<0.001; 29/50,58%,
P<0.001) and in high dose female mice (1/50, 2%; 6/50,
12%; 11/50,22%, P=0.002).
Male rats had a dose related increase in kidneyminer-
alization. Nephropathy was increased in dosed mice of
both sexes; renal papillary mineralization was greater
in high dose male mice and female mice than in the
controls.
Other tumors that were elevated in dosed animals
included adrenal pheochromocytomas in male mice (con-
trol, 2/48,4%; lowdose, 12/49,24%, P. 0.006; high dose,
14/49, 29%; P. 0.001), alveolar/bronchiolar adenoma in
female mice (1/50, 2%; 2/50, 4%; 6/49, 12%, P.< 0.05) and
malignant lymphomas in female mice (13/50,26%; 28/50,
56%, P=0.002; 29/50, 58%; P =0.001).
Uncommon tumors were observed in dosed animals at
low incidences but may be important because the histor-
ical control incidences areverylow; bile duct adenomain
1/50 high dose male rats (historical control 3/3,663),
transitional-cell papillomas of the urinary bladder in
female rats (historical control, 3/3,664, 0.08%; low dose,
2/50,4%; high dose, 1/50, 2%) and granulosa cell tumors
of the ovary in female rats (historical control, 11/3,642,
0.3%; low dose, 3/50, 6%; high dose, 2/50, 4%).
Decreases in tumor incidences were observed for leu-
kemia in male rats (control, 12/50, 24%; low dose, 6/50,
12%; high dose, 5/50, 10%, P= 0.048) and alveolar or
bronchiolar adenomas (combined) in male mice (12/49,
24%; 9/49,18%; 3/49, 6%, P 0.011).
Under the conditions of these studies, 4,4'-
methylenedianiline dihydrochloridewas carcinogenic for
F344/N rats and B6C3F1 mice of each sex, causing
significantly increased incidences of thyroid follicular
cell carcinomas in male rats, thyroid follicular cell ade-
nomas in female rats and in mice of each sex, C-cell
adenomas ofthe thyroid gland in female rats, neoplastic
nodules in the liver of male rats, hepatocellular car-
cinomas in mice of each sex, adenomas of the liver and
malignant lymphomas in female mice, and adrenal phe-
ochromocytomas in male mice.
Report Date: June 1983
TR-249 Lifetime Carcinogenesis Studies
ofAmosite Asbestos (CAS No. 12172-73-5)
in Syrian Golden Hamsters (Feed Studies)
Carcinogenesis studies ofamosite asbestos were con-
ducted by administering diets containing 1% of the
asbestos in pellets from the conception of the mothers
through the lifetime of male and female Syrian golden
hamsters. Control groups consisted of127 male and 126
female hamsters and the amosite asbestos groups con-
sisted of252 male and 254 female hamsters.
No adverse effect on body weight gain or survival was
observedfromtreatmentwithamositeasbestos. Neitherof
theamositeasbestosgroups showedincreasedneoplasiain
any organ or tissue compared to the control groups.
Underthe conditions ofthese studies, the ingestion of
amosite asbestos at a level of 1% in the diet for their
lifetime was not toxic and did not cause a carcinogenic
response in male and female Syrian golden hamsters.
Report Date: November 1983
Note: Amosite Asbestos was subsequently tested in
F344 rats administered in feed (See TR-279, reported
1990).
TR-250 Toxicology and Carcinogenesis
Studies ofBenzyl Acetate (CAS No.
140-11-4) in F344/N Rats and B6C3F1 Mice
(GavageStudies)
Benzyl acetate, a water-white liquid with a pear-like
odor, is a natural constituent ofseveral essential oils and
flower absolutes extracted fromjasmine, hyacinth, gar-
137NTP/NIEHS
denia, tuberose, ylang-ylang, cananga, and neroli. Com-
mercial benzyl acetate, a liquid prepared synthetically
from benzyl chloride, acetic acid, and triethylamine is
usedprimarilyasacomponent ofperfumes forsoapsand
as a flavoring ingredient. This compound is practically
insoluble inwaterbutis miscible in alcohol and etherand
soluble in benzene and chloroform.
Toxicology and carcinogenesis studies of benzyl ace-
tate (>99% pure) were conductedbyadministering ben-
zyl acetatein corn oil gavage to groups of50male and 50
female F344/N rats atdoses of0,250, or500mg/kgbody
weight and to groups of 50 male and 50 female B6C3F1
mice atdoses of0,500, or1,000mg/kgoncedailyfivedays
per week for 103 weeks. Dose selection for the 2-year
study was based on mean body weight gain depression
and decreased survival observed at higher doses in 13
week studies.
The absence ofanyobservable adverse effectofbenzyl
acetate on the survival ormeanbodyweightgains ofthe
rats or mice in the 2-year studies suggests thatboth the
rats and the mice ofeach sex could have tolerated higher
doses. An infection in the genital tract was probably
responsible for the deaths of 26/35 control, 14/32 low-
dose, and 8/20 high-dose female mice before the end of
the study.
Acinar-cell adenomas in the pancreas of male rats
occurredwithapositivetrend(P<0.01),andtheincidence
in the high-dose group (37/49, 76%) was significantly
(P<0.01) higherthaninthevehicle controls (22/50,40%).
The incidence of these tumors in the low-dose group
(27/50, 54%) was comparable to that in the gavage con-
trols. Acinar-cell hyperplasia of the pancreas was
observedin37/50control,34/50low-dose, and36/49high-
dose male rats. No acinar-cell hyperplasia oradenoma of
the pancreas was observed in female rats.
Theincidence ofretinopathyandcataractsinthehigh-
dosemaleratswasincreasedcomparedwiththe controls
(retinopathy: 1/50; 0/50; 20/50; cataracts: 0/50; 0/50;
13/50). Low-dose female rats had an increased incidence
ofretinopathy (18/50). Retinopathy and cataracts in rats
have been associated with proximity to fluorescent light
in this and previous studies.
Preputial gland neoplasms occurred with a positive
trend (P<0.05) in male rats (cystadenocarcinoma: 0/50;
0/50; 3/50; alladenocarcinoma: 0/50; 1/50;4/50; adenocar-
cinomaorcarcinomacombined: 1/50;1/50;6/50). However,
the incidence of all preputial gland tumors was not
significantly elevated (2/50; 1/50; 6/50). For female rats
the incidence ofclitoral gland neoplasms wasmarginally
increased (2/50; 0/50; 5/50).
Hepatocellular adenomas occurred in mice ofeach sex
with statisticallypositivetrends(males: 0/50; 5/49; 13/50;
females: 0/50; 0/50; 6/50), and the incidences in the high-
dose groups were greater than those in the controls
(males: P<0.001; females: P<0.05). Hepatocellular car-
cinomas were marginally elevated in dosed male and
high-dose female mice (males: 10/50; 14/49; 12/50;
females: 1/50; 0/50; 4/50).
Squamous cell papillomas or carcinomas of the for-
estomach (uncommon neoplasms) occurred with a posi-
tive trend (P<0.05) in male mice (4/49; 4/48; 11/49). The
incidenceofthesetumorswasalsomarginally(P=0.054)
increased in the high-dose female mice (0/50; 0/50; 4/48).
The incidences of these tumors in both the high-dose
male and the high-dose female mice were considerably
higherthanthehistorical corn oilgavage controlrates at
this laboratory (males, 2/296, 0.7%; females, 2/297, 0.7%)
and throughout the program (males, 14/1,070, 1.3%;
females, 3/1,073, 0.3%). Forestomach hyperplasia
occurred at increased incidences in dosed mice ofeither
sex (males: 1/49, 7/48, 22/49; females: 1/50, 6/50, 17/48).
The neoplasms and hyperplasia ofthe forestomach were
probably related to administration ofbenzyl acetate.
In a separate metabolism study, benzyl acetate was
absorbed from the gastrointestinal tract of rats and
mice, with approximately 90% ofthe administered dose
recovered as various metabolites in the urine within 24
hr.Theprimarymetabolitewashippuricacid,withminor
amounts ofa mercapturic acid, and one or more uniden-
tified metabolites. This capacity for absorption, metabo-
lism, and disposition was unaffected by the amount or
number ofdoses administered.
Benzyl acetate was not mutagenic in strains TA100,
TA98, TA135, or TA137 ofSalmanella typhimurium in
the presence or absence of Aroclor 1254-induced
Sprague-Dawley rat or Syrian hamster S9 when tested
according to the preincubation protocol. Benzyl acetate
did not induce sister-chromatid exchanges or chromoso-
mal aberrations in Chinese hamster ovary cells in the
presence or absence of Aroclor 1254-induced Sprague-
DawleyratliverS9. Benzyl acetatewas mutagenic inthe
mouse lymphoma L5178Y/TK+/- assay in the presence,
but not in the absence, of Aroclor 1254-induced Fisher
344 rat liver S9.
An audit was conducted on the experimental data and
the draft technical report for these 2-year studies on
benzyl acetate. Based on the results of this audit addi-
tional pathology examinations were conducted on all
targetorgansinmaleratsandmaleandfemalemice.The
Technical Report reflects these final pathology evalua-
tions. The overall conclusions regarding the toxicology
andcarcinogenicity ofbenzyl acetatedid notchange as a
result ofthis evaluation.
Under the conditions of these gavage studies, benzyl
acetate increased the incidence of acinar-cell adenomas
ofthe exocrinepancreasinmaleF344/Nrats; thegavage
vehicle may have been a contributing factor. There was
no evidence ofcarcinogenicity forfemale F344/N rats.
For male and female B6C3F1 mice there was same
evidence of carcinogenicity in that benzyl acetate
caused increased incidences ofhepatocellular adenomas
and squamous cell neoplasms ofthe forestomach.
Synonyms: alpha-acetoxytoluene; benzyl ethanoate; ace-
tic acid, benzyl ester
Report Date: August 1986
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TR-251 Toxicology and Carcinogenesis
Studies of Commercial Grade 2,4 (80%)-
and 2,6 (20%)- Toluene Diisocyanate (CAS
No. 26471-62-5) in F344/N Rats and B6C3Fj
Mice (Gavage Studies)
Toluene diisocyanate (TDI) is commercially produced
as an approximate 80:20 mixture of the 2,4- and 2,6-
isomers. In 1980, 580,000 pounds of this chemical were
produced in the United States, primarily for use in the
manufacture offlexible polyurethane foams. These foam
elastomers are found in furniture and automobile
cushions, carpet underlays, pillow filling, mattresses,
insulation, shoes, purses, and toys. TDI is also used to
produce polyurethane coatings for lacquers and wood
finishes.
Groups of50 female F344/N rats and 50 B6C3F1 mice
were administered commercial grade toluene diisocya-
nate (80% 2,4- and 20% 2,6-) in corn oil by gavage at
doses of60 or120mg/kgbodyweight, 5 daysperweekfor
105 or106weeks. Groups of50male F344/N rats received
30 or 60 mg/kg and groups of 50 male B6C3F1 mice
received 120 or240 mg/kg on the same schedule. Dosage
analyses oftoluene diisocyanate indicated thatthechem-
ical had reacted inthe corn oilvehicle, resultingin actual
gavage concentrations 77% to 90% oftheoretical values.
Groups of50rats and50miceofeach sexreceived cornoil
only and served as vehicle controls.
Survival in all groups of dosed rats in the 2-year
studieswereshorter(PK 0.005) thanthatofthecontrols;
depressions of the mean body weight gain relative to
controls were greater than 10% in all dosed rat groups
throughout most ofthe study. Adose-dependent pattern
ofcumulative toxicitybegan at 70weeks and culminated
in excessive mortality, indicating the estimated tolerated
dose had been exceeded for rats. Acute bronchop-
neumonia occurred at increased incidences in groups of
dosed male and female rats (males: control, 2/50; low
dose, 6/50; high dose, 14/50; females: 1150, 10/50, 25/49).
Subcutaneous tissue fibromas or fibrosarcomas (com-
bined) in male rats occurred with a positive trend
(P<0.01; 3/50, 6/50,12/50). Theincidence in thehigh dose
groupwashigherthanthatinthe controls (PK 0.01). The
same tumor comparisons were significant (P<0.001) in
female rats by the life table analysis. Mammary gland
fibroadenomas in female rats occurred with a positive
trend (P<0.001), and the incidences in low and high dose
groups were significantly higher than that in controls
(P. 0.01).
Pancreatic acinar cell adenomas in male rats occurred
with a positive trend (P<0.05; 1/47, 3/47, 7/49). The
incidence in the high dose group was higher than that in
thecontrols (P<0.05).
The incidences of pancreatic islet cell adenomas in
female ratswere higherbytheincidental tumortest(P<
0.01) in low dose (6/49) and high dose (2/47) groups than
in controls (0/50). An islet cell carcinoma was also
observed in a low dose female rat. The incidences of
female rats with neoplastic nodules in the liver occurred
with a positive trend (P<0.05; 3/50, 8/50, 8/48), and the
incidence in the high dose group was higher (P<0.05)
than that in the controls.
Survival ofhigh dose male mice in the 2-year studywas
significantly shorter than that of the controls (P<0.001).
During the second year of the study, mean body weight
gains ofhigh dose male mice were less than those of the
controls. Cytomegaly of kidney tubular epithelium was
found in 45/48 (94%) low dose male mice and 41/50 (82%)
high dose male mice but not in any ofthe controls.
Hemangiomas or hemangiosarcomas (combined) of
the circulatory system in female mice occurred with a
positivetrend(PK 0.01; control, 0/50; lowdose, 1/50; high
dose, 5/50). The incidence in the high dose group was
significantly higher than that in the controls (P<0.05).
Hepatocellular adenomasinfemalemiceoccurredwith
a positive trend (P< 0.001; 2/50, 3/50, 12/50), and the
incidence in the high dose groupwas higher than that in
thecontrols (P<0.01).
Toluene diisocyanate was mutagenic in Salmonella
typhimurium strains TA98 and TA100 in the presence
(but not the absence) of Aroclor 1254-induced male
Sprague-Dawley rat or male Syrian hamster liver S9; it
was not mutagenic in strains TA 1535 or 1537.
An audit of the experimental data for these 2-year
toxicological and carcinogenicity studies on commercial
grade 2,4- and 2,6-toluene diisocyanate was conducted.
There were no data discrepancies that influenced the
final interpretations.
Underthe conditions ofthesegavage studies, commer-
cial grade toluene diisocyanate in corn oil was car-
cinogenic for F344/N rats, causing subcutaneous
fibromas and fibrosarcomas (combined) in males and
females, pancreatic acinar cell adenomas in males, and
pancreatic islet cell adenomas, neoplastic nodules ofthe
liver, and mammary gland fibroadenomas in females.
Toluene diisocyanate was not carcinogenic for male
B6C3F1 mice. TDI was carcinogenic for female B6C3F1
mice, causinghemangiomas orhemangiosarcomas (com-
bined), as well as hepatocellular adenomas.
Synonym: TDI
Report Date: August 1986
TR-252 Carcinogenesis Studies of Food
Grade Geranyl Acetate (71% Geranyl
Acetate, 29% Citronellyl Acetate) (CAS No.
105-87-3) in F344/N Rats and B6C3F1 Mice
(GavageStudy)
Geranyl acetate is a colorless liquid prepared by frac-
tional distillation ofselected essential oils or by acetyla-
tion ofgeraniol. It is a natural constituent ofmore than
60 essential oils, including Ceylon citronella, palmarosa,
lemon grass, petitgrain, nerolibigarade, geranium, cori-
ander, carrot, and sassafras.
Geranyl acetate is used primarily as a component of
perfumes for creams and soaps and as aflavoringingre-
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dient. OntheU.S. FoodandDrugAdministration'slistof
substances "generally recognized as safe", the Food
Chemicals Codex (1972) specifies that geranyl acetate
must contain at least 90% total esters.
Carcinogenesis studies offood-grade geranyl acetate
(containing approximately 29% citronellyl acetate) were
conducted by administering the test chemical in corn oil
by gavage to groups of 50 male and 50 female F344/N
rats at doses of1,000 or2,000mg/kgbodyweight and to
groups of50maleand50femaleB6C3F1 miceatdosesof
500 or 1,000 mg/kg. Doses were administered five times
perweek for 103weeks. Groups of50 rats and 50mice of
each sex received corn oil by gavage on the same dosing
schedule and served as vehicle controls.
The cumulative toxicity of geranyl acetate in the
2-year study was indicated by the significantly shorter
survival ofhigh dose male rats (control, 34/50; low dose,
29/50; high dose, 18/50) and of high dose male mice
(control, 31150; low dose, 32/50; high dose, 0/50) and of
dosed female mice (38/50; 15/50; 0/50) when compared
withcontrols.Throughoutmostofthe2-yearsbudy,mean
bodyweights ofhigh dose rats andmice ofeach sexwere
lower than those ofthe controls.
The occurrence ofretinopathyor cataracts inthe high
dose male rats and low dose female rats as compared
with the controls does not appear to be related to the
administration of geranyl acetate but rather the prox-
imity of the rats to fluorescent light. The incidence of
retinopathy or cataracts (combined) was: males: control,
0/50, 0%; low dose, 1/50, 2%; high dose, 11150, 22%;
females: control, 1/50, 2%; low dose, 13/50, 26%; high
dose, 2/50,4%. Kidneytubular cell adenomas, an uncom-
mon tumor type, were found in 2/50 (4%) low dose male
rats. The historical incidence of male corn oil gavage
control F344/N ratswithkidneytumorsis1V250(0.4%) at
this laboratory and 4/998 (0.4%) in the program.
Squamous cell papillomas in the skin were increased
marginally in low dose male rats (control, 0/50; low dose,
4/50, 8%; high dose, 1150, 2%). In addition, one low dose
male rat had a squamous cell carcinoma ofthe skin. The
incidence oflow dose male rats with either squamous cell
papillomas or carcinomas was greater (P<0.05) in com-
parison with the controls. The historical incidence of
squamous cell papillomas or carcinomas (combined) in
gavage control male F344/N rats is 3.6% (9/250) at this
laboratoryand2.5% (25/999)throughouttheprogram.The
incidence of all epidermal tumors was not significantly
elevated in dosed male rats relative to controls (control,
3/50, 6%; low dose, 6/50,12%; high dose, 1150, 2%).
Allhighdose (1,000mg/kg)male andfemalemicewere
dead byweek 91 as a result ofaccidentally being admin-
istered2,800mg/kgfor3daysduringweek91;survivalof
lowdose andcontrolmalemicewascomparable. Survival
ofhigh dose male and dosed female mice may have been
inadequate for the detection of late-appearing tumors.
No evidence of any carcinogenic effect was found in
eitherlow orhigh dose mice ofeither sex. Aninfection of
the genital tractwas probablyresponsible forthe deaths
of14/22 control and 8/32 lowdosefemale mice before the
end ofthe study.
Cytoplasmic vacuolization was increased in the liver.
and in the kidney of male and female mice and was
considered to be compound related (liver-male: control,
1150, 2%; low dose, 7/50, 14%; high dose, 47/50, 94%;
female:1150,2%;27/50,54%;46/50,92%;kidneyorkidney
tubule-male: 0/50; 0/50; 41150, 82%; female: 0/50; 24/49,
49%; 37/50, 74%).
Underthe conditions ofthese studies, geranyl acetate
was notcarcinogenic for F344/N rats orB6C3F1 mice of
either sex; however, the reduced survival observed in
high dose male rats, high dose male mice, and high and
low dose female mice lowered the sensitivity of these
studies for detecting neoplastic responses in these
groups. Inmaleratsthemarginalincreases ofsquamous
cell papillomas ofthe skin and tubular cell adenomas of
the kidney may have been related to administration of
geranyl acetate.
Synonym: 3,7-dimethyl-2,6-octadiene-1-ol acetate
Report Date: October 1987
TR-253 Carcinogenesis Studies ofAllyl
Isovalerate (CAS No. 2835-39-4) in F344/N
Rats and B6C3F1 Mice (Gavage Studies)
Allyl isovalerate, a synthetic fragrance and flavoring
ingredientinuse sincethe 1950s, maybefoundinvarious
products at the following concentrations: soap, 30 ppm;
detergent, 3 ppm; creams, 15 ppm; perfume, 50 ppm;
nonalcoholicbeverages, 9 ppm; ice cream, 18 ppm; candy,
22 ppm; baked goods, 15-48 ppm; and gelatins and pud-
dings, 1 ppm. A colorless liquid with an apple-like odor
and taste, allyl isovalerate is approved by the U.S. Food
and Drug Administration for use in foods. Specific pro-
duction figures are not available, but U.S. production in
1980 exceeded 1,000 pounds.
Carcinogenesis studies ofallyl isovalerate (96% pure)
were conducted by administering the test chemical in
corn oil gavage to groups of50male and 50female F344/
N rats and to groups of 50 male and 50 female B6C3F1
mice at doses of31 or 62 mg/kg. The doses selected were
based on the chemically-induced toxic effects and
depressedweightgains obtained from the 13-week stud-
ies. Doseswere administered five times perweekfor 103
weeks. Groups of50ratsand 50miceofeach sexreceived
corn oil by gavage on the same dosing schedule and
served as vehicle controls.
Survivalandmeanbodyweightgainofratsofeach sex
andmalemicewere notadversely affectedbythe admin-
istration ofallyl isovalerate. The significantly lower sur-
vival (P=0.001) and the lower mean bodyweight oflow-
dose female as compared with controls are likely conse-
quences ofthe high incidence ofa genital tract infection
in the low-dose females. This infection was probably
responsibleforthedeathsof11/19control,22/33 low-dose,
and 13/25 high-dose female mice thatdiedbefore the end
ofthe study.
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Squamous cellpapillomas andepithelialhyperplasia of
the nonglandular stomach were observed in dosed male
mice in the 2-year studies (squamous cell papillomas:
0/50,1150, 2%, 3/48, 6%; epithelial hyperplasia: 1/50, 2%,
1150, 2%, 7/48, 15%). The papillomas occurred with a
significantpositivetrend(P<0.05).Theincidenceofhigh-
dose male mice with squamous cell papillomas of the
nonglandularstomachwas alsohigher (P<0.01)thanthe
historical rate for vehicle control male B6C3F1 mice in
theBioassayProgram(5/881,0.6%). Forestomach lesions
were also observed in female mice: squamous cell
papillomas (1150, 0/50,2/50) and epithelial hyperplasia of
the nonglandular stomach (0/50, 2/50, 3/50). Pancreatic
acinar-cell adenomasoccurredathigherincidencesinthe
dosed male rats than in the controls (control, 1150, 2%;
low-dose, 4/50, 8%; high-dose, 2/50, 4%). Pancreatic
acinar-cell tumors were not observed in female rats.
Preputial gland adenomas were observed in increased
incidence in low-dose male rats (0/50, 4/50, 8%; P<0.05,
1/50, 2%).
Mononuclear-cell leukemias in rats and lymphomas in
mice occurredwithincreased incidences. This consistent
dose-response increase among both rats and mice indi-
cates that allyl isovalerate adversely affects the hema-
topoietic system.
Cholangiofibrosis, nodular regeneration, cirrhosis,
focal necrosis, fatty metamorphosis, and cytoplasmic
vacuolization were observed at increased incidences in
thelivers ofhigh-dose male andfemale rats inthe2-year
study. No compound-related nonneoplastic lesions were
observed in the mice ofeither sex. Liverneoplasms were
not increased in either dosed rats or mice ofeither sex.
Significant (P<0.05) decreases in tumorincidenceswere
observed in male mice for hepatocellular carcinomas
(18/50, 6/50, 9/50), for alveolar/bronchiolar adenomas or
carcinomas (13/50, 6/50, 5/49), and for follicular-cell ade-
nomas ofthe thyroid gland (5/47, 0/46, 1/49).
Allyl isovalerate was not mutagenic for Salmrnella
typhimurium (tester strains TA98,100,1535, and1537)
with orwithout metabolic activation.
Underthe conditions ofthese studies, allylisovalerate
was carcinogenic for F344/N rats and B6C3F1 mice,
causing increased incidences of hematopoietic system
neoplasms (mononuclear-cell leukemia in male rats and
lymphoma in female mice).
Report Date: May 1983
TR-254 Dichloromethane (Methylene
Chloride) (CAS: 75-09-2)
Studyconsideredinadequate; noTechnical Reportwillbe
issued. Dichloromenthane was subsequently studied in
F344 rats and B6C3F1 mice by inhallation (See TR-306
published in 1986).-
TR-255 Toxicology and Carcinogenesis
Studies of1,2-Dichlorobenzene (o-
Dichlorobenzene) (CAS No. 95-50-1) in
F344/N Rats and B6C3F1 Mice (Gavage
Studies)
The major use of 1,2-dichlorobenzene is as an inter-
mediate in the synthesis of several organic compounds
(e.g 3,4-dichloroaniline) and in the syntheses of the
herbicidespropanil, diuron, andneburon. Itis used as an
industrial solventfortoluene diisocyanate, an additive to
degreasingagents, aheatexchangemedium, adeodorant
forgarbageand sewage, aningredientinpaintremovers,
an engine cleaner and de-inking solvent, and a solvent
and intermediate in dye manufacture). 1,2-
Dichlorobenzene is also used as an insecticide and a
fumigant to control peach tree borers, bark beetles,
grubs, and termites and to killmites and otherinsects in
poultryhouses and animal sleeping quarters. Because of
its properties as both an insecticide and a solvent, 1,2-
dichlorobenzene has been used in low-pressure aerosol
formulations of insecticides. Approximately 49 million
pounds of 1,2-dichlorobenzene were produced in the
UnitedStatesin1980. Firstreportedcommercialproduc-
tion began in 1921.
In13-weekstudiesusingF344/NratsandB6C3F1mice,
500 mg/kg of1,2-dichlorobenzene (>99% pure) decreased
survival in male and female mice and female rats when
administered in corn oil by gavage five times perweek. At
this dose, 1,2-dichlorobenzene produced centrolobular
necrosis of the liver, hepatocellular degeneration, and
depletion oflymphocytes in the thymus and spleen ofboth
sexes ofrats and mice. At a dose of250 mg/kg, necrosis of
individual hepatocytes was observed in both sexes ofrats
and in male mice. Minimal hepatocellular necrosis was
observedin afewratsatadoseof125mg/kg,butnohepatic
alterations were observed in mice at this dose. Renal
tubular degenerationwas observed inmalerats at500mg/
kg,andmultifocalmineralizationofthemyocardialfibersof
the heart and skeletal muscle were seen in mice. The only
hematologic changes considered notable were slight
decreases in hemoglobin and hematocrit in the 500 mg/kg
maleandfemalerats andinredblood cell countsinthe500
mg/kg male rats; no other marked hematological changes
were observed in either species.
Two-yeartoxicology and carcinogenesis studies of1,2-
dichlorobenzene were conducted by administering the
test chemical in corn oil gavage five times per week for
103 weeks to groups of 50 male and 50 female F344/N
rats and B6C3F1 mice at doses of 60 and 120 mg/kg.
Groupsof50ratsand50miceofeachsexreceived cornoil
by gavage on the same schedule and served as vehicle
controls.
Survivals of female rats, male mice, and female mice
were comparable to those of the corresponding vehicle
controls in the 2-year study, but survival of high dose
male rats was (P<0.001) shorter than that ofthe vehicle
controls. Inthisgrouptherewerethreeaccidentaldeaths
and five deaths probably due to the gavage process; in
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addition aspiration of1,2-dichlorobenzene in corn oil into
the lungs may have been a contributing factor to the
deathsof12highdosemalerats.The120mg/kgdoselevel
of1,2-dichlorobenzene did not affect bodyweight in rats
ormiceofeithersexorsurvivalofmiceorfemalerats.An
increase in tubular regeneration in the kidney of high
dose male mice was observed in the 2-year study (con-
trol, 8/48, 17%; low dose, 12/50, 24%; high dose, 17/49,
35%). No other compound-related nonneoplastic histo-
logical lesions were noted in the 2-year study.
The incidence of pheochromocytoma of the adrenal
gland in low dose male rats was elevated (P<0.05, life
tabletest)relativetocontrols (9/50,16/50,6/49). However,
the incidence inthe high dose groupwas lowerthan that
of the controls and the dose-response trend was not
statistically significant. Therefore, the increase in phe-
ochromocytomainthelowdosemaleratsisnotregarded
as related to administration of1,2-dichlorobenzene.
A dose-related increase (P<0.05) in malignant his-
tiocytic lymphoma was observed in male mice (control,
0/50, 0%; low dose, 1150, 2%; high dose, 4/50, 8%) and in
female mice (0/49, 0%; 0/50, 0%; 3/49, 6%); however,
comparisons ofthe numbers ofanimals with all types of
lymphomas is considered to be a more appropriate com-
parison. 1,2-Dichlorobenzene did not increase the inci-
dence ofall types oflymphomas (combined) inmalemice
(8/50,16%; 2/50,4%;4/50,8%) orfemalemice (11V49,22%;
11150, 22%; 13/49, 27%). Therefore, the increase in his-
tiocytic lymphomas was discounted.
Undertheconditions ofthesetwo-yeargavagestudies,
there was no evidence of carcinogenicity of 1,2-
dichlorobenzene for male or female F344/N rats or
B6C3F1 mice receiving 60 or 120 mg/kg per day.
Synonym: o-dichlorobenzene
Report Date: October 1985
TR-256 Sodium (2-Ethylhexyl) Alcohol
Sulfate (CAS: 126-92-1)
Studyconsideredinadequate; noTechnical Reportwill
be issued.
TR-257 Toxicology and Carcinogenesis
Studies ofDiglycidyl Resorcinol Ether
(Technical Grade) (CAS No. 101-90-6) In
F344/N Rats and B6C3F1 Mice (Gavage
Studies)
Diglycidyl resorcinol ether (DGRE), a pale, yellow,
translucent, amorphous solid at room temperature, is
used as a liquid spray epoxy resin, as a diluent in the
production ofother epoxy resins used in electrical, tool-
ing, adhesive, and laminating applications, and as a
curing agentforpolysulfide rubber.Approximately3,000
workers are exposed to DGRE. The quantity of DGRE
produced in the United States is not known.
Toxicology and carcinogenesis studies of technical
grade diglycidyl resorcinol ether (81% pure) were con-
ducted by administering the chemical in corn oil by
gavagetogroupsof50maleand50femaleF344/Nratsat
doses of 25 or 50 mg/kg and to groups of 50 male and
female B6C3F1 mice at doses of 50 or 100 mg/kg. A
supplemental study ofsimilar design in male and female
rats (0or12mg/kg)wasstartedapproximately12months
later because of high mortality in the 50 mg/kg dose
groups. Doseswere administered fivetimes perweekfor
103 weeks. Groups of 50 rats and 50 mice of each sex
received corn oil by gavage on the same dosing schedule
and served as vehicle controls.
Throughout most of the primary study, mean body
weights of high dose male and female rats and female
mice were lower than those ofthe correspondingvehicle
controls. Inthesupplementalstudy,bodyweights ofboth
sexes ofthe dosed rats were unaffected by administra-
tion of DGRE. Survival of dosed rats ofeach sex in the
primary study was dose related and was shorter
(P<0.001) than that ofthevehicle controls. No high dose
male rats and only1/50 high dosefemale rats lived to the
end of the study. Bronchopneumonia was the most fre-
quent cause ofearly death amongthe rats and may have
resulted from the animals' aspiration ofcorn oil contain-
ingdiglycidylresorcinolether. Survivalofthedosedmale
rats in the supplemental study was reduced (P<0.005)
when compared to controls. There was no significant
difference in survival between dosed and control female
rats in the supplemental study. Survival of dosed and
control mice was comparable but poorer in females, with
20/50 (40%) ofthe controls, 13/50 (26%) ofthe low dose,
and10/50(20%)ofthehighdosegroupsaliveattheendof
2 years. These early deaths were due to suppurative and
necrotizinginflammationofthereproductivetract,possi-
bly caused by aKlebsiella sp. infection.
The incidences of rats and mice with hyperkeratosis
and hyperplasia of the forestomach were compound
related. For rats and mice of each sex, incidences of
animals with squamous cell papillomas, squamous cell
carcinomas, or both occurred with statistically signifi-
cantpositivetrends and theincidences observed in other
organs in dosed groups relative to the controls.
An audit of the experimental data was conducted for
the 2-year studies ofdiglycidyl resorcinol ether. No data
discrepancies were found that influenced the final inter-
pretations.
Under the conditions of these 2-year gavage studies,
technical grade diglycidyl resorcinol ethercausedhyper-
keratosis and hyperplasia ofthe forestomach in rats and
mice. DGRE was carcinogenicformaleandfemale F344/
N rats and for male and female B6C3F1 mice, causing
both benign and malignant neoplasms of the for-
estomach.
Synonym: DGRE
Report Date: October 1986
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TR-258 Dimethylbenzanthracene (CAS
No. 57-97-6)/Tetradecanoyl Phorbol Acetate
(CAS No. 20839-11-6) (DMBAITPA)
Studyconsideredinadequate; noTechnical Reportwill
be issued.
TR-259 Carcinogenesis Studies ofEthyl
Acrylate (CAS No. 140-88-5) in F344/N Rats
and B6C3F1 Mice (Gavage Studies)
Ethyl acrylate is a monomer used to produce polymers
and copolymers for use in latex paints, textiles, paper
coatings, fabric finishes, dirt release agents, and specialty
plastics. In 1980, 268 million pounds ofethyl acrylate were
produced in the United States ofwhich 209million pounds
were used by the producers and 59 million pounds sold.
Carcinogenesis studies ofethyl acrylatewere conducted
byadministeringthistestchemicalincornoilbygavageto
groups of50 male and 50 female F344/N rats andB6C3Fj
mice at doses of 100 or 200 mg/kg. Ethyl acrylate was
administered five times perweek for103weeks. Groups of
50rats and 50mice ofeach sexreceived corn oilbygavage
on the same schedule and served as vehicle controls.
Survival ofdosed male and female rats and mice was
comparable with that of the corresponding vehicle con-
trols. There was no evidence of systemic toxicity in the
prechronic or in the 2-year studies.
Compound-related increased incidences of hyper-
keratosis, inflammation, and hyperplasia of the fore-
stomach were observed in rats and mice in the prechronic
as well as 2-year studies. In the 2-year studies, squamous
cell papillomas and squamous cell carcinomas of the for-
estomach occurred at the site ofchemical deposition with
significant positive trends and increased incidences in
dosed groups versus vehicle controls forboth sexes ofrats
andmice. Nonneoplastic and neoplastic forestomach lesion
frequencies were related to the concentration of ethyl
acrylate in dosing solutions used. Significant negative
trends for several common rodent tumors were found in
treated animals in the 2-year studies.
Undertheconditions ofthese studies,ethylacrylatewas
carcinogenic for the forestomach of F344/N rats and
B6C3F1 mice, causing squamous cell carcinomas in male
rats and male mice, squamous cell papillomas in male and
femaleratsandmalemice, andsquamouscellpapillomas or
carcinomas (combined) in male and female rats and mice.
Evidence for carcinogenicity was greater in males than in
females. Ethyl acrylate also caused irritation of the fore-
stomach mucosa in male and female rats and mice.
Synonym: 2-propenoic acid, ethyl ester
Report Date: December 1986
TR-260 Tetracholoroethylene (CAS:
127-18-4)
Studyconsidered inadequate: noTechnical Reportwill
be issued. Tetrachloroethylene was previously tested in
Osborne-Mendel rats and B6C3F1 mice by gavage (See
TR-13, reported 1977) and also in F344 rats andB6C3F,
mice by inhalation (See TR-311 published in 1986).
TR-261 Toxicology and Carcinogenesis
Studies ofChlorobenzene (CAS No.
108-90-7) in F344/N Rats and B6C3F1 Mice
(GavageStudies)
Chlorobenzene is acolorless, volatileliquidunder stan-
dard environmental conditions (vapor pressure= 11.8
mm Hg at 25°C, 760 mm Hg). It is used primarily as a
solvent (e.g. resins, dyes, pesticides, and perfumes), a
degreasing agent, and a chemical intermediate, particu-
larly in the synthesis of nitrobenzenes. Although still
considerable, estimates ofthe yearly production volume
ofchlorobenzene in the United States indicate declining
use in recent years, due to the reduced demand for
organochlorine pesticides utilizing chlorobenzene as an
intermediate.
Toxicology and carcinogenesis studies of chlo-
robenzene(>99%pure)wereconductedbyadministering
the test chemical in corn oil by gavage to groups of 50
male and 50 female F344/N rats and 50 female B6C3F1
mice at doses of 60 or 120 mg/kg. Groups of 50 male
B6C3F1 mice received 30 or 60 mg/kg. Chlorobenzene
was administered five times per week for 103 weeks.
Groupsof50ratsand50miceofeachsexreceivedcornoil
by gavage on the same schedule and served as vehicle
controls, and additional groups of50 rats and 50 mice of
eachsexserved asuntreatedcontrols.Thechlorobenzene
doses were chosen on the basis of 90-day studies, in
which-doses 2-fold or greater in excess ofthe doses used
in the 2-year study caused death, hepatocellular
necrosis, renal tubular injury, thymic necrosis, or lym-
phoid or myeloid depletion of bone marrow, spleen or
thymus.
Mean body weights of dosed rats and mice were
essentiallythe same orgreaterthanthoseofthecontrols
during the 2-year studies. Survivals of low dose male
rats, dosed female rats, dosed male mice, and dosed
female mice were not adversely affected by administra-
tion ofchlorobenzene. Survival ofhigh dose male rats in
the 2-year studywas significantly (P=0.033) lowerthan
that of the vehicle controls. No chlorobenzene-induced
toxic lesions responsible for this reduction in survival
were observed. Based on the prechronic results and on
the above data, the doses used in the 2-year study
were considered to be adequate for carcinogenicity
testing.
Maleratsdosedwithchlorobenzeneexhibited asignifi-
cant (P<0.05) increase in the incidence ofanimals with
neoplastic nodules ofthe liver (overall incidences: untre-
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ated control, 4/50 (8%); vehicle control, 2/50 (4%); low
dose, 4/49 (8%); high dose, 8/49 (16)). Increased inci-
dences of hepatocellular carcinomas in male rats or of
neoplastic nodules or hepatocellular carcinomas in
female rats were not observed. No increased tumor
incidences were observed in female rats or in male or
female mice.
Under the conditions of these studies, chlorobenzene
administration increased the occurrence of neoplastic
nodules of the liver in high dose (120 mg/kg/day) male
F344/N rats, providing some but not clear evidence of
carcinogenicity of chlorobenzene in male rats. Car-
cinogenic effects of chlorobenzene were not observed
in female F344/N rats or in male or female B6C3Fj
mice.
Synonyms: monochlorobenzene; chlorobenzol; phenyl
chloride; benzene monochloride
Report Date: October 1985
TR-262 1,1,1-¶Xichloroethane (Methyl
Chloroform) (CAS: 71-55-6)
Studyconsidered inadequate; noTechnical Reportwill
be issued. 1,1,1-Trichloroethane was previously tested in
Osborne-Mendel rats and B6C3F1 mice by gavage (See
TR-003, reported 1977).
TR-263 Toxicology and Carcinogenesis
Studies of1,2-Dichloropropane (Propylene
Dichloride) (CAS No. 78-87-5) in F344/N
Rats and B6C3F1 Mice (Gavage Studies)
1,2-Dichloropropane is a chemical intermediate widely
used intheproduction oftetrachloroethylene and carbon
tetrachloride. It is an oil and fat solvent in certain
furniture finishes, dry cleaning fluids, and paint
removers and has been used to fumigate grain and soil
and to control peach tree borers. Approximately 77 mil-
lion pounds of1,2-dichloropropane were produced in the
United States in 1980. The current 8-hour time-
weighted-average concentration to which workers may
be exposed to is 75 ppm.
Carcinogenesis studies of1,2-dichloropropane (>99%
pure) were conducted by administering the chemical in
cornoilbygavagetogroupsof50femaleF344/Nratsand
50maleand50femaleB6C3F1 mice atdosesof125or250
mg/kgbodyweightandtogroups of50maleF344/N rats
at doses of 62 or 125 mg/kg body weight. Doses were
administered five times per week for 103 weeks. Vehicle
control groups of50rats and 50mice ofeach sexreceived
an equivalent amount ofcorn oil by gavage on the same
dosing schedule.
Survival was reduced for high dose female rats
(P<0.001)andforhighdosefemalemice(P<0.05)relative
to controls; 16/50 high dose female rats and 26/50 high
dose female mice survived to the end ofthe experiment.
Survival in the other groups was comparable to the
control groups. Infemalemice, ovarian,uterine, ormulti-
ple organ infections may have contributed to the deaths
of5/11 vehicle control, 9/14 low dose, and 14/22 high dose
animals that died before the end ofthe study. There was
no evidence ofan adverse effect on survival in male rats
or in male mice.
Meanbodyweights ofhigh dose male (-14%) and high
dose female (-24%) rats were lower than those of the
controls. Low dose rats and all groups ofmice had mean
body weights comparable to the controls.
Highdosefemaleratshadincreasedincidencesofboth
clear-cell changes and necrosis oftheliver; buttherewas
no increase in theincidence ofliver tumors in the female
rats. Therewas no treatment-related effects observed in
the male rats, other than decreased body weights.
Dose-relatedincreaseswereobserved foradenomasof
the liverin bothmale (control, 7/50; low dose,10/50; high
dose 17/50) and female (1150, 5/50, 5/50) mice. The
increase in the frequency ofliver carcinomas supported
the evidence that there was a neoplastic response in the
mouse liver for both sexes (males: 11V50, 17/50, 16/50,
females: 1150, 3/50, 4/50). Hepatocytomegaly and hepatic
necrosis were increased in male mice, but not in female
mice.
A dose related increase in adenocarcinomas of the
mammary gland was observed in female rats (control,
1/50; lowdose,2/50; high dose, 5/50)with themajorityof
these tumors being found at the end of the study (1/37,
3%; 2/43, 5%; 4/16, 25%). The incidence of mammary
adenocarcinomas was increased when compared to the
historical controls for this laboratory (3/150, 2.0%) and
for all laboratories combined (11/895, 1.2%). Mammary
fibroadenomas were decreased in the high dose treated
female rats (15/50, 20/50, 7/50).
The mutagenic activity of 1,2-dichloropropane was
marginal. The compound was tested in strains TA100,
TA98,TA1537, andTA1535ofSalmonellatyphimurium
in the presence or absence of S9 and no clearly positive
response was obtained. Chromosomal aberration and
sister chromatid exchange data showed that 1,2-
dichloropropane caused increases in both in the absence
or presence ofS9.
Under the conditions of these 2-year gavage studies,
therewasnoevidenceofcarcinogenicityformaleF344/N
ratsreceiving62 or125mg/kg. Forfemaleratstherewas
equivocal evidence ofcarcinogenicity in that 250 mg/
kg 1,2-dichloropropane caused a marginally increased
incidence of adenocarcinomas in the mammary gland;
these borderline malignant lesions occurred concurrent
with decreased survival and reduced body weight gain.
There was some evidence ofcarcinogenicity for male
andfemaleB6C3F1 miceexposedto1,2-dichloropropane,
as indicated by increased incidences of hepatocellular
neoplasms, primarily adenomas.
Synonym: propylene dichloride
Report Date: August 1986
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TR-264 Ethoxylated Dodecyl Alcohol
(CAS: 9002-92-0)
Studyconsideredinadequate; noTechnical Reportwill
be issued.
TR-265
Sodium)
C.I. Acid Yellow 73 (Fluorescein
(CAS: 518-47-8)
Studyconsidered inadequate; noTechnical Reportwill
be issued.
TR-266 Toxicology and Carcinogenesis
Studies ofMonuron (CAS No. 150-68-5) in
F344/N Rats and B6C3F1 Mice (Feed
Studies)
Carcinogenesis studies of monuron (greater than 99%
pure), a substituted urea herbicide, were conducted by
feeding diets containing 0, 750, or 1,500 ppm monuron to
groups of 50 F344/N rats of each sex and 0, 5,000, or
10,000 ppm to groups of50 B6C3F1 mice ofeach sex for
103 weeks. Survivors then were fed a control diet for 1
week, killed, and examined.
Throughout mostofthe studies, meanbodyweights of
dosed rats and mice ofeach sex were lower than those of
the controls. Survival rates oflow dose female rats and
high dose male and female mice were increased relative
to those ofthe controls.
In 13-week toxicity studies, the lympho/hematopoietic
system of rats and mice was the primary site affected.
The lymphoid depletion found in these animals was not
seen in rats ormice survivingto the end ofthe 104-week
studies.
Nonneoplastic changes associated with the long-term
administration ofmonuron to rats included renal tubular
cellcytomegaly,mainlyinvolvingtheproximalconvoluted
tubules in male and female rats, and dose-related hepatic
cytoplasmic changes in male rats.
In the 104-week study, the kidneys and liver of male
rats were the primary tissues affected. Long-term
administration of monuron was associated with an
increaseinrenaltubularcell adenomas (control,0/50; low
dose, 2/50; high dose, 7/50) and renal tubular cell ade-
nocarcinomas (0/50; 1/50; 8/50). Administration of
monuron to male rats was associated with increased
incidences of neoplastic nodules of the liver (1/50; 6/49;
7/50) and ofneoplastic nodules orcarcinomas (combined)
ofthe liver (1/50; 6/49; 9/50).
Dosed male and female rats had decreased incidences
ofmononuclear cell leukemia; dosed male rats had lower
incidences ofpheochromocytomas ofthe adrenal glands
and C-cell carcinomas ofthethyroid gland; dosed female
rats had reduced incidences of mammary gland flbro-
adenomas.
In male mice, dose-related decreases occurred in the
incidences ofhepatocellular carcinomas (6/50; 5/49; 2/50)
and hepatocellular adenomas or carcinomas (12/50; 8/49;
6/50); incidences of hepatocellular tumors in low dose
female mice were reduced in dosed female mice (16/50;
8/50; 7/50).
Monuron was not mutagenic in Salmonella strains
TA98, TA100, TA1535, or TA1537 in the presence or
absence of Aroclor 1254-induced rat liver S9. Monuron
did induce chromosomal aberrations and sister chro-
matid exchanges in cultured Chinese hamster ovary
cells.
Thedata, documentsandpathologymaterialsfromthe
2-year studies ofmonuron have been audited. The audit
findings show that the conduct of the studies is docu-
mented adequately and support the data and results
given in this Technical Report.
Under the conditions of these 2-year feed studies,
there was clear evidence ofcarcinogenicity for male
F344/Nratsinthatmonuroncausedincreasedincidences
oftubularcelladenocarcinomasofthekidney,tubularcell
adenomas of the kidney, and neoplastic nodules or car-
cinomas (combined) of the liver. Monuron induced
cytomegaly of the renal tubular epithelial cells in both
male and female F344/N rats. There was no evidence of
carcinogenicity for female F344/N rats or for male or
female B6C3F1 mice.
Synonyms and Trade Names: N'-(4-chlorophenyl)-N,N-
dimethylurea; 1,1-dimethyl-3-(p-chlorophenyl)urea;
CMU; Karmex Monuron Herbicide; Telvar
Report Date: August 1988
TR-267 Toxicology and Carcinogenesis
Studies ofPropylene Oxide (CAS no.
75-56-9) in F344/N Rats and B6C3F1 Mice
(InhalationStudies)
Propylene oxideis avolatile, colorless liquid used as an
intermediate in theproduction ofpolyetherpolyols, poly-
urethane foams, and unsaturated polyester resins and
also as a fumigant for sterilizing a variety of materials
ranging from plastic medical instruments to foodstuffs.
In the United States, propylene oxide is registered as a
fumigant for packaged dried prunes and glace fruits
such as candied cherries and as an insecticidal and
fungicidal fumigant for bulk quantities of cocoa, gums,
andprocessed spices.
The 2-year carcinogenesis studies of propylene oxide
(greater than 99.9% pure) were conducted by exposing
groupsof50F344/Nratsand50B6C3F1 miceofeachsex
to air containing propylene oxide at concentrations of 0
(chamber control), 200, or400 ppm for 6 hours per day, 5
days per week, for 103 weeks.
The survival of rats exposed to propylene oxide was
comparable with that of the controls; terminal body
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weights were lower than those of the controls for high
dose males (8%) and high dose females (6%). Survival of
exposed male and female mice decreased relative to that
ofthecontrols (male: control, 42/50; lowdose,34/50; high
dose, 29/50; female: 38/50; 29/50; 10/50), but the dif-
ference was significant only for animals in the high dose
groups. Highdosefemalemicehadameanterminalbody
weight 22% below that ofthe controls.
Therespiratoryepitheliumofthenasalturbinateswas
one of the primary tissues affected in male and female
rats; exposure-related increases occurred in the inci-
dences of suppurative inflammation, epithelial hyper-
plasia, and squamous metaplasia. Papillary adenomas,
involving therespiratory epithelium and underlying sub-
mucosal glands ofthe nasalturbinates,were observed in
threefemaleratsand twomaleratsexposed topropylene
oxide at 400 ppm. The incidence ofadenomas in females
was significant by the trend tests.
The proportions of high dose female rats with C-cell
adenomas and with C-cell carcinomas of the thyroid
glandwereincreased, butonlythe combinedincidence of
these tumors was significant (2/45; 2/35; 7/37). These
tumors were not considered to be related to exposure to
propylene oxide because there was no other evidence for
C-cells' being a target tissue and because there was no
increase in C-cell hyperplasia.
The combined incidences of female rats with
endometrial stromal polyps and endometrial stromal
sarcomas of the uterus were significantly increased in
the dosed groups (3/49;12/50; 10/47). However, the occur-
rence ofthese lesions in the dosed groups was similar to
theaverage (306/1,502,20%) seeninuntreatedcontrols in
NTPcarcinogenesis studies, andhencethisincreasewas
not regarded as being related to exposure to propylene
oxide.
Therespiratoryepitheliumofthenasalturbinateswas
also one of the primary tissues affected in male and
female mice; exposure-related increases occurred in the
incidences of inflammation, and squamous metaplasia
was observed in one low dose male and two high dose
female mice. One squamous cell carcinoma and one
papilloma occurred in the nasal cavity of different high
dose male mice, and two high dose female mice had
adenocarcinomas of the nasal cavity. The endothelial
cells of the submucosal vascular plexus in the nasal
turbinates also appeared to be a major site affected in
high dose male mice. Three high dose male and three
high dose female mice had a saccular dilation (classified
as angiectasis) ofsubmucosal turbinatevessels. Further,
hemangiomas were seen in the nasal cavity of5/50 high
dose male mice and 3/50 high dose female mice, and
hemangiosarcomaswerefoundinthenasalcavityof5/50
high dosemalemice and2/50high dosefemalemice. The
increased incidences of hemangiomas in males and
females and ofhemangiosarcomas in males were statis-
tically significant. Vascular tumors were not present in
the nasal turbinates ofany low dose or control mice.
Under the conditions ofthese studies, therewas some
evidence of carcinogenicity for F344/N rats, as indi-
cated by increased incidences of papillary adenomas of
the nasal turbinates in male and female rats exposed to
propyleneoxideat400ppm. FormaleandfemaleB6C3F1
mice, there was clear evidence ofcarcinogenicity, as
indicated by increased incidences of hemangiomas or
hemangiosarcomas of the nasal turbinates at 400 ppm.
In the respiratory epithelium of the nasal turbinates,
propylene oxide also caused suppurative inflammation,
hyperplasia, and squamous metaplasia in rats and
inflammation in mice.
Report Date: March 1985
TR-268 Sodium Dodecyl Sulfate (CAS:
151-21-3)
Studyconsideredinadequate; noTechnical Reportwill
be issued.
TR-269 Toxicology and Carcinogenesis
Studies ofTelone TI® (Technical-Grade 1,3-
Dichloropropane [CAS No. 542-75-6]
Containing 1.0% Epichlorohydrin as a
Stabilizer) in F344/N Rats and B6C3Fj
Mice (Gavage Studies)
Toxicology and carcinogenesis studies ofTelone IIJ (a
soil fumigant containing approximately 89% cis- and
trans-1,3-dichloropropene, 2.5% 1,2-dichloropropane,
1.5% of a trichloropropene isomer, and 1.0% epi-
chlorohydrin) were conducted by administering the
commercial-grade formulation in corn oil by gavage to
groups of52 male and 52 female F344/N rats at doses of
0,25, or50mg/kgandto groups of50male and50female
B6C3F1 mice atdoses of0, 50, or100mg/kg. Doseswere
administered three times perweek for 104 weeks. Ancil-
lary studies were conducted in which dose groups con-
taining five male and five female rats were killed after
receiving Telone Il® for 9, 16, 21, 24, or 27 months.
Mean bodyweights ofhigh dose male rats were about
5% lower than those forthe vehicle control and low dose
male rats; no differences in bodyweights were observed
among groups of female rats. Survival was comparable
forthedifferentgroupsofmaleandfemalerats. Formale
and female mice, the dosed groups initially weighed
6%-22% less than did the vehicle controls; the weight
differential decreased to5%-9%bytheendofthestudies.
Twenty-five vehicle control male mice died duringweeks
48-51 from suppurative inflammation ofthe heart (myo-
carditis). At the end ofthe studies, the survival ofmale
micewas asfollows:vehiclecontrol,8/50;lowdose,28/50;
high dose 31150. Survival of female mice was lower
(P<0.05) in the high dose group than in the vehicle
controls (46/50; 45/50; 36/50).
The primary organs affected were the forestomach
(rats and mice), urinary bladder (mice), lung (mice), and
liver (rats). Compound-related nonneoplastic lesions
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included basal cell or epithelial hyperplasia of the for-
estomach (rats and mice), epithelial hyperplasia of the
urinary bladder (mice), and kidney hydronephrosis
(mice). Neoplastic lesions associatedwith administration
of Telone IL® included squamous cell papillomas of the
forestomach (malerats: 1/52;1152; 9/52;femalerats: 0/52;
2/52; 3/52; female mice: 0/50; 1150; 2/50), squamous cell
carcinomas of the forestomach (male rats: 0/52; 0/52;
4/52; female mice: 0/50; 0/50; 2/50), transitional cell car-
cinomas ofthe urinary bladder (female mice: 0/50; 8/50;
21148), alveolar/bronchiolar adenomas (female mice: 0/50;
3/50; 8/50), and neoplastic nodules ofthe liver (male rats:
1152; 6/52; 7/52).
Althoughthestudyinmalemicewasconsideredinade-
quate due to the deaths at weeks 48-51 of 25/50 vehicle
control animals, 2/50 ofthe high dose males had transi-
tional cell carcinomas of the urinary bladder. Further-
more, increases were seen in the incidences of alveolar/
bronchiolar neoplasms ofthelung(1150; 13/50; 12/50) and
of squamous cell papillomas of the forestomach (0/50;
2/50;3/50).Thesefindingsplusthefindingofnonneoplas-
tic lesions in two ofthese organs (basal cell or epithelial
hyperplasia of the forestomach: 0/50; 0/50; 4/50; epi-
thelial hyperplasia of the urinary bladder: 0/50; 9/50;
18/50) suggestthatTelone II® mayhavebeenresponsible
for the development ofthese lesions in male mice.
Development of lesions ofthe forestomach (basal cell
hyperplasia and squamous cell papilloma) was observed
to be time dependent. The results ofthe scheduled kills
supported the findings of the carcinogenesis studies.
When the results from the scheduled kills at all time
points were pooled with those of the 24-month car-
cinogenesis studies, theincidences were asfollows: basal
cell or epithelial hyperplasia of the forestomach-male
rats: 3/77; 13/77; 31177; female rats: 1175; 5/77; 35/77;
squamous cell papilloma ofthe forestomach-male rats:
1177; 1177; 13/77; female rats: 0/75; 2/77; 8/77; neoplastic
nodules of the liver-male rats: 1177; 6/76; 8/77; female
rats: 6/75; 8/77; 12/77.
cis- and trans-1,3-Dichloropropane are the principle
components (89%) in Telone II@, but the 1.0% epi-
chlorohydrin, a direct-acting mutagen and carcinogen
added as a stabilizer, may have influenced the develop-
ment ofthe forestomach lesions.
1,3-Dichloropropene was mutagenic in Salmonella
typhimurium strains TA98, TA100, andTA1535without
metabolic activation andinTA100andTA1535withmeta-
bolicactivationbyAroclor-inducedmaleSprague-Dawley
rat and Syrian hamsterliver S9. No mutagenic response
wasseeninTA1537. Sex-linkedrecessivelethalmutations
were observed in Drosophila melanogaster, and 1,3-
dichloropropene did notinduce reciprocal translocations
in D. melanogaster.
A data audit was conducted on the Telone IJJ 2-year
carcinogenesis studies in rats and mice and the ancillary
studies in rats. Except forthe already known problem of
survival ofmalevehicle controlmice, no otherdiscrepan-
cies or problems that would compromise the validity of
the findings or alter the interpretations ofthese studies
were found.
Under the conditions of these gavage studies, there
was clearevidence ofcarcinogenicity formale F344/N
rats, as indicated by Telone II-related increased inci-
dences of squamous cell papillomas and carcinomas of
the forestomach, as well as an increased incidence of
neoplastic nodules of the liver. In female F344/N rats,
there was soame evidence of carcinogenicity because
Telone IJJ caused an increased incidence of squamous
cell papillomas of the forestomach. The experiment in
male B6C3F1 mice was considered to be an inadequate
study ofcarcinogenicity because ofreduced survival in
the vehicle control group. However, there was some
indication in the male mice of Telone I®g-related
increases of transitional cell carcinomas of the urinary
bladder, squamous cell papillomas of the forestomach,
and alveolar/bronchiolar adenomas and carcinomas of
the lung. There was clear evidence ofcarcinogenicity
for female B6C3F1 mice, since Telone II® caused
increased incidences of transitional cell carcinomas of
the urinary bladder; Telone Il® also increased the inci-
dences ofalveolar/bronchiolar adenomas ofthe lung and
of squamous cell papillomas or carcinomas of the for-
estomach in the female mice. Telone II®-related non-
neoplastic lesions included basal cell or epithelial cell
hyperplasia in the forestomach of male and female and
male and female mice and epithelial hyperplasia of the
urinary bladder in male and female mice.
Synonyms: cis,trans-1,3-dichloropropene, D-D® Soil Fu-
migant;Telone® Soil Fumigants;Vorlex® SoilFumigants
Report Date: May 1985
TR-270 Gilsonite (CAS: 12002-43-6)
Studyconsideredinadequate; noTechnicalReportwill
be issued.
TR-271 Toxicology and Carcinogenesis
Studies ofHC Blue No. 1 (CAS No.
2784-94-3) in F344/N Rats andB6C3Fj
Mice (FeedStudies)
Toxicology and carcinogenesis studies ofHC Blue No.
1 (97% pure), a semipermanent hair dye, were conducted
by administering the test chemical in feed for 103 weeks
to groups of50 F344/N rats and 50 B6C3F1 mice ofeach
sex. The dietary concentrations used were 0, 1,500, or
3,000 ppm for rats and male mice and 0, 3,000, or 6,000
ppmforfemalemice. These concentrations were selected
onthebasisofresultsfromsingle-administrationgavage
studies and 14-day and 13-week feed studies.
The survival of male and female rats and male mice
was not affected by administration of HC Blue No. 1.
Survival ofhigh dosefemalemicewasreduced (P<0.05);
the early deaths in this group are believed to have been
caused by hepatocellular carcinomas. Body weights of
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high dose rats and dosed mice were lower than those of
the respective control groups; female rats and micewere
more affected than were males.
Administration ofHC Blue No. 1 produced significant
positive trends in the incidences of male rats with
hepatocellularneoplastic nodules/carcinomas (neoplastic
nodules: control, 0/49; low dose, 0/50; high dose, 3/50;
neoplastic nodules/carcinomas: 1/49; 0/50; 6/50). In male
and female mice, both doses ofHC Blue No. 1 increased
the incidences of hepatocellular carcinoma (male: 11/50;
20/50; 30/50; female: 1/50; 24/48;47/49) andthelowdoses
increased the incidences of hepatocellular adenomas
(male: 4/50; 17/50; 10/50; female: 2/50; 11/48; 4/49).
HC Blue No. 1 produced dose-related increases in the
incidences of proliferative lesions of the lungs (ade-
nomatous hyperplasia and alveolar/bronchiolar ade-
nomas or carcinomas) in female rats (hyperplasia: 2/50;
5/49; 8/50; adenoma/carcinoma: 1/50; 3/49; 7/50).
In male mice, HC Blue No. 1 at the 6,000-ppm dose
increased the incidences of thyroid gland follicular cell
hyperplasia and adenomas (hyperplasia: 3/47; 7/49;
14/50; adenoma: 0/47; 0/49; 5/50).
HC Blue No. 1 was mutagenic in strains TA97, TA98,
and TA100 ofSalmonella typhimurium in thepresence
or absence ofAroclor-induced male Sprague-Dawley rat
orSyrianhamsterliverS9; HCBlueNo.1wasnegativein
strain TA1535. HC Blue No. 1 was mutagenic in the
absence of activation in the L5178Y/TK+/- mouse lym-
phoma assayandinduced unscheduled DNAsynthesis in
rat hepatocytes in vitro.
An audit of the experimental data was conducted for
these carcinogenesis studies on HC Blue No. 1. No data
discrepancies were found that influenced the final inter-
pretations.
Under the conditions ofthese feed studies, there was
equivocal evidence ofcarcinogenicity in male F344/N
rats, since HC Blue No. 1 caused a marginal increase in
the incidence of hepatocellular neoplastic nodules/
carcinomas. For female F344/N rats, there was some
evidence of carcinogenicity in that HC Blue No. 1
inducedincreasedincidences ofalveolar/bronchiolar neo-
plasms. Therewas clearevidence ofcarcinogenicity of
HC Blue No. 1 for male and female B6C3F1 mice as
shown by increased incidences of hepatocellular car-
cinomas. Theincidences offollicularcell adenomas ofthe
thyroid glandwere alsoincreased inmale micereceiving
HC Blue No.1.
Synonym: 2,2'((4-(methylamino)-3-nitrophenyl)
imino)bis (ethanol)
Report Date: August 1985
TR-272 Toxicology and Carcinogenesis
Studies ofPropylene (CAS No. 115-07-1) in
F344/N Rats and B6C3F1 Mice (Inhalation
Studies)
Propylene isused as a startingmaterial intheproduc-
tion of polypropylene plastics and various other chemi-
cals, including acrylonitrile, isopropyl alcohol, propylene
oxide, butyraldehyde, cumene, dodecane, nonene, and
allyl chloride. The major derivatives are polypropylene
(25%), acrylonitrile (15%), isopropyl alcohol (10%), and
propylene oxide (10%). It is also a valuable feed-stock
chemical for the production of gasoline. Other mis-
cellaneous applications include use as a startingmaterial
for polymerization reactions to form vinyl chloride
copolymers and low-molecular-weight homopolymers
that are used as additives in lubricating oils and in the
manufacture ofhydroquinone. The chemical is also used
as an aerosol propellant or component. The major end
uses of propylene are in the production of fabricated
plastics (50%) and fibers (15%).
Toxicology and carcinogenesis studies of propylene
(greater than 99% pure) were conducted by exposing
groups of 50 F344/N rats and 49 or 50 B6C3F1 mice of
each sex to propylene in air by inhalation at concentra-
tions of5,000 or 10,000 ppm, 6 hours per day, 5 days per
week, for 103weeks. Other groups of50 rats and 50mice
of each sex in chambers received air only on the same
schedule and served as chamber controls. The highest
concentration ofpropylene that was considered safe for
these studies was 10,000 ppm because of the risk of
explosion that can occur at higher concentrations.
The survival ofexposed and control rats and mice was
comparable. Throughout most ofthe studies, mean body
weights of exposed male and female rats were slightly
lower (0%-5%) than those ofthe controls, but the decre-
ments were not concentration related. After week 59 of
the study, mean body weights of10,000-ppm male mice
were usually slightly lower (5%) than those of the con-
trols,whereasthose inotherexposed groups ofmale and
female miceweregenerallycomparablewith those ofthe
controls. No compound-related adverse clinical signs
were observed in either species.
An increased incidence ofsquamous metaplasia ofthe
nasal cavity was observed in female rats exposed at the
5,000-ppm and 10,000-ppm concentrations (control, 0/49;
low, 15/50; high, 6/50) and in male rats exposed at 5,000
ppm (2/50; 19/50; 7/50). Epithelial hyperplasia of the
nasal cavitywas increased in female rats exposed at the
10,000-ppm concentration (0/49; 4/50; 9/50); the inci-
dences in male rats were 2/50, 2/50, and 5/50. Inflamma-
tion of the nasal cavity, characterized by an influx of
lymphocytes, macrophages, and granulocytes into the
submucosaandbygranulocytesintothelumen, occurred
at increased incidences in low concentration and high
concentrationmaleratsandinhighconcentrationfemale
rats. Chronic focal inflammation ofthe kidneys occurred
at an increased incidence in low concentration and high
concentration mice ofeach sex.
Hemangiosarcomas were found in one low dose male
mouse(liver), twohighdosemalemice(spleen), andthree
high dose female mice (subcutis, spleen, and uterus).
Hemangiomaswerefoundinonelowdoseandinonehigh
dose female mouse (liver). Vascular tumors were not
found in control mice ofeither sex. The lowincidences of
vascular tumors and their occurrence in a variety of
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organs suggest that they are not related to administra-
tion ofpropylene.
The occurrence ofuterine endometrial stromal polyps
in female mice showed a positive trend (P<0.05; 0/47;
0/47;3/48);theincidenceinthe10,000-ppmgroupwasnot
significantly greater than that in the concurrent control
group, but the incidence was higher than the mean
historical controlrate (22/2,411, 0.9%) andwaswithinthe
range (0%-6%) observed in studies throughout the Car-
cinogenesis Program. The occurrence of endometrial
stromal polyps in three high concentration female mice
was not considered to be clearly related to exposure to
propylene.
The incidence of male mice with alveolar/bronchiolar
adenomas or carcinomas (combined) occurred with a
negative trend (P<0.05; 16/50; 4/49; 7/50), and the
reduced incidences in both exposed groups were less
(P<0.05) than that in the control group. The control
incidence of these tumors in an inhalation study con-
ducted concurrently at the same laboratory was similar
(15/50), suggesting apossible exposure-related decrease.
The biologic significance ofthis decrease in male mice is
difficult to assess; the incidences seen in these control
and exposed animals are within the range ofincidences
(2%-34%; mean, 16.7%) observed in control male mice in
other studies throughout the Carcinogenesis Program.
An audit of the experimental data was conducted for
these carcinogenesis studies on propylene. No data dis-
crepancies were found that influenced the final inter-
pretations.
Under the conditions of these studies, there was no
evidence ofcarcinogenicity inmaleandfemale F344/N
rats or in male and female B6C3F1 mice exposed to
propylene by inhalation at concentrations of 5,000 or
10,000 ppm for 103 weeks. In the nasal cavity, propylene
induced squamous metaplasia of the respiratory epi-
thelium in male and female rats and epithelial hyper-
plasia in female rats.
Synonyms: propene; methylethylene; methylethene
Report Date: November 1985
TR-273 Toxicology and Carcinogenesis
Studies of¶richloroethylene (CAS No.
79-01-6) in Four Strains ofRats (ACI,
August, Marshall, Osborne-Mendel)
(GavageStudies)
Trichloroethylene is an industrial solvent used pri-
marily for vapor degreasing and cold cleaning. It was
selected for study because of its industrial use and for
potential for human exposure. (An estimated 3.5 million
workers are exposed to trichloroethylene.) In an earlier
study trichloroethylene (stabilized with epichlorohydrin
and 1,2-epoxybutane) administered by gavage caused
hepatocellular carcinomas in male and female B6C3F1
mice. Trichloroethylene administration did not increase
the incidence of tumors in male or female Osborne-
Mendel rats. However, the survival of dosed rats was
reduced, thereby compromising the sensitivity of the
study to detect a carcinogenic effect.
Thestudiesdescribedinthisreportwereconducted to
compare the sensitivities of four strains of rats (ACI,
August, Marshall, andOsborne-Mendel) todiisopropyla-
mine-stabilized trichloroethylene. The results ofthepre-
sent studies demonstrate that long-term administration
of trichloroethylene produces nephrotoxicity in four
strains of rats and that the susceptibilities of these
strains to the nephrotoxic effects of the chemical are
similar. Because of chemically induced toxicity, reduced
survival, and incomplete documentation of the experi-
mental data, the studies are considered inadequate for
eithercomparingorassessingtrichloroethylene-induced
carcinogenesis in these strains ofrats.
Toxicology and carcinogenesis studies of tri-
chloroethylene (more than 99% pure, stabilized with 8
ppmdiisopropylamine)wereconductedbyadministering
thechemicalin cornoil gavage atdoses of0,500, or1,000
mg/kgperday, 5dayperweek,for103weekstogroupsof
50 male and 50 female ACI, August, Marshall, and
Osborne-Mendel rats. The doses were selected on the
basis of results from 13-week gavage studies in which
groups of 10 male and 10 female ACI, August, and
Marshall rats received daily doses or trichloroethylene
(male: 125-2,000 mg/kg; female: 63-1,000 mg/kg). Doses
for Osborne-Mendel rats were selected to conform with
doses used in an earlier carcinogenicity study in that
strain (NCI TR-2).
In the 13-week studies, male ACI and August rats
receiving 2,000 mg/kg trichloroethylene and male and
female Marshall rats receiving 1,835 mg/kg had final
mean body weights 12%-17% lower than those of the
vehicle controls. All other dose groups had bodyweights
comparable to those ofthe vehicle controls. Three male
August rats dosed with 2,000 mg/kg died. Histo-
pathologic evaluation of tissues revealed no lesions
attributable to trichloroethylene administration in the
13-weekstudies.Thisabsenceofhistopathologicfindings
didnotaccuratelypredictthenephrotoxiceffects oflong-
term administration oftrichloroethylene to rats.
BodyWeightand SurvivalintheTwo-YearStudies: In
the 2-year studies, all dosed groups exhibited some
reduction in mean body weights relative to the vehicle
controls. Survival relative tovehicle controls was signifi-
cantly reduced in 7/16 dosed groups (see page 6 of the
Technical Report). Also, the survival of high dose male
Marshall ratswasreducedby alargenumberofacciden-
tal deaths. Nephrotoxicity, reduced survival, and central
nervous system toxicity (characterized by sedation, loss
ofconsciousness, tremors, and convulsions) showed that
the doses of trichloroethylene selected for the 2-year
studies were too high.
Renal Effects in the Two-Year Studies: Trichloroe-
thylene caused tubular cell cytomegaly in 82%-100% ofall
dosed animals. In addition, trichloroethylene produced
toxic nephropathy (which was distinguishable from age-
related nephropathy) in 17%-80% of the dosed animals.
Cytomegaly, karyomegaly, or toxic nephropathy was not
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found in untreated or vehicle control animals. Tri-
chloroethylene administration was also associated with
increased incidences of renal tubular cell adenomas and
adenocarcinomas. The incidences of renal lesions are
shown in the following table (see page 7 of Technical
Report).
Other Pathologic Effects in the Two-Year Studies: An
increasedincidenceofinterstitial celltumorsofthetestis
was observed inhighdosemaleMarshallrats (untreated
control, 16/46; vehicle control, 17/46; lowdose, 21148; high
dose, 32/48; P = 0.002). The incidences of phe-
ochromocytomas ofthe adrenal gland were significantly
reduced in male ACI, female August, female Marshall,
and male and female Osborne-Mendel rats.
Genetic Toxicology: Trichloroethylene did not cause
mutations in Salmonella typhimurium strains TA98,
TA100, TA1535, or TA1537 with or without metabolic
activation. In Chinese hamster ovary cells, tri-
chloroethylene did not induce chromosomal aberrations;
the results for sister chromatid exchanges were consid-
ered positive. Trichloroethylene was mutagenic to mouse
L5178Y lymphoma cells in the presence of rat liver S9.
Data Audit: Audits ofthe experimental data for these
2-year studies of trichloroethylene were conducted by
the National Toxicology Program (seeAppendix Q ofthe
Technical Report). The results of the audits revealed
evidence that the doses of trichloroethylene were too
high. Inaddition, therewasinsufficientdocumentation of
animal breeding, clinical observations, environmental
conditions, and analytical chemistry data. Also, indi-
vidual animal identification was not always verifiable.
Conclusions: Under the conditions of these 2-year
gavage studies of trichloroethylene in male and female
ACI, August, Marshall, and Osborne-Mendel rats, tri-
chloroethylene administration caused renal tubular cell
cytomegalyandtoxicnephropathyinboth sexes ofthefour
strains. However, these are considered to be inadequate
studies of carcinogenic activity because of chemically
induced toxicity, reduced survival, and deficiencies in the
conduct of the studies. Despite these limitations, tubular
cell neoplasms ofthekidneywereobservedinratsexposed
to trichloroethylene and interstitial cell neoplasms of the
testis were observed in Marshall rats exposed to tri-
chloroethylene.
Synonyms: acetylene trichloride; 1-chloro-2,2-
dichloroethylene; 1,1-dichloro-2-chloroethylene; ethinyl
trichloride; ethylene trichloride; 1,1,2-trichloroethylene;
trichloroethene
Trade names offormulations: Algylen; Anamenth; Ben-
zinol; Blacosolv; Blancosolv; Cecolene; Chlorilen; Chlo-
rylea; Chorylen; Circosolv; Crawhaspol; Densinfluat;
Dow-Tri; Dukeron; Fleck-Flip; Flock Flip; Fluate;
Gemalgene; Germalgene; Lanadin; Lethurin; Narcogen;
Narkogen; Narkosoid; Nialk; Perma-A-Chlor; Perm-
A-Clor; Petzinol; Philex; Threthylen; Threthylene;
Trethylene; Tri; Triad; Trial; Triasol; Trichloran; Tri-
chloren; Triclene; lri-Clene; Trielene; Trielin; Triklone;
Trilen;Trilene;Triline;Trimar;Triol;TRI-plus;TRI-plus
M; Vestrol; Vitran; Westrosol
Report Date: April 1988
Note: Trichloroethylene was previously tested in
Osborne-Mendel rats and B6C3F1 mice by gavage (See
TR-2, reported 1977) and also in F344 rats and B6C3Fj
mice by gavage (See TR-243, reported 1990).
TR-274 Tbxicology and Carcinogenesis
Studies of¶hs(2-ethylhexyl)phosphate
(CAS No. 78-42-2) In F344/N Rats and
B6C3F1 Mice (Gavage Studies)
Tris(2-ethylhexyl)phosphate is one of a family of tri-
akyl phosphates that have been widely used as fire
retardants and plasticizers. Another triakyl phosphate,
tris(2,3-dibromopropyl)phosphate (Tris-BP), once used
as a flame retardant in children's sleepwear, has been
shown to be carcinogenic, but tris(2-ethylhexyl)-
phosphate has not been previously studied. Tris(2-
ethylhexyl)phosphate, a clear, viscous liquid, is used as a
component of vinyl stabilizers, grease additives, and
flame-proofing compositions; however, it is used pri-
marily as a plasticizer for vinyl plastic and synthetic
rubber compounds. In 1974, approximately 3 million
pounds of tris(2-ethylhexyl)phosphate was produced in
theUnited States; imports duringthatyearwereneglig-
ible. Substantial human exposure probably occurs
during production of tris(2-ethylhexyl)phosphate and
during the manufacture and use of products contain-
ing it, but data on the magnitude of exposure are not
available.
Two-year toxicology and carcinogenesis studies of
tris(2-ethylhexyl)phosphate were conducted by admin-
isteringthetestchemicalincornoilbygavage,5daysper
week for 103 weeks, to groups of 50 male and 50 female
F344/N rats and B6C3F1 mice. Male rats received doses
of2,000or4,000mg/kgbodyweight,femaleratsreceived
1,000 or2,000mg/kg, and male andfemalemice received
500 or 1,000 mg/kg. Fiftyvehicle control animals ofeach
sex and species received 10 ml/kg body weight (rats)
or 3.3 mVkg (mice) corn oil by gavage on the same
schedule.
Inflammation ofthe gastric mucosa in mice and mild
weight depression in rats and mice were the only dose-
relatedeffectsobservedinthepreliminarystudies. Inthe
2-year studies, survival rates and mean body weight
gains ofdosed female rats and dosed micewere compar-
able to those oftheirperspective controls. Survival rates
ofdosedmaleratswere comparable to thatofthevehicle
controls, but body weight gains were depressed. One
nonneoplastic lesion, follicular cell hyperplasia of the
thyroid, was observed at increased incidences in dosed
male and female mice.
Two compound-related increased incidences of neo-
plasms could not be discounted. In male rats, the inci-
dence ofpheochromocytoma ofadrenalglandsincreased
with dose (2/50, 4%; 9/50, 18%; 12/50, 24%). There were
alsotwoadditionalmalignantpheochromocytomasinthe
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high dose group. However, the incidence ofadrenal phe-
ochromocytoma in vehicle controls of this study (2/50,
4%) was low compared with the 25% incidence observed
in two previous studies in this laboratory or the overall
historical incidence of18% observed throughoutthe Pro-
gram, and thus the evidence of carcinogenicity was
considered to be equivocal. In female mice, the incidence
ofhepatocellularcarcinoma(0/48;4/50; 7/50)inhighdose
animals (1,000 mg/kg) was significantly increased rela-
tive to that ofthe vehicle controls.
Decreased incidences were observed for acinar cell
adenomas ofthepancreas indosedmalerats (14/50,28%;
5/48,10%;2/49,4%)andforfibroadenomas ofthemamm-
ary glands in low dose female rats (11150, 22%; 2/50, 4%;
7/50,14%). Hemangiosarcomas ofthe circulatory system
inmalemice (7/50,14%; 0/50;1/49,2%) andlymphomas of
the hematopoietic system in female mice (14/49, 29%;
10/50, 20%; 6/50, 12%) were decreased compared with
vehicle controls. A decrease in the incidence of lym-
phomas and an increased incidence ofcarcinomas ofthe
liver in female mice (both seen in this study) were
observedinstudiesofdi(2-ethylhexyl)adipate. Increased
incidences ofliver carcinomas and decreased incidences
of mammary fibroadenomas were observed also in
female rats in the di(2-ethylhexyl)phthalate studies. A
possible link among these three chemicals maybe meta-
bolic conversion to 2-ethylhexanol.
Tris(2-ethylhexyl)phosphate wasnotmutagenicinSal-
monella typhimurium strains TA98, TA100, TA1535, or
TA1537 in the presence or absence of 9000 x g (S9)
fractionsfromAroclor1254-inducedSprague-Dawleyrat
or Syrian hamster liver.
An audit of the experimental data from these car-
cinogenesis studies was conducted by the National Tox-
icology Program. No data discrepancies were found that
significantly influenced the final interpretations ofthese
experiments.
Underthe conditions ofthese studies, acomparison of
concurrent and historical controls indicated that there
was equivocal evidence of carcinogenicity in male
F344/N rats receiving 2,000 and 4,000 mg/kg tris(2-
ethylhexyl)phosphate, as evidenced by increased inci-
dences of pheochromocytomas of the adrenal glands.
There was no evidence of carcinogenicity in female
F344/N rats or in male B6C3F1 mice receiving tris(2-
ethylhexyl)phosphate. There was some evidence ofcar-
cinogenicity in female B6C3F1 mice that received 1,000
mg/kg tris(2-ethylhexyl)phosphate, as shown by an
increased incidence of hepatocellular carcinoma. Tris(2-
ethylhexyl)phosphate was associated with increased
incidences of follicular cell hyperplasias of the thyroid
gland in male and female B6C3F1 mice.
Synonyms and Trade Names: TOF; trioctyl phosphate;
phosphoric acid tri(2-ethylhexyl) ester; Flexol® TOF;
Kronitex®
Report Date: August 1984
TR-275 Toxicology and Carcinogenesis
Studies of2-Chloroethanol (Ethylene
Chlorohydrin) (CAS No. 107-07-3) in F344/
N Rats and Swiss CD-1 Mice (Dermal
Studies)
Toxicology and carcinogenesis studies of 2-chlo-
roethanol (99% pure), an industrial chemical and an
intermediate in the synthesis of ethylene oxide, were
conducted by dermal application of 2-chloroethanol dis-
solvedin70%ethanol:30%water(v/v) solutionstogroups
of50 F344/N rats ofeach sexat doses of0,50, or100mg/
kg for 103 weeks or to groups of 50 Swiss CD-1 mice of
each sex at doses of 0, 7.5, or 15 mg per animal for 104
weeks (0,253, or630mg/kgatweek1; 0,180,411mg/kgat
week 100). The control groups received skin applications
ofthe vehicle; the mouse studies also included untreated
control groups of 50 male and 50 females.
2-Chloroethanol solutions were applied to the clipped
interscapular area ofthe animals once daily, 5 days per
week for the test period. Rats received a volume of
0.18-0.22 ml ofsolution; mice received 0.10 ml ofsolution.
In the 13-week studies, mortality was observed in male
and female rats receiving 20 mg per day and higher. In
the104-week studies, the survival ofhigh dosemalemice
was lower (P<0.05) than that of the vehicle controls
(vehicle control, 26/50; 7.5 mg, 16/50; 15 mg, 12/50). Body
weights of dosed mice were unaffected by 2-chlo-
roethanol. The survival and bodyweight gain data sug-
gestthatthe male and female rats and femalemice could
have tolerated a higher dose of 2-chloroethanol. Male
miceprobablycouldnothavetolerated ahigherdosethan
was applied to the skin. Seven high dose male mice died
within 3 days of the start of dosing; all of these had
inflammation at the site ofdermal application. Five also
had ulceration at the site of dermal application, and five
had lung congestion, inflammation, or hemorrhage.
Marginal increases were found in the incidence of
lymphomas or leukemias (combined) as well as in the
incidence of alveolar/bronchiolar adenomas or car-
cinomas (combined) in low dose male mice. Since there
wasno dose-related trendforthesetumorincidences and
because the increaseswere observed in only one sex, the
increaseswerenotconsidered toberelated tothe dermal
application of2-chloroethanol.
2-Chloroethanol was mutagenic in Salmonella
typhimurium strains TA100 and TA1535 (but not
TA1537 orTA98) in either the presence orthe absence of
Aroclor 1254-induced male Sprague-Dawley rat or Syr-
ianhamsterliverS9.2-Chloroethanol did notinduce sex-
linked recessive lethal mutations in Drosophila
melanogaster.
An audit of the experimental data was conducted for
these 2-year studies. No data discrepancies were found
that influenced the final interpretations.
Under the conditions of these 2-year dermal studies,
there was no evidence of carcinogenicity of 2-chlo-
roethanol for male and female F344/N rats given 50 or
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100 mg/kg per day or for male and female Swiss CD-1
mice given 7.5 or 15 mg per animal per day.
Synonyms: ethylene chlorohydrin; chloroethanol; glycol
chlorohydrin; P-chloroethanol
Report Date: November 1985
TR-276 Toxicology and Carcinogenesis
Studies of8-Hydroxyquinoline (CAS No.
148-24-3) in F344/N Rats and B6C3F1 Mice
(FeedStudies)
Carcinogenesis studies of 8-hydroxyquinoline (99%
pure), a metal chelator and antimicrobial agent, were
conducted by administering the test chemical in feed to
groups of 50 male and 50 female F344/N rats and
B6C3F1 mice at concentrations of0, 1,500, or 3,000 ppm
for 103 weeks. These concentrations were selected
becausethechemical athigherconcentrationsresultedin
reduced feed consumption, decreases in mean body
weights, and deaths in the 15-day and 13-week studies.
The average daily doseswere estimated tobe 73 and 143
mg/kgformalerats,89and166mg/kgforfemalerats,217
and 396mg/kgformalemice, and 349 and 619mg/kgfor
female mice.
Survival ofdosedmaleandfemale rats andmiceinthe
2-yearstudieswascomparabletothatofthecorrespond-
ing controls. The high dose rats and mice of each sex
exhibited slight decreases in mean body weights and
decreased feed consumption.
Compound-related gross or microscopic pathologic
effects were not observed in either species in the 15-day
or 13-week studies. In the 2-year studies, C-cell
adenomas/carcinomas of the thyroid gland showed a
positive trend (P=0.03) for male rats (control, 1150; low
dose, 1/49; high dose, 6/47). The incidence ofC-cell neo-
plasms in the high dose was not significantly increased
compared with the controls, and the occurrence ofC-cell
hyperplasia was not elevated (4/50; 3/49; 1/47). The inci-
dence of alveolar/bronchiolar adenomas or carcinomas
(combined) in male rats with a positive trend, and the
incidence inthehigh dosegroupwasgreaterthanthatin
the controls (0/50; 3/50; 4/50). This marginal effect was
not supported by an increase in epithelial hyperplasia
(5/50; 5/50; 3/50). These marginal increases in male rats
were notregarded asbeingrelated tothe administration
of8-hydroxyquinoline.
In in vitro tests, 8-hydroxyquinoline did not induce
either unscheduled DNAsynthesis in rathepatocytes or
transformation ofBALB/c-3T3 cells.
An audit of the experimental data for these car-
cinogenesis studies on 8-hydroxyquinoline was con-
ducted. No data discrepancies were found that
significantly influenced the final interpretations.
Under the conditions of these studies, there was no
evidence ofcarcinogenicity for male and female F344/
N rats or for male and female B6C3F1 mice given
8-hydroxyquinoline in feed at concentrations of1,500 or
3,000 ppm for 103 weeks.
Synonyms: 8-quinolinol; oxine; hydroxybenzopyridine
Report Date: April 1985
TR-277 Toxicology and Carcinogenesis
Studies ofTemolite (CAS No. 14567-73-8)
in F344/N Rats (Feed Studies)
Acarcinogenesisbioassayofblocky(nonfibrous)trem-
olite was conducted with male and female F344/N rats.
Tremolite was administered at a concentration of 1% in
pelleted diet for the entire lifetime of the rats, starting
with the dams of the study animals. The studies were
started in 1978 and ended in 1981. Group sizes were 118
male and female controls and 250 male and female
tremolite-exposed rats.
Litter size was not effected by the administration of
tremolite to the dams. The offspring from mothers
exposed to tremolite were the same size at birth as the
controls but were slightly smaller at weaning and
remained sothroughouttheirlife.Survivalwas similarin
theexposedandcontrolgroups. Notoxicityorincreasein
incidence of neoplasia was observed in the tremolite-
exposed animals comparedwith the concurrent controls.
Conclusions: Under the conditions ofthese feed stud-
ies, nonfibrous tremolite was not overly toxic or car-
cinogenic for male or female F344/N rats, following
lifetime ingestion ofa diet containing 1% tremolite.
Report Date: March 1990
TR-278 Tbxicology and Carcinogenesis
Studies of2,6-Xylidine (2,6-
Dimethylaniline) (CAS No. 87-62-7) in
Charles River CD Rats (Feed Studies)
2,6-Xylidine is a chemical intermediate used prin-
cipallyintheproductionofdyes. Itisalso acomponentof
tobacco smoke, a degradation product of aniline-based
pesticides, andametaboliteofcertaindrugs,particularly
the xylide group of local anesthetics. The National Tox-
icology Program (NTP) sponsored single-
administration, 2-week, and 13-week studies of 2,6-
xylidinebygavageinF344/Nrats.TheU.S. Environmen-
tal Protection Agency (EPA) sponsored short-term
gavage studies and 10-week range-finding studies in
Charles River CD rats (a Sprague Dawley-derived
strain). A carcinogenesis study of2,6-xylidine was initi-
ated by the EPA, which designed and monitored the
studyduring the 2-year exposure period. The NTPthen
assumed responsibility for the study, conducting termi-
nal kill, necropsy, histopathologic evaluation, data anal-
ysis, and report preparation.
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Oral LD50 values of 1.2-1.3 g/kg were calculated for
F344/N and Charles River CD rats administered single
doses of2,6-xylidine. Marginallytoxiceffects occurredin
the hepatic, renal, and hematopoietic systems of dosed
rats in the single-administration, 2-week, 10-week, and
13-week studies.
The 56male and56female Charles RiverCDratsused
in the 104-week carcinogenesis studies were the off-
spring of animals fed diets containing 0, 300, 1,000, or
3,000 ppm 2,6-xylidine before breeding, during preg-
nancy, and through the lactation period. The concentra-
tions of 2,6-xylidine offered to animals in the 104-week
studies were the same as those given to their parents.
During most ofthe 2-year studies, high dose male and
female rats showed areduction (greaterthan10%) inbody
weight gain. Survival in the high dose male rats was
significantly reduced (P<0.001) relative to that in controls.
Survival also was reduced in the 1,000-ppm group. There
was no significant relationship between concentration and
mortality in female rats, but mortality was high for all
groups offemale rats during the second year ofthe study.
Theepitheliumofthenasalcavitywastheprimarysite
of compound-related neoplastic and nonneoplastic
lesions. The incidences of both papillomas and car-
cinomas ofthe nasal cavitywere significantly increased
in high dose male and female rats. Carcinomas or ade-
nocarcinomas (combined) occurred in 28/56 high dose
males, 24/56 high dose females, and 1/56 mid dose
females. Papillary adenomas occurred in 10/56 high dose
males, 2/56 mid dose males, and 6/56 high dose females.
None occurred intheothergroups. The carcinomaswere
highlyinvasive andfrequentlydestroyedthenasalturbi-
nates and nasal septum. Metastasis to the brain was
present in 5/56 male and 7/56 females high dose rats.
Malignant mesenchymal tumors were observed in the
nasal cavity. Rhabdomyosarcomas occurred in two high
dose male rats and two high dose female rats. These rare
malignanttumorshavenotbeenpreviouslyreportedatthis
site in Sprague Dawley rats. Malignant mixed tumors
having features of adenocarcinomas and rhabdomyosar-
comas were reported in one high dose male and one high
dose female rat. One undifferentiated sarcomawas seen in
ahigh dose female rat. The nonneoplastic lesions observed
in the nasal cavity included acute inflammation, epithelial
hyperplasia, and squamous metaplasia.
The incidences of subcutaneous tissue fibromas were
increased in high dose male and female rats (male:
control, 0/56; low dose, V56; mid dose, 2/56; high dose,
4/56;female: 0/56; 2/56; V56;4/56) andwere doserelated.
Subcutaneous fibrosarcomas were observed in three
high dose females, one high dose male, one mid dose
female, one low dose male, and one control female.
A significant dose-related increase occurred in the
incidence of female rats with neoplastic nodules of the
liver (0/56; V56; 2/56; 4/55). Thisincreasewas significant
in the high dose group by the incidental tumor test.
Conclusions: Undertheconditions ofthese2-yearfeed
studies, 2,6-xylidine was clearly carcinogenic for male
and female Charles River CD rats, causing significant
increases in the incidences ofadenomas and carcinomas
ofthenasalcavity.Arhabdomyosarcoma, araretumorof
the nasal cavity, was observed in dosed rats ofeach sex.
In addition, the increased incidences of subcutaneous
fibromas and fibrosarcomas in male and female rats and
the increased incidence ofneoplastic nodules ofthe liver
in female rats may have been related to the administra-
tion of2,6-xylidine.
Synonym: 2,6-Dimethylaniline
Report Date: January 1990
TR-279 Toxicology and Carcinogenesis
Studies ofAmosite Asbestos (CAS No.
12172-73-5) in F344/N Rats (Feed Studies)
Theterm"asbestos"hasacommerciaVindustrial deriva-
tion limited to naturally occurring fibrous minerals ofthe
serpentine or amphibole series. Chrysotile is the onlytype
ofasbestosintheserpentineseries,whereastheamphibole
series is represented by actinolite, amosite, anthophyllite,
crocidolite, and tremolite. The essential characteristic of
asbestos minerals is their fibrous nature.
Large portions of the population ingest asbestos
through consumption of food and water. Asbestos or
asbestos-like fibers maygain access towater supplies as
a result ofmining (Lake Superior), from the presence of
natural serpentine or or amphibole deposits in water-
sheds (Seattle, WA, and San Francisco, CA) or, under
certain conditions, through the use of asbestos-cement
pipesformunicipalwatersupplies. Forthelatter, erosion
of the pipe with release of fibers is associated with the
"aggressiveness" of the water, a term representing a
mathematical expression of pH, alkalinity, and calcium
content. The EPAestimatedthat68.5% ofwatersystems
in the United States utilize water that is potentially
capable oferoding asbestos-cement pipe.
Carcinogenesis studies ofamosite asbestos alone orin
combination with the intestinal carcinogen 1,2-
dimethylhydrazine dihydrochloride (DMH) were con-
ducted in male and female rats. Amosite asbestos was
administered at a concentration of1% in pelleted dietfor
the entire lifetime ofthe rats, starting with the dams of
the study animals. One group of amosite asbestos-
exposed rats (amosite preweaning gavage) also received
chrysotile asbestos via gavage during lactation. Group
sizesvariedfrom100to250. Littersizewasthe same,but
the offspring from mothers exposed to amosite asbestos
were smaller at weaning than those from nonexposed
mothers and remained smallerthroughouttheirlife. The
DMHwas administered bygavage at adose of7.5mg/kg
for males and 15 mg/kg for females every 14 days, start-
ing at 8 weeks of age, for a total of five doses. The
administration of DMH did not affect body weight gain
either in amosite-exposed or nonexposed animals.
The amosite-exposed rats showed enhanced survival
compared with that of the nonexposed rats. DMH
exposure reduced survival by approximately 1 year,
although the survival of the amosite plus DMH groups
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was slightly greater than that ofthe DMH group alone.
Significant increases in the incidences of C-cell car-
cinomas of the thyroid gland (untreated control, 111117;
amosite, 50/246, P<0.05; amosite preweaning gavage,
14/100) and ofleukemia (38/117; 106/249, P<0.05; 49/100,
P<0.01) in male rats were observed in amosite-exposed
groups. However, the biologic significance of the C-cell
carcinomas in relation to amosite asbestos exposure is
discounted because of a lack ofsignificance when C-cell
adenomas and carcinomas were combined and because
the positive effect was not observed in the amosite
preweaninggavage group. Thebiologic significance ofan
increased incidence of leukemia is questionable because
of a lack of statistical significance in the amosite group
whenevaluatedbylifetableanalysis andbecause notoxic
lesionswere observedin thetarget organs, i.e., gastroin-
testinal tract and mesothelium.
DMH caused a high incidence (62%-74%) of intestinal
neoplasia in amosite-exposed and nonexposed groups. Nei-
ther an enchanced carcinogenic nor aprotective effectwas
demonstrated by exposure to amosite asbestos.
Conclusions: Under the conditions ofthese feed stud-
ies, amosite asbestoswas notovertlytoxic, did not affect
survival, and was not carcinogenic when ingested at a
concentration of1% in the dietbymale orfemale F344/N
rats. The cocarcinogenic studies using DMH were con-
sidered inadequate because of the high incidence of
DMH-induced intestinal neoplasia in both the amosite
asbestos-exposed and nonexposed groups.
Report Date: November 1990
Note: Amosite Asbestos was previously tested in Syrian
Golden Hamsters administered in feed (See TR-249,
reported 1983).
TR-280 Toxicology and Carcinogenesis
Studies of Crocidolite Asbestos (CAS No.
12001-28-4) In F344/N Rats (Feed Studies)
Carcinogenesis studies of crocidolite asbestos were
conducted with male and female F344/N rats. This form
ofasbestos was administered at a concentration of1% in
pelleted dietforthe lifetime ofthe rats, startingwiththe
dams of the study animals. The studies were started in
January 1978 and ended in December 1980. Group sizes
were 118 for male and female controls and 250 for male
and female crocidolite asbestos-exposed rats.
The offspring from mothers exposed to crocidolite
asbestos andthecontrolswere similarin size atbirthbut
were slightly smaller at weaning and remained so
throughout their life. Feed consumption and survival
were comparable in the exposed and control groups. No
overt toxicity was observed in the crocidolite asbestos-
exposed animals. There was an elevated (P<0.05) inci-
dence of thyroid gland C-cell adenomas (control, 4/117,
3%, vs. exposed, 23/250, 9%) and ofthyroid gland C-cell
carcinomas (12/117, 10%, vs. 46/250, 18%) in crocidolite
asbestos-exposed female rats relative to concurrent con-
trols. Because these control incidences were low relative
to control incidences observed in other contemporary
studies at this laboratory (21% for thyroid gland C-cell
tumors), this slight increase was not regarded as being
biologically important.
The data, documents, and pathology materials from
the lifetime studies of crocidolite asbestos have been
audited. The audit findings show that the conduct of
these studies is documented adequately and supportthe
data and results presented in this Technical Report.
Conclusions: Under the conditions ofthese feed stud-
ies, crocidolite asbestoswas notovertlytoxic and did not
cause a carcinogenic response when ingested at a con-
centration of1% in the diet by male and female F344/N
rats for their lifetime.
Report Date: December 1988
TR-281 Toxicology and Carcinogenesis
Studies ofHC Red No. 3 [2,((Amino-2-
nitrophenyl)amino)ethanol] (CAS No.
2871-01-4) In F344/N Rats and B6C3F1 Mice
(Gavage Studies)
Toxicologyand carcinogenesis studiesofHC Red No.3
(97% pure), a semipermanent hair dye, were conducted
by administering the chemical in corn oil by gavage for
105 weeks to groups of 50 male and 50 female F344/N
rats andfor104weeks togroups of50maleand50female
B6C3F1 mice. The dosage regimen used for rats was 0,
250, or500mg/kgperdayandformice, 0,125, or250mg/
kgperday. Doseswereadministered 5 daysperweek. In
prior 13-week studies, these doses produced no signs of
toxicity when administered 5 days per week.
In the 2-year studies, the administration of HC Red
No. 3 did not affect bodyweight gains ofmale or female
rats or mice. Body weight gains by all groups offemale
mice were reduced because ofareproductive tractinfec-
tion. Survival ofmale and female rats and mice was not
reducedbyadministration ofHC Red No.3.The survival
of female mice, including vehicle controls, was reduced
relative to historical survival rates due to areproductive
tract infection. The infection, accompanied by weight
loss, high mortality, and suppurative inflammation of
multiple organs,was found in 36/50vehicle control, 32/50
low dose, and 29/50 high dose female mice. Klebsiella
pneumaniae was isolated from infected tissues.
Pigmentation of various tissues in both rats and mice
was a common observation in both the 13-week and the
2-year studies. The pigment was not identified but was
presumedtobeaderivativeofHC RedNo.3.Veryminimal
nephropathy was found in dosed female rats, but its rela-
tionship to HC Red No. 3 is equivocal. Mild nephrosis was
found in dosed female mice, but this effect may have been
secondary to the infection ofthe genital tract.
There was an increase in the incidence of mammary
glandfibroadenomas orcystadenomasinlowdosefemale
rats. The incidence ofthis lesion in high dose female rats
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was not increased (vehicle control, 14/50, 28%; low dose,
25/50,50%; highdose,11/50,22%). Largelybecauseofthe
lackofadoseresponse, theincreasedincidenceinthelow
dosefemaleswasnotconsidered tobeduetoHC Red No.
3. No increased incidences of neoplasms were seen in
male rats.
Transitional cell papillomas of the urinary bladder
were detected in one high dose male rat, two low dose
female rats, and one high dose female rat; none was
observed in the vehicle controls. These uncommon neo-
plasmswere foundin animals that survived to the termi-
nation ofthe study and were not accompanied by other
proliferative lesions.
The incidence of hepatocellular adenomas or car-
cinomas (combined) was increased in high dose male
mice, whereas the incidence of these neoplasms in low
dose male mice was significantly lower than that in the
vehicle controls (25/50; 15/50; 35/50). Hepatocellular car-
cinomas in three vehicle control, one low dose, and five
high dose male mice metastasized to the lung. The
incidences ofliver neoplasms in dosed female mice were
not significantly different from those in the vehicle con-
trol group.
HC Red No. 3 was mutagenic in Salmonella
typhimurium strainsTA97, TA98, andTA100, butnotin
TA1535, in the presence or absence of Aroclor 1254-
induced male Sprague-Dawley rat or male Syrian ham-
sterliverS9whentestedbythepreincubationalprotocol.
An audit of the experimental data was conducted for
these 2-year toxicology and carcinogenesis studies on
HC Red No. 3. No data discrepancies were found that
influenced the final interpretations.
Underthe conditions ofthese2-yeargavage studies of
HCRedNo.3,therewasnoevidenceofcarcinogenicity
for male or female F344/N rats given 250 or 500 mg/kg
per day. There was equivocal evidence of car-
cinogenicity for male B6C3F1 mice as indicated by an
increased incidence of hepatocellular adenomas or car-
cinomas (combined) in the 250 mg/kg dose group. Poor
survival coupled with lack of significant findings ren-
dered the study in female B6C3F1 mice an inadequate
study of carcinogenicity. Both sexes of both species
may have been able to tolerate higher doses of HC Red
No. 3. Therefore, the sensitivity of these studies for
detecting carcinogenesis may have been limited.
Synonym: 2,((amino-2-nitrophenyl)amino)ethanol
Report Date: January 1986
TR-282 Toxicology and Carcinogenesis
Studies ofChlorodibromomethane (CAS
No. 124-48-1) in F344/N Rats and B6C3F
Mice (Gavage Studies)
Toxicology and carcinogenesis studies of chlo-
rodibromomethane (greater than 98% pure), a tri-
halomethane formed afterchlorination ofwatersupplies,
were conducted by administering this test chemical in
corn oil gavage five times per week for 104 weeks to
groups of50 male and 50 female F344/N rats at 0,40, or
80mg/kgperdayand to groups of50male and 50 female
B6C3F1 micefor105weeks atdosesof0,50, or100mg/kg
per day. Survival of dosed male and female rats and
femalemicewas comparable to thatofthecorresponding
vehiclecontrolgroups.Anoverdoseofchemicalwasgiven
to low dose male and female mice at week 58; this
overdose killed 35 male mice, whereas the female mice
were apparently not affected. Because this mortality
significantly reduced the number of survivors, the low
dose male mouse groupwas considered to be inadequate
foranalysisofneoplasms.Highdosemalemicehadlower
survival than the vehicle controls (44/50 vs 29/50;
P<0.001).Atweek82, ninehigh dosemalemice haddied;
the cause remains unknown. High dose male rats and
dosed male and female mice had lower body weights
compared with those ofthe vehicle controls.
Compound-related nonneoplastic lesionswere found in
the liver and kidney in male and female rats and in male
mice in the 13-week studies at the highest dose (250 mg/
kg). Inthe2-yearstudies, compound-related toxicitywas
seenprimarilyinthelivers ofmale andfemalerats (fatty
metamorphosis and ground-glass cytoplasmic changes)
and in the male mice (hepatocytomegaly, necrosis, fatty
metamorphosis) and female mice (calcification and fatty
metamorphosis). Toxicity was also seen in the kidneys
(nephrosis) ofmale mice and female rats.
Administration ofchlorodibromomethane significantly
increased the incidence of hepatocellular adenomas
(vehicle control,2/50; lowdose,4/49;highdose,11/50) and
the combined incidences of hepatocellular adenomas or
carcinomas (6/50; 10/49; 19/50) in high dose female mice.
The incidence ofhepatocellular carcinomas (vehicle con-
trol, 10/50; high dose, 19/50) was significantly increased
in high dosemale mice, although the combined incidence
of hepatocellular adenomas or carcinomas (vehicle con-
trol, 23/50; high dose, 27/50) was marginally significant
bythe life table testbut notbythe incidental tumor test.
Negative trends in several common rodent tumors
werefound in dosed animals inthe2-yearstudies. These
neoplasms included fibroadenomas of the mammary
gland in female rats, endometrial stromal polyps of the
uterus in female rats, and malignant lymphomas in male
mice.
Chlorodibromomethane was not mutagenic in Salmo-
nella typhimurium strains TA98, TA100, TA1535, or
TA1537 in the presence or absence of Aroclor-induced
male Sprague-Dawley rat or male Syrian hamster liver
S9.
An audit of the experimental data was conducted for
the 2-yeartoxicology and carcinogenesis studies ofchlo-
rodibromomethane. No data discrepancies were found
that influenced the final interpretations.
Under the conditions of these gavage studies, there
was no evidece ofcarcinogenicity in male or female
F344/Nratsreceivingchlorodibromomethane atdosesof
40 or 80 mg/kg five times perweek for 104 weeks. Fatty
metamorphosis and ground-glass cytoplasmic changes
ofthe liver in male and female F344/N rats were related
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to administration of chlorodibromomethane. There was
equivocal evidence of carcinogenicity for male
B6C3F1 mice; chlorodibromomethane caused an
increased incidence of hepatocellular carcinomas,
whereas the combined incidence of hepatocellular ade-
nomas or carcinomas was only marginally increased.
Some evidence of carcinogenicity was observed for
female B6C3F1 mice, since chlorodibromomethane
caused an increased incidence of hepatocellular ade-
nomas and an increased combined incidence of
hepatocellular adenomas or carcinomas.
Synonym: Dibromochloromethane
Report Date: August 1985
TR-283 Pyridine (CAS: 110-86-1)
Studyconsideredinadequate; noTechnical Reportwill
be issued.
TR-284 Toxicology and Carcinogenesis
Studies ofDiallylphthalate (CAS No.
131-17-9) in F344/N Rats (Gavage Studies)
Diallylphthalate is widely used as a crosslinking agent
for unsaturated polyesters. Diallylphthalate or
diallylphthalate polyester blends are used primarily as
plasticizers andcarriersforaddingcatalysts andpigments
to polyesters and in molding, electrical parts, laminating
compounds, and impregnation of metal castings. Rubber
compounds, epoxy formulations, and polyurethane foams
may also contain diallylphthalate. Precise figures are not
currently available, although annual production of
diallylphthalate in the United States is known to exceed
5,000 pounds, and an estimated 57,000 pounds were
imported into the United States in 1982.
Toxicology and carcinogenesis studies ofdiallylphtha-
late (approximately 99%pure)wereconducted byadmin-
isteringthe testchemical in corn oilbygavage to groups
of 50 male and 50 female F344/N rats at doses of 0
(vehicle control), 50, or100mg/kg5daysperweekfor103
weeks. The diallylphthalate doses used in the 2-year
studies were chosen on the basis of 13-week studies,
wherein doses of200 or 400 mg/kg caused death, reduc-
tions in body weight gains, or periportal hepatocellular
necrosis and fibrosis in both sexes.
Mean body weights and survival of male and female
rats administered diallylphthalate were essentially the
same as those of the vehicle controls throughout the
2-year studies, although hepatotoxicity was produced in
both sexesbythe100mg/kgdose.Based ontheresults of
the prechronic studies and the effects on the liver in the
2-year studies, the doses used in the2-year studieswere
considered to be adequate for carcinogenicity testing.
Male and female rats receiving the 100 mg/kg dose of
diallylphthalate in the 2-year studies developed chronic
liver diseases characterized by periportal fibrosis,
periportal accumulation ofpigment, and severe bile duct
hyperplasia. Pigment accumulation also occurred at the
50 mg/kg dose in both sexes.
Diallylphthalate administration increased the occur-
renceofmononuclearcellleukemiainfemalerats(P<0.05
by trend tests), and the increase in the 100 mg/kg dose
female rats was greater (P. 0.05) than in the vehicle
controls by pairwise comparisons (vehicle control, 15/50,
30%; low dose, 15/43, 35%; high dose, 25/49, 51%). An
increased occurrence of mononuclear cell leukemia was
not observed in male rats receiving diallylphthalate.
A previous NTP carcinogenesis study (NTP TR 242)
reported an increased incidence of lymphomas in male
B6C3F1 mice receiving diallylphthalate by gavage for 2
years at doses of0, 150, or 300 mg/kg. This increasewas
considered to be equivocally related to diallylphthalate
administration. The incidences of hyperplasia and
inflammatory lesions ofthe forestomach were increased
in a dose-related fashion in both sexes of mice in that
study, and uncommon forestomach papillomas were
observed in 0%, 2%, and 4% of both sexes of mice.
Because of the numerical increase in forestomach
papillomas, the concomitant presence of forestomach
hyperplasia, and the rarityofforestomach papillomas in
vehicle control (corn oil gavage) B6C3F1 mice, the devel-
opment ofthese proliferative lesions ofthe forestomach
inmice mayhavebeen related to diallylphthalate admin-
istration. In the current study in rats, a squamous cell
carcinoma was found in one high dose male rat.
Diallylphthalate was not mutagenic in Salmcnella
typhimurium strains TA98, TA100, TA1535, or TA1537
with or without activation by a 9,000 x g supernatant
fraction from the livers of Aroclor 1254-treated male
Sprague-Dawley rats or Syrian hamsters. Diallylphtha-
late did not induce sex-linked recessive lethal mutations
inDrosophila melanogaster.
An audit of the experimental data was conducted for
these carcinogenicity studies on diallylphthalate. No
data discrepancies were found that influenced the final
interpretations.
Under the conditions ofthis study, the administration
of diallylphthalate by gavage in corn oil to male and
female F344/N rats for 2 years caused chronic liver
disease characterized byperiportal fibrosis andpigment
accumulation and an increased severity of bile duct
hyperplasia. The incidence ofmononuclear cell leukemia
was significantly increased in female rats receiving 100
mg/kg. Because ofthevariability in the incidence ofthis
neoplasm in aged Fisher 344 rats and the difficulty in
definitivelydiagnosingthis lesionin Fisher344 rats, this
increase was considered to be equivocal evidence of
carcinogenicity ofdiallylphthalateinfemalerats.There
was no evidence ofcarcinogenicity in male rats.
Synonym: DAP
Report Date: August 1985
Note: Diallylphthalate was previously tested inB6C3Fj
mice by gavage (See TR-242, reported 1983).
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TR-285 lbxicology and Carcinogenesis
Studies of C.I. Basic Red 9
Monohydrochloride (Pararosaniline) (CAS
No. 569-61-9) In F344/N Rats andB6C3Fj
Mice (FeedStudies)
C.I. Basic Red 9 monohydrochloride is a tri-
phenylmethane dye used for coloring textiles, leather,
and paper and as a biological stain. Toxicology and
carcinogenesis studieswere conducted byadministering
the test chemical in feed to groups of 50 male and 50
female F344/N rats and B6C3F1 mice for 103 weeks at
concentrations of0, 1,000, or2,000ppmformale rats and
0, 500, or1,000 ppm forfemale rats and mice ofeach sex.
The average daily doses of C.I. Basic Red 9 mono-
hydrochloridewere estimated tobe49and103mg/kgfor
male rats, 28 and 59 for female rats, 196 and 379 mg/kg
for male mice, and 149 and 407 mg/kg for female mice.
Two lots of the test chemical were used in the 2-year
studies with purities of 93% (water content approx-
imately 9%) and 99%.
In rats, the thyroid gland and pituitary gland were
identified as target sites in the 13-week studies. There-
fore, 10 additional rats of each sex were added to the
control and high dose groups in the 2-year studies to
examine the effects on these organs after 1 year of
exposure.
In the 1-year studies in rats, final mean body weights
were slightly decreased in both sexes. The thyroid gland
weighttobodyratioofdosedmaleswas1.7timesthatofthe
controls, and the concentration of serum thyroxin in male
and female rats was significantly lower than that of the
controls at week 52. Compound-related histopathologic
effectsincludedthyroidglandcystsinbothsexes(1/10; /10)
and thyroid gland follicular cell hyperplasia (/10), ade-
nomas (1110), and carcinomas (V10) and fatty meta-
morphosisoftheliver(4/10,twoofthesewithfocalnecrosis)
in males; no effect was seen in the controls.
The doses selected for the 2-year studies were based
on the results of the 13-week studies. The absence of
toxicologic signs, histopathologic changes, significant
bodyweight depressions, or mortality after 13 weeks of
exposure to C.I. Basic Red 9 monohydrochloride sug-
gested that these concentrations would not shorten sur-
vival. However, throughout the 2-year studies, mean
body weights of high dose rats and dosed mice were
lower than those of the controls, and significantly
reduced survival relative to controls was observed for
high dose rats ofeach sex (P<0.001), lowdosemale mice
(P<0.03), and low dose and high dose female mice
(P<0.001).
In the 2-year studies, several types of neoplastic
lesions occurred with significantly increased incidences
in dosed animals (see table page 12 of the Technical
Report). Highdosemaleratshadincreasedincidences of
squamous cell carcinomas, trichoepitheliomas, and
sebaceous adenomas of the skin. Greater incidences of
follicular cell carcinomas and offollicular cell adenomas
were found in the thyroid glands ofhigh dose male rats
than in controls, whereas in high dose female rats, the
combined incidence of follicular cell adenomas or car-
cinomas was greaterthan thatin controls. Dosed rats of
each sex had increased incidences of subcutaneous
fibromas, and high dose rats hadincreased incidences of
Zymbal gland carcinomas. Hepatocellular carcinomas
were the compound-related neoplasms common to both
species; the incidences were increased in both high dose
male rats and in dosed mice of each sex. Dosed female
mice had an increased incidence ofpheochromocytomas
or malignant pheochromocytomas. In addition, mar-
ginally increased incidences ofmammary gland tumors
(23/50; 32/50; 32/50) in female rats, and malignant lym-
phomas (17/50; 24/50; 25/50) in female mice were
observed.
C.I. Basic Red 9monohydrochloride was mutagenic in
strains TA98 and TA100 of Salmonella typhimurium by
the preincubational protocol with or without metabolic
activation. It was not mutagenic in strains TA1535 and
TA1537 in this system with or without metabolic activa-
tion. Itwas mutagenic in the L5178Y/TK+/- mouse lym-
phoma assay with or without metabolic activation. C.I.
BasicRed9monohydrochloride didnotinducechromoso-
mal aberrations in Chinese hamster ovary cells; it did
induce sister-chromatid exchanges in the presence of
Aroclor 1254-induced male Sprague-Dawley rat liver S9.
C.I. Basic Red 9 monohydrochloride also induced
unscheduled DNA synthesis in F344 male rat
hepatocytes in vitro.
An audit of the experimental data was conducted for
these 2-year studies of C.I. Basic Red 9 monohydro-
chloride. No data discrepancies were found that influ-
enced the final interpretations.
Under the conditions of these 2-year feed studies,
there was clear evidence of carcinogenicity of C.I.
Basic Red 9 monohydrochloride for male and female
F344/N rats and for male and female B6C3F1 mice. In
male rats, C.I. Basic Red 9 monohydrochloride caused
squamous cell carcinomas, trichoepitheliomas and
sebaceous adenomas ofthe skin, subcutaneousfibromas,
thyroid gland follicular cell adenomas or carcinomas
(combined), and Zymbalgland carcinomas. Inmalemice,
C.I. Basic Red 9 monohydrochloride caused hepatocellu-
lar carcinomas. In female mice, C.I. Basic Red 9 mono-
hydrochloride caused hepatocellular carcinomas and
adrenal gland pheochromocytomas or malignant phe-
ochromocytomas (combined).ExposuretoC.I.BasicRed
9 monohydrochloride also may have been related to
increased incidences of mammary gland tumors in
female rats and hematopoietic system tumors in female
mice.
Synonyms: pararosaniline; benzeneamine 4-((4-
aminophenyl)(4-imino-2,5-cyclohexadian-1-ylidene)
methyl)-monohydrochloride; paramagenta
Report Date: January 1986
157NTP/NIEHS
TR-286 Hamamelis Water (Witch Hazel)
(CAS: 68916-39-2)
Studyconsidered inadequate; noTechnical Reportwill
be issued.
TR-287 Toxicology and Carcinogenesis
Studies ofDimethyl Hydrogen Phosphite
(CAS No. 868-85-9) in F344/N Rats and
B6C3F1 Mice (Gavage Studies)
Dimethyl hydrogen phosphite (DMHP) is used as an
intermediate in the production of insecticides and her-
bicides, as an additive to lubricants, and as astabilizer in
oil and plaster and was considered for use as a chemical
to stimulate thephysical (but notthebiologic)properties
of anticholinesterase agents. Results of13-week gavage
studies in F344/N rats (0-400 mg DMHP/kg body
weight) andinB6C3F1 mice (0-1,500mgDMHP/kgbody
weight) were used to identify short-term toxicity and to
establish doses for the 2-year toxicology and car-
cinogenesis studies. In these studies, dimethyl hydrogen
phosphite (greater than 97% pure) was administered for
103 weeks in corn oil by gavage to groups of 50 male
F344/Nratsandtogroups of50maleandfemaleB6C3F1
mice at doses of0, 100, or 200 mg/kg and to groups of50
female F344/N rats at doses of0, 50, or 100 mg/kg.
In the 2-year studies, survival ofhigh dose male rats
andhigh dosemalemicewaslower(P<0.05) thanthatof
thevehicle controls (male rats:vehicle control, 39/50; low
dose, 29/50; high dose, 23/50; male mice: 42/50; 34/50;
32/50).Attheendofthestudies,meanbodyweightswere
lowerthanthoseofthecorrespondingvehiclecontrolsfor
high dose male rats (-15%), for high dose female rats
(-5%), and for high dose male mice (-5%).
Dimethyl hydrogen phosphite caused dose-related
increases in nonneoplastic and neoplastic lesions of the
lung in male and female rats. In high dose male rats,
there were increased incidences of lung neoplasms,
including squamous cell carcinomas (0/50; 0/50; 5/50),
alveolar/bronchiolar adenomas (0/50; 0/50; 5/50), and
alveolar/bronchiolar carcinomas (0/50; 1/50; 20/50). In
high dose female rats, there was a marginal increase in
the incidence of alveolar/bronchiolar carcinomas of the
lung (0/50; 1/49; 3/50). Hyperplasia of the lung and
chronic interstitial pneumonia were increased in dosed
male rats and in high dose female rats.
Dimethyl hydrogen phosphite caused increases in
forestomachlesionsinmaleandfemalerats. Inmalerats,
there was an increased incidence of forestomach neo-
plasms, including squamous cell papillomas (0/50; 1150;
3/50) and squamous cell carcinomas (0/50; 0/50; 3/50).
High dose male rats had increased incidences ofhyper-
keratosis and hyperplasia of the forestomach. In high
dose female rats, the incidence of forestomach hyper-
plasia was increased. Neoplastic lesions of the fore-
stomach (a squamous cell papilloma and a squamous cell
carcinoma) were found in two high dose female rats.
Mineralization ofthecerebellumwas seeninhigh dose
male rats (12/49) and in no other group. Focal calcifica-
tionofthetestis occurredatincreasedincidencein dosed
male mice in the 2-year studies (2/50; 9/47; 24/50).
Compound-related testicular atrophy was seen in male
mice in the 13-week study.
Dimethyl hydtogen phosphite did not induce any neo-
plasms in male or female mice.
Dimethyl hydrogen phosphite was not mutagenic in
Salmnellatyphimurium strainsTA98,TA100,TA1535,
or TA1537 in the presence or absence of Aroclor 1254-
induced male Sprague-Dawley rat or Syrian hamster
liver S9. This chemical did not induce sex-linked reces-
sive lethal mutations inDrosophila melanogaster.
An audit of the experimental data was conducted for
these carcinogenic studies on dimethyl hydrogen phos-
phite. No data discrepancies were found that influenced
the final interpretations.
Under the conditions of these gavage studies, there
was clear evidence of carcinogenicity in male rats
receiving dimethyl hydrogen phosphite, as shown by
increased incidences of alveolar/bronchiolar adenomas,
alveolar/bronchiolar carcinomas, and squamous cell car-
cinomas ofthelungandofneoplasms oftheforestomach.
There was equivocal evidence of carcinogenicity in
female F344/N rats receiving dimethyl hydrogen phos-
phite, as shown by marginally increased incidences of
alveolar/bronchiolar carcinomas of the lung and of neo-
plasms of the stomach. There was no evidence ofcar-
cinogenicity in male or female B6C3F1 mice receiving
dimethyl hydrogen phosphite at doses of100 or 200 mg/
kg for 103 weeks.
Synonyms: phosphonic acid, dimethyl ester (9CI);
dimethyl phosphite; dimethyl phosphorus acid; methyl
phosphonate; dimethyl phosphonate; dimethox-
yphosphine oxide; TL 585; DMHP; phosphorous acid,
dimethyl ester; dimethylphosphite; dimethylphospho-
nate; dimethylphosphorous acid; bis(hydroxymethyl)
phosphine oxide
Report Date: November 1985
TR-288 Toxicology and Carcinogenesis
Studies of1,3-Butadiene (CAS No. 106-99-0)
in B6C3F1 Mice (Inhalation Studies)
1,3-Butadieneisusedasanintermediateintheproduc-
tion ofelastomers, polymers, and other chemicals. Ofthe
1,3-butadiene usedin1978,44%wasusedtomanufacture
styrene-butadiene rubber (a substitute for natural rub-
ber, produced by copolymerization of1,3-butadiene with
styrene), and 19% was used to produce polybutane elas-
tomer (a substance that increases resistance of tire
products towear, heat degradation, andblowouts). Chlo-
roprene monomer, derived from 1,3-butadiene, is used
exclusively to manufacture neoprene elastomers for non-
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tire and latex applications. Commercial nitrile rubber,
used largely in rubber hoses, seals, and gaskets for
automobiles, is a copolymer of 1,3-butadiene and
acrylonitrile. Acrylonitrile-butadiene-styrene resins,
usuallycontaining20%-30% 1,3-butadienebyweight, are
usedtomakepartsforautomobiles andappliances. Other
polymer uses include specialty polybutadiene polymers,
thermoplastic elastomers, nitrile barrier resins, and K
resins®. 1,3-Butadiene is used as an intermediate in the
production ofavariety ofindustrial chemicals, including
two fungicides, captan and captofol. Itis approvedbythe
U.S. Food and Drug Administration for use in the pro-
duction of adhesives used in articles for packaging,
transporting, or holding food; in components of paper
and paperboard that are in contactwith dryfood; and as
a modifier in the production of semigrid and rigid vinyl
chlorideplasticfood-contactarticles. Noinformationwas
located on the levels of monomer or on its elution rate
fromanyofthecommerciallyavailablepolymers. Itisnot
known ifunreacted1,3-butadiene migrated frompackag-
ing materials.
Male and female B6C3F1 mice were exposed to air
containing 1,3-butadiene (greater than 99% pure) at con-
centrations of0-8,000 ppm in 15-day and 14-weekinhala-
tion studies. In the 15-day studies, survival was
unaffected by dose, and no pathologic effects were
observed; slight decreases in mean body weight
occurred at the high concentrations. In the 14-week
studies, meanbodyweightgaindecreasedwithdose,and
survivalinthe5,000-ppm and8,000-ppmgroupsofmales
was markedly reduced; no other compound-related
effects were reported.
Inhalation carcinogenesis studies of 1,3-butadiene
were conducted by exposing groups of 50 male and
female B6C3F1 mice 6 hours perdayfor 5 days perweek
to air containing the test chemical at concentrations of0
(chambercontrols),625, or1,250ppm.Thesestudieswere
planned for 103-week exposures but were terminated at
week 60 for male mice and week 61 for female mice
because of the rapidly declining survival, primarily due
to neoplasia. Body weights were not affected by 1,3-
butadiene.
Significantly increased incidences of neoplasms at
multiple sites were observed in mice exposed to 1,3-
butadiene. Hemangiosarcomas of the heart occurred at
increasedincidencesinexposedmalesandfemales(male:
control, 0/50; low dose, 16/49; high dose, 7/49; female:
0/50; 11/48; 18/49). Hemangiosarcomas were also
observed in the peritoneal cavity (one high dose male),
subcutaneous tissue (two low dose females), and liver
(one high dose female).
Malignant lymphomas, diagnosed as early asweek20,
were observed at increased incidences in exposed male
and female mice (male: 0/50; 23/50; 29/50; female: 1150;
10/49; 10/49).
Alveolar/bronchiolar adenomas and alveolar/
bronchiolar (both separately and combined) occurred at
increased incidences in exposed male and female mice
(combined incidences - male: 2/50; 14/49; 15/49; female:
3/49; 12/48; 23/49).
Epithelial hyperplasia ofthe forestomach occurred at
increasedincidencesindosedmice(male: 0/49;5/40; 7/44;
female: 0/49; 5/42; 9/49). Papillomas of the forestomach
occurred in low dose male and in lowdose and high dose
female mice (male: 0/49; 5/40; 0/44; female: 0/49; 4/42;
10/49). Squamous cell carcinomas of the forestomach
were observed in dosed mice (male: 0/49, 2/40, 1/44;
female: 0/49, 1/42, 1/49).
Acinar cell carcinomas of the mammary gland were
observed at an increased incidence in high dose female
mice (0/50; 2/49; 6/49); adenosquamous carcinomaswere
found in four low dose females. The incidences of gran-
ulosa cell tumors of the ovary were increased in dosed
females (0/49; 6/45; 12/48). A granulosa cell carcinoma
was observed in another high dose female. Gliomaswere
observedintwo 68-to69-week-oldlowdoseand onehigh
dose male mice; brain tumors are uncommon even in
2-year old mice.
Liver necrosis occurred at increased incidences in
dosed male and low dose female mice (male; 1/50, 8/49,
8/49; female: 6/50, 15/47, 6/49). Hepatocellular adenomas
orcarcinomas (combined)were observed at anincreased
incidence in high dose female mice (0/50, 2/47 5/49).
Noneoplasticlesionsofthenasalcavitywereobserved
at any dose level. The following nonneoplastic lesions of
the nasal cavity occurred in mice exposed at 1,250 ppm:
chronic inflammation (male, 35/50; female, 2/49); fibrosis
(male, 33/50; female, 2/49); cartilaginous metaplasia
(male, 16/50; female, 1/49); osseous metaplasia (male,
11/50; female, 2/49); and atrophy of the sensory epi-
thelium (male, 32/50). No nonneoplastic lesions of the
nasal cavity were found in the controls. The incidence of
testicular atrophy (0/50,19/49, 11/48) or ovarian atrophy
(2/49, 40/45, 40/48) was increased in exposed male or
female mice.
An audit ofthe experimental data from these studies
on 1,3-butadiene was conducted by the National Toxicol-
ogy Program. No data discrepancies were found that
influenced the final interpretation ofthese experiments.
Underthe conditions ofthese studies, therewas clear
evidence of carcinogenicity for 1,3-butadiene in male
and female B6C3F1 mice, as shown by increased inci-
dences and early induction ofhemangiosarcomas ofthe
heart, malignant lymphomas, alveolar/bronchiolar ade-
nomas and carcinomas, andpapillomas ofthe stomach in
males and females; and of acinar cell carcinomas ofthe
mammarygland, granulosacell tumors ofthe ovary, and
hepatocellular adenomas and adenomas or carcinomas
(combined)infemales.1,3-Butadienewasassociatedwith
nonneoplastic lesions in the respiratory epithelium, liver
necrosis, and testicular or ovarian atrophy.
Synonyms: butadiene; biethylene; bivinyl; divinyl;
erythrene; vinylethylene;pyrrolylene
Report Date: August 1984
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TR-289 Toxicology and Carcinogenesis
Studies ofBenzene (CAS No. 71-43-2) in
F344/N Rats and B6C3F1 Mice (Gavage
Studies)
Benzene ranks 16th in production volume for chemicals
produced in the United States, with approximately 9.9
billion pounds beingproduced in 1984, 9.1billion pounds in
1983, and 7.8billion pounds in 1982. This simplest aromatic
chemical in used in the synthesis of styrene (polystyrene
plastics and synthetic rubber), phenol (phenolic resins),
cyclohexane (nylon), aniline, maleic anhydride (polyester
resins), alkylbenzenes (detergents), chlorobenzenes, and
other products used in the production of drugs, dyes,
insecticides, and plastics. Benzene, alongwith other light,
high-octane aromatic hydrocarbons, such as toluene and
xylenes, is a component ofmotor gasoline. Benzene is also
used as a solvent, but for most applications, it has been
replaced by less hazardous solvents.
During the 17-week studies, groups of 10 or 15 male
andfemale F344/N rats and B6C3F1 micewere gavaged
5 days per week with benzene in corn oil (5 mVkg) at
doses of 0 to 600 mg/kg. No benzene-related deaths
occurred; in rats that received benzene, final mean body
weights were 14%-22% lower compared with vehicle
controls and inmice, slight dose-related reductions were
observed (less than 10% differences). Doses for the
2-year studies were selected based on clinical observa-
tions (tremors in higher dosed mice), on clinical patho-
logic findings (lymphoid depletion in rats and leukopenia
in mice), and on bodyweight effects.
Two-year toxicology and carcinogenesis studies of
benzene (greater than 99.7% pure) were conducted in
groupsof50F344/Nratsand50B6C3F1 miceofeach sex
andforeach dose. Doses of0, 50, 100, or200mg/kgbody
weight benzene in corn oil (5 mVlkg) were administered
by gavage to male rats, 5 days per week, for 103 weeks.
Doses of0, 25, 50, or 100 mg/kgbenzene in corn oilwere
administered by gavage to female rats and to male and
femalemicefor103weeks. Tenadditional animalsineach
ofthe 16 groups were killed at 12 months and necropsies
wereperformed. Hematologicprofileswereperformed at
3-month intervals. These studies were designed and
conductedbecauseoflargeproductionvolumeandpoten-
tial human exposure, because ofthe epidemiologic asso-
ciationwithleukemia, and becauseprevious experiments
wereconsideredinadequate orinconclusive fordetermin-
ing potential carcinogenicity in laboratory animals.
In the 2-year studies, mean body weights of the 200
mg/kgmale rats (-23%) and the 100mg/kgmice (-14% to
-19%) were lower than those ofthe vehicle controls, and
survival ofdosed groups decreasedwithincreasing dose
(rats-male: vehicle control, 32/50; low dose, 29/50; mid
dose, 25/50; high dose, 16/50; female: 46/50; 38/50; 34/50;
25/50; mice-male: 28/50; 23/50; 18/50; 7/50; female:
30/50; 26/50; 24/50; 18/50). Atweek 92 for rats and week
91 formice, survival was greaterthan 60% in all groups;
most ofthe dosed animals that died before week 103 had
neoplasia.
Compound-related nonneoplastic or neoplastic effects
on the hematopoietic system, Zymbal gland, fore-
stomach, and adrenal glandwere foundbothforrats and
mice. Further, the oral cavity was affected in rats, and
the lung, liver, harderian gland, preputial gland, ovary,
and mammaryglandwere affected in mice. Significantly
increased (P<0.05) incidences of neoplasms were
observed at multiple sites for male and female rats and
for male and female mice. Primary neoplasms observed
inratsandmicearesummarizedinTable1(seepage12of
the Technical Report).
Hematologic data from vehicle control and dosed rats
andmicewereobtained at3-monthintervalsfrom0 to 24
months. Reliably identifiable hematologic effects were
limited to lymphocytopenia and associated leuko-
cytopenia in benzene-dosed rats and mice. These effects
were seen from 3 to 18 months in dosed male rats and in
dosed male mice; a similarbutless pronounced response
was observed in dosedfemalerats duringthis same time
period. The effect in female mice was limited to 12-18
months. The technical quality of certain of these data
was questionable; thus, more detailed analyses (e.g.,
investigation ofthe association between hematologic and
pathologic changes) are deemed inappropriate for these
data. Benzeneincreasedthefrequencyofmicronucleated
normchromatic peripheral erythrocytes in male and
female mice (rats were not examined); males were more
sensitive than females.
The hematopoietic system ofrats and mice ofeach sex
was affected by benzene in the 2-year studies. The
incidencesofmalignantlymphomasinalldosedgroupsof
mice were greater than those in the vehicle controls
(male: 4/49; 9/48; 9/50; 15/49; female: 15/49; 24/45; 24/50;
20/49). Lymphoid depletion of the splenic follicles (rats)
and thymus (male rats) was observed at increased inci-
dences. Bone marrow hematopoietic hyperplasia was
observed at increased incidences in dosed mice of each
sex (male: 0/49; 11/48; 10/50; 25/49; female: 3/49; 14/45;
8/50; 13/49).
Theincidences ofZymbalglandcarcinomasinmidand
high dose male rats and in dosed female rats were
greater than those in the vehicle controls (male: 2/32;
6/46; 10/42; 17/42; female: 0/45; 5/40; 5/44; 14/46). The
incidences of Zymbal gland carcinomas in mid and high
dose male mice and in high dose female mice were
greater than those in the vehicle controls (male: 0/43;
1/34;4/40;21/39; female: 0/43;0/32;1/37;3/31). Inmid and
high dose male mice and in high dose female mice, the
incidences ofepithelial hyperplasia ofthe Zymbal gland
were also increased (male: 0/43; 3/34; 12/40; 10/39;
female: 1/43; 1/32; 2/37; 6/31).
Hyperplasia of the adrenal capsule was observed at
increased incidences in dosed mice of each sex (male:
2/47; 32/48; 14/49; 4/46; female: 5/49; 19/44; 34/50; 30/48).
The incidence of pheochromocytomas in mid dose male
mice was greater than thatin the vehicle controls (male:
1/47; 1/48; 7/49; 1/46), whereas the incidences in dosed
female mice were lower than that in the vehicle controls
(female: 6/49; 1/44; 1/50; 1/48). Hyperplasia of the zona
fasciculata of the adrenal cortex was observed at
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increased incidences in low dose rats of each sex (male:
0/50; 13/49; 0/48; 2/49; female: 0/50; 17/50; 0/47; 0/49).
Benzene was associated with increased incidences of
neoplasms of the skin and oral cavity of rats. The inci-
dences of squamous cell papillomas and squamous cell
carcinomas of the skin in high dose male rats were
greater than those in the vehicle controls (squamous cell
papilloma: 0/50; 2/50; 1/50; 5/50; squamous cell car-
cinoma: 0/50; 5/50; 3/50; 8/50). Increased incidences of
uncommon squamous cell papillomas or squamous cell
carcinomas (combined) ofthe oral cavity were observed
in dosed male and female rats (male: 1/50; 9/50; 16/50;
19/50; female: 1/50; 5/50; 12/50; 9/50). Incidences of
squamous cell papillomas or carcinomas (combined)
(male:2/45; 2/42;3/44; 5/38;female: 1142;3/40; 6/45; 5/42),
hyperkeratosis, and epithelial hyperplasia of the fore-
stomach were increased in some dosed groups of male
and female mice; incidences of hyperkeratosis and
acanthosis were increased in high dose male rats.
Compound-related effectsinthelung,harderiangland,
preputial gland, ovary, mammary gland, and liver were
seen in mice but not in rats. Administration of benzene
was associated with increased incidences of alveolar
epithelial hyperplasia in mid and high dose mice (male:
2/49; 3/48; 7/50; 10/49; female: 1/49; 1/42; 9/50; 6/49).
Increased incidences ofalveolar/bronchiolar carcinomas
and alveolar/bronchiolar adenomas or carcinomas (com-
bined) were observed in high dose male mice (car-
cinomas: 5/49; 11/48; 12/50; 14/49; adenomas or
carcinomas: 10/49; 16/48; 19/50; 21/49). Alveolar/
bronchiolar adenomas were seen atincreased incidences
in high dose female mice (4/49; 2/42; 5/50; 9/49), as were
alveolar/bronchiolar carcinomas (0/49; 3/42; 6/50; 6/49)
and alveolar/bronchiolar adenomas or carcinomas com-
bined (4/49; 5/42; 10/50; 13/49) in mid and high dose
female mice.
The incidences of focal or diffuse hyperplasia of the
harderianglandwereincreasedindosedmiceofeach sex
(male: 0/49; 5/46; 11/49; 7/48; female: 6/48; 10/44; 11/50;
10/47). The incidences of harderian gland adenomas
(0/49; 9/46; 13/49; 11/48) in dosed male mice were greater
than that in the vehicle controls. A marginal increase in
the incidence of adenomas or carcinomas (combined) of
the harderian gland was seen in high dose female mice
(5/48; 6/44; 10/50; 10/47).
The administration ofbenzene to male mice was asso-
ciated with increased incidences of hyperplasia (1/21;
18/28; 9/29; 1/35) and squamous cell carcinomas (0/21;
3/28; 18/29; 28/35) of the preputial gland. Increased
incidences ofmammary gland carcinomas were found in
mid dose and high dose female mice (0/49; 2/45; 5/50;
10/49) and carcinosarcomas in high dose female mice
(0/49; 0/45; 1/50; 4/49).
Increased incidences ofvarious uncommon neoplastic
and nonneoplastic lesions of the ovary (papillary
cystadenoma, luteoma,granulosacelltumor,tubularade-
noma, benign mixed tumor, epithelial hyperplasia, and
senile atrophy) were associated with the administration
ofbenzene to female mice. In mid and high dose female
mice, the incidences ofgranulosa cell tumors (1/47; 1/44;
6/49; 7/48) and benign mixed tumors (0/47; 1/44; 12/49;
7/48) were greater than those in the vehicle controls.
Increased incidences ofhepatocellular adenomaswere
observed in low dose female mice (1/49; 8/44; 5/50; 4/49)
and hepatocellular adenomas or carcinomas (combined)
in low dose and mid dose female mice (4/49; 12/44; 13/50;
7/49).
An audit of the experimental data was conducted for
these 2-year carcinogenesis studies on benzene. No data
discrepancies were found that influenced the final inter-
pretations.
Under the conditions of these 2-year gavage studies,
therewas clearevidence ofcarcinogenicity ofbenzene
for male F344/N rats, for female F344/N rats, for male
B6C3F1 mice, and for female B6C3F1 mice. For male
rats, benzene caused increased incidences of Zymbal
gland carcinomas, squamous cell papillomas and
squamous cell carcinomas of the oral cavity, and
squamous cell papillomas and squamous cell carcinomas
of the skin. For female rats, benzene caused increased
incidences of Zymbal gland carcinomas and squamous
cell papillomas and squamous cell carcinomas ofthe oral
cavity. For male mice, benzene caused increased inci-
dences of Zymbal gland squamous cell carcinomas,
malignant lymphomas, alveolar/bronchiolar carcinomas
and alveolar/bronchiolar adenomas or carcinomas (com-
bined), harderian gland adenomas, and squamous cell
carcinomas of the preputial gland. For female mice,
benzene caused increased incidences of malignant lym-
phomas, ovarian granulosa cell tumors, ovarian benign
mixed tumors, carcinomas and carcinosarcomas of the
mammary gland, alveolar/bronchiolar adenomas,
alveolar/bronchiolar carcinomas, and Zymbal gland
squamous cell carcinomas. Dose-related lympho-
cytopeniawas observed formaleandfemaleF344/N rats
and male and female B6C3F1 mice.
Synonyms: benzol, cyclohexatriene, pyrobenzol
Report Date: April 1986
TR-290 Castor Oil (CAS: 8001-79-4)
Studyconsideredinadequate; noTechnical Reportwill
be issued.
TR-291 Toxicology and Carcinogenesis
Studies ofIsophorone (CAS No. 78-59-1) in
F344/N Rats and B6C3F1 Mice (Gavage
Studies)
Toxicology and carcinogenesis studies of isophorone
(greater than 94% pure), a widely used solvent and
chemicalintermediate, were conductedbyadministering
0, 250, or 500 mgisophorone/kg bodyweight per day by
gavage in corn oil to groups of 50 F344/N rats and 50
B6C3F1 mice ofeach sex, 5 days perweekfor 103weeks.
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Doses selected for the 2-year studies were based on the
16-daystudiesinwhichratsandmiceofeachsexreceived
doses of0-2,000mg/kgperdayand on13-week studies in
which rats and mice ofeach sexreceived doses ranging
from 0 to 1,000 mg/kg per day by gavage in corn oil. No
chemically related gross or histopathologic effects were
observed in the 16-day or 13-week studies, but 1/5 high
dose male rats, 4/5 high dose female rats, and all high
dose male and female mice died during the 16-day stud-
ies. During the 13-week studies, 1/10 high dose female
rats and 3/10 high dose female mice died. The high dose
for the 2-year studies was set at 500 mg/kg per day for
each sex ofrats and mice, based mainly on the deaths in
the 13-week studies.
Throughout the 2-year study, the mean body weights
ofthe high dose male rats averaged 5% lowerthan those
ofthevehicle controls. Duringthe second year, the mean
body weights ofthe female high dose rats averaged 8%
lowerthanthoseofthevehiclecontrols,andthehighdose
femalemiceaveraged5%lower.Thesurvivalofhighdose
male ratswas significantlylowerthan that ofthevehicle
controls after week 96 (final survival: vehicle control,
33/50; low dose, 33/50; high dose, 14/50). The survival of
dosed female rats was poor (30/50; 23/50; 20/50), due in
part to 20 gavage-related accidental deaths of dosed
animals. The survival ofmale mice was also low (16/50;
16/50; 19/50), but there was a significant trend toward
increasedsurvival ofdosedfemalemicerelativetothatof
the vehicle controls (26/50; 35/50; 34/50).
Dosed male rats showed a variety of proliferative
lesions ofthe kidney (tubular cell hyperplasia: 0/50; 1/50;
4/50; tubular cell adenoma: 0/50; 0/50; 2/50; tubular cell
adenocarcinoma: 0/50; 3/50; 1/50; epithelial hyperplasia
ofthe renalpelvis: 0/50; 5/50; 5/50). Dosed male rats also
exhibited increased mineralization ofthe medullary col-
lecting ducts (1/50; 31/50; 20/50), and low dose male rats
showed a more severe nephropathy than is commonly
seen in aging F344/N rats. Carcinomas ofthe preputial
gland were increased in high dose male rats (0/50; 5/50;
5/50). With the exception of a moderate increase in
nephropathy (21/50; 39/50; 32/50), female rats did not
showchemicallyrelated increased incidences ofneoplas-
tic or nonneoplastic lesions.
In high dose male mice, isophorone exposure was
associated with increased incidences of hepatocellular
adenomas and carcinomas (18/48; 18/50; 29/50) and of
mesenchymal tumors of the integumentary system
(fibroma, fibrosarcoma, neurofibrosarcoma, or sarcoma:
6/48; 8/50; 14/50). An increased incidence of lymphomas
or leukemias was noted in low dose male mice (8/48;
18/50; 5/50). Coagulative necrosis (3/48; 10/50; 11/50) and
hepatocytomegaly (23/48; 39/50; 37/50) were observed
more frequently in the livers ofdosed male mice than in
vehicle controls. No compound-related neoplastic or non-
neoplastic lesions associated with isophorone exposure
were seen in female mice.
Isophorone was not mutagenic in strains TA100,
TA1535, TA1537, or TA98 ofSalmonella typhimurium
in the presence or absence ofAroclor 1254-induced male
Sprague-Dawley rat or male Syrian hamster liver S9.
Isophorone wasweaklymutagenic in the mouse L5178Y/
TK+/- assayin the absence ofS9; itwas nottested in the
presence of S9. Isophorone induced sister-chromatid
exchanges intheabsenceofS9inChinesehamsterovary
cells; it did not induce sister-chromatid exchanges in the
presence ofAroclor1254-induced maleratliverS9, andit
didnotinduce chromosomal aberrations in Chineseham-
ster ovary cells in the presence or absence of S9.
An audit of the experimental data was conducted for
the 2-year toxicology and carcinogenesis studies of iso-
phorone. No data discrepancies were found that influ-
enced the final interpretations.
Under the conditions of these 2-year gavage studies,
there was soae evidence of carcinogenicity of iso-
phoroneinmale F344/N rats as shownbythe occurrence
of renal tubular cell adenomas and adenocarcinomas in
animals given 250 or 500 mg/kg per day; carcinomas of
the preputial gland were also observed at increased
incidence in male rats given 500 mg/kg. There was no
evidence of carcinogenicity in female F344/N rats
given 250 or 500 mg/kg per day. Formale B6C3F1 mice,
there was equivocal evidence of carcinogenicity of
isophorone as shown by an increased incidence of
hepatocellular adenomas or carcinomas (combined) and
ofmesenchymal tumors in the integumentary system in
animals given 500 mg/kg per day and by an increase in
malignant lymphomas in animals given 250 mg/kg per
day. There was no evidence ofcarcinogenicity of iso-
phorone in female B6C3F1 mice given 250 or 500 mg/kg
per day.
Synonym: 3,5,5-trimethyl-2-cyclohexen-1-one
Report Date: January 1986
TR-292 Tlrichlorfon (CAS: 52-68-6)
Studyconsideredinadequate; noTechnical Reportwill
be issued.
TR-293 Toxicology and Carcinogenesis
Studies ofHC Blue No. 2 [2,2'-((4-((2-
Hydroxyethyl)amino)-3-nitrophenyl)
imino)bis(ethanol)] (CAS No. 33229-34-4)
in F344/N Rats and B6C3F1 Mice (Feed
Studies)
Toxicology and carcinogenesis studies ofHC Blue No.
2 (approximately 98% pure), a semipermanent hair dye,
were conducted by administering the test chemical in
feedfor103weekstogroupsof50F344/N ratsofeach sex
and for 104 weeks to groups of 50 B6C3F1 mice ofeach
sex. The dietary concentrations used were 0, 5,000, or
10,000 ppm formale rats and male mice and 0, 10,000, or
20,000 ppm for female rats and female mice. These
concentrations were selected onthe basis ofresults from